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ABSTRACT	
Mitochondria	 derive	 from	 the	 capture	 of	 an	 ancestral	 α-proteobacteria	 within	 an	
archaeal	 cell	 about	 2	 billion	 years	 ago.	 Since	 then	 mitochondria	 have	 retained	 a	
small	 proportion	 of	 genes	 within	 their	 multi-copy	 genome	 mitochondrial	 DNA	
(mtDNA)	 that	 encode	proteins	 essential	 to	 the	 oxidative	 phosphorylation	 system.	
They	 have	 also	 evolved	 into	 a	 major	 metabolic	 hub	 in	 eukaryotic	 cells.	 Many	
biosynthetic	 pathways	 require	 mitochondria	 such	 as	 the	 synthesis	 of	 iron-sulfur	
clusters,	heme,	lipids	and	coenzyme	Q.	However,	mitochondria	are	best	known	for	
their	efficient	ATP	production	through	aerobic	metabolism.	
	 The	 mitochondrial	 network	 is	 a	 dynamic	 structure.	 Through	 coordinated	
actions	 of	 membrane	 fusion	 and	 fission,	 mitochondria	 are	 able	 to	 remodel	 their	
shapes	and	sizes,	but	also	their	distribution	within	the	cell.	Mitochondrial	dynamics	
is	an	essential	process	that	impacts	mammalian	physiology	in	many	different	ways.	
One	of	the	clearest	examples	is	the	relationship	between	mitochondrial	fusion	and	
mtDNA	 maintenance.	 In	 animal	 studies,	 the	 absence	 of	 mitochondrial	 fusion	
proteins	 resulted	 in	 severe	 reduction	 in	 mtDNA	 copy	 number.	 Moreover,	 loss	 of	
mitochondrial	 fusion	 proteins,	mitofusins,	was	 also	 associated	with	 an	 increase	 in	
mtDNA	 point	 mutations	 and	 deletions.	 However,	 the	 molecular	 basis	 of	 these	
findings	is	poorly	understood.		
	 The	 research	 presented	 in	 this	 thesis	 aims	 to	 address	 the	 underlying	 link	
between	 mitochondrial	 fusion	 and	 mtDNA	 maintenance.	 We	 report	 that	
inactivation	of	mitofusin	1	and	2	leads	to	mtDNA	depletion	and	nucleoid	clustering	
in	mouse	embryonic	fibroblasts	and	heart	tissue.	With	super-resolution	microscopy	
and	fluorescent	in	situ	hybridization,	we	show	that	clustered	nucleoids	have	normal	
diameters	and	are	transcribed.	We	report	that	the	loss	of	mtDNA	accounts	for	the	
reduction	in	transcription	and	bioenergetic	defects.	Moreover,	we	demonstrate	that	
the	profound	mtDNA	depletion	is	not	explained	by	genome	instability,	but	instead	it	
is	caused	by	altered	stoichiometry	of	protein	components	of	the	mtDNA	replisome.	
Lastly,	we	show	that	outer	membrane	 fusion	 is	necessary	 to	sustain	 rapid	mtDNA	
replication	 in	 MEFs	 recovering	 from	 mtDNA	 depletion	 and	 in	 the	 mouse	 heart	
during	postnatal	development.	We	 thus	 report	an	unexpected	 link	between	OMM	
fusion	and	replication	and	distribution	of	mtDNA	in	mammalian	cells.	 	
	 	 	 	
ZUSAMMENFASSUNG	
Mitochondrien	entstanden	vor	etwa	2	Milliarden	Jahren	aus	der	endosymbiotischen	
Aufnahme	eines	α-Proteobakteriums	in	ein	Archaeon.	Die	Evolution	führte	zu	einer	
starken	Reduktion	von	genetischer	 Information	im	mitochondrialen	Erbgut.	Dieses	
mitochondriale	 Multi-Kopien-Genom,	 die	 sogenannte	 mtDNA,	 kodiert	
ausschließlich	 für	 RNAs	 und	 Proteine,	 welche	 essentiell	 für	 die	 oxidative	
Phosphorylierung	sind.	Ferner	haben	sich	Mitochondrien	während	der	Evolution	zu	
einem	wichtigen	metabolischen	 Zentrum	 in	 eukaryotischen	 Zellen	 entwickelt.	 So	
sind	 Mitochondrien	 unter	 anderem	 an	 der	 Biosynthese	 von	 Eisen-Schwefel-
Clustern,	 Häm-,	 Lipid-	 und	 Coenzym-Q	 Molekülen	 beteiligt.	 Mitochondrien	 sind	
jedoch	 am	 bekanntesten	 für	 ihre	 Effizienz	 bei	 der	 ATP-Produktion	 durch	 den	
aeroben	Stoffwechsel.		
	 In	Zellen	 formen	Mitochondrien	ein	dynamisches	Netzwerk,	welches	durch	
die	 koordinierte	 Fusion	 und	 –Spaltung	 von	Membranen	 die	mitochondriale	 Form,	
Größe	 und	 Verteilung	 innerhalb	 der	 Zelle	 beeinflusst.	 Diese	 mannigfaltigen	
Prozesse	 werden	 unter	 dem	 Begriff	 der	 mitochondrialen	 Dynamik	
zusammengefasst	 und	 haben	 entscheidenden	 Einfluss	 die	 Physiologie	 der	 Zelle.	
Diesbezüglich	 konnten	 experimentelle	 Tierstudien	 zeigen,	 dass	 das	 Fehlen	 von	
mitochondrialen	Fusionsproteinen	die	Gesamtmenge	an	mtDNA	und	die	Anzahl	von	
mtDNA-Molekülen	reduziert.	Darüber	hinaus	berichtet	eine	Studie,	dass	der	Verlust	
von	 Mitofusinen	 mit	 einer	 Steigerung	 von	 mtDNA-Punktmutationen	 und	 -
Deletionen	einhergeht.	Die	molekulare	Grundlage	dieser	Beobachtungen	ist	jedoch	
kaum	verstanden.	
	 Das	 Ziel	 dieser	 Dissertation	 ist	 es,	 die	 exakten	molekularen	Mechanismen	
zwischen	mitochondrialer	Fusion	und	mtDNA-Integrität	zu	untersuchen.	Wir	zeigen,	
dass	 die	 Inaktivierung	 von	 Mitofusin	 1	 und	 2	 in	 embryonalen	 Mausfibroblasten	
(MEF)	und	in	konditionalen	Maus-Knock-outs	zu	einer	Reduktion	und	Clusterbildung	
der	mtDNA	führt.	Mit	Hilfe	von	Super-Resolution-Mikroskopie	und	Fluoreszenz-in-
situ-Hybridisierung	 können	 wir	 nachweisen,	 dass	 geclusterte	 Nukleoide	
interessanterweise	 eine	 normale	 Morphologie	 haben	 und	 transkribiert	 werden.	
Ferner	 können	 wir	 durch	 biochemische	 Experimente	 demonstrieren,	 dass	 die	
mtDNA	Reduktion	die	Gesamttranskription	 verringert	und	 so	 zu	bioenergetischen	
	 	 	 	
Defekten	beiträgt.	Außerdem,	zeigen	unsere	Experimente,	dass	die	starke	mtDNA	
Reduktion	 nicht	 durch	 Genom-Instabilität	 ausgelöst	 wird,	 sondern	 durch	 eine	
gestörte	 Stöchiometrie	 der	 Proteinkomponenten	 der	 mtDNA	 Replikations-
maschinerie.	Des	Weiteren	können	wir	experimentell	beweisen,	dass	die	Fusion	der	
äußeren	 mitochondrialen	 Membran	 notwendig	 ist,	 um	 eine	 schnelle	 mtDNA-
Replikation	 in	 MEFs	 zu	 gewährleisten.	 Letzteres	 erklärt	 somit	 auch	 die	 wichtige	
Bedeutung	 der	 mitochondrialen	 Fusion	 für	 die	 postnatale	 Entwicklung	 des	
Mausherzens.	Zusammenfassend	berichten	wir	über	eine	unerwartete	Verbindung	
zwischen	 der	 Fusion	 der	 äußeren	 mitochondrialen	 Membran	 und	 der	 mtDNA	
Replikation	und	Verteilung	in	Säugetierzellen.	
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1.0	INTRODUCTION		
	
1.1	Mitochondrial	origin		 	
Present	 day	mammalian	mitochondria	 have	 bacterial	 ancestry	 (Gray	 et	 al.,	 1999).	
The	endosymbiosis	 theory	postulates	 that	mitochondria	evolved	 from	the	capture	
of	an	ancestral	α-proteobacterium	within	an	archaeal	cell.	This	acquisition	occurred	
about	2	billion	years	ago	and	since	then	an	evolving	symbiotic	relationship	between	
the	archaeal	cell	and	ancestral	bacterium	has	given	rise	to	the	mitochondria	found	
today	 in	 mammals	 (Kurland	 and	 Andersson,	 2000).	 Endosymbiosis	 likely	 lead	 to	
mutual	 benefits	 to	 both	 host	 and	 captive	 with	 regards	 to	 the	 exchange	 of	 lipids,	
iron,	and	aerobic	respiration,	and	lead	to	the	development	of	new	biology	and	the	
evolution	of	eukaryotes	(McBride,	2018).	This	relationship	was	further	solidified	by	
the	 early,	maybe	 rapid,	 loss	or	 integration	of	 parts	 of	 the	 ancestral	mitochondrial	
genetic	material	into	the	host	DNA	(Keeling	and	Palmer,	2008;	Gray,	2015).		
	
1.2	Mitochondrial	structure	and	functions		
Mitochondria	have	a	distinct	architecture	that	facilitates	the	wide	variety	of	cellular	
functions	 (Neupert,	 2012).	A	mitochondrion	 contains	 two	 lipid	membranes,	which	
compartmentalizes	 the	 mitochondrion	 into	 four	 subcompartments.	 The	 outer	
mitochondrial	membrane	(OMM)	acts	as	a	barrier	to	the	cytosol	and	delineates	the	
aqueous	 intermembrane	space	 (IMS)	where	specialized	 redox	 reactions	 take	place	
(Herrmann	and	Köhl,	2007;	Hu	et	al.,	2008).	The	second	lipid	membrane,	the	inner	
mitochondria	membrane	 (IMM),	 forms	 a	 boundary	 with	 the	 IMS	 allowing	 for	 the	
generation	 of	 a	 membrane	 potential	 important	 for	 respiratory	 chain	 activity	 and	
import/export	 of	 ions	 between	 compartments	 (Zorova	 et	 al.,	 2018).	 Additionally,	
IMM	invaginations	form	cristae	that	not	only	 increase	the	surface	area	of	 IMM	but	
are	 important	 structures	 housing	 the	 respiratory	 chain	 (Gilkerson	 et	 al.,	 2003).	
Lastly,	 the	 innermost	 compartment	 is	 the	mitochondrial	 matrix	 where	 numerous	
metabolic	 pathways	 converge	 (Spinelli	 and	 Haigis,	 2018)	 and	 where	 the	
mitochondrial	genome	resides	(Figure	1.1,	Kukat	et	al.,	2015).		
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	 The	 contribution	 of	 mitochondria	 to	 cell	 metabolism	 is	 multifaceted.	
Mitochondria	are	best	known	for	their	role	in	ATP	production	by	using	pyruvate	and	
fatty	 acids	 as	 fuel	 sources	 (Nicholls	 and	 Ferguson,	 2013a).	 They	 can	 also	 initiate	
gluconeogenesis	by	carboxylation	pyruvate	into	oxaloacetate	followed	by	export	to	
the	cytosol	where	 it	can	be	converted	 into	glucose	(Berg	et	al.,	2002).	Many	other	
biosynthetic	 pathways	 require	 mitochondria,	 such	 as	 the	 synthesis	 of	 iron-sulfur	
clusters,	 heme,	 phospholipids,	 cholesterol,	 fatty	 acids,	 coenzyme	Q,	 amino	 acids,	
and	nucleotides	(Spinelli	and	Haigis,	2018).	These	diverse	biosynthetic	pathways	are	
intimately	 connected,	 sharing	 the	 TCA	 or	 amino	 acid	 intermediates	 as	 well	 as	
anabolic	 and	 catabolic	 reactions	 (Spinelli	 and	 Haigis,	 2018).	 Lastly,	 mitochondria	
also	 facilitate	 broader	 cellular	 functions	 like	 thermoregulation	 and	 apoptosis	
(Cannon	and	Nedergaard,	2008;	Wang	and	Youle,	2009).		
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1.3	Oxidative	phosphorylation	system	 	
Mitochondrial	are	energy	powerhouses	that	supply	the	cell	with	ATP.	The	oxidative	
phosphorylation	system	(OXPHOS)	 is	at	 the	core	of	ATP	production.	The	proteins	
involved	 in	 OXPHOS	 have	 dual	 genetic	 origins	 (Gustafsson	 et	 al.,	 2016).	 The	
majority	of	 the	OXPHOS	subunits	 (76	proteins)	are	nuclear-encoded,	 translated	 in	
the	 cytosol	 and	 imported	 into	mitochondria,	 while	 13	 additional	 components	 are	
encoded	 by	 the	 multi-copy	 mitochondrial	 genome	 (Larsson,	 2010).	 There	 is	 no	
definitive	 explanation	 for	 this	 dual	 genetic	 origin;	 however,	 three	 theories	 have	
been	 proposed.	 One	 theory	 refers	 to	 differences	 in	 the	 decoding	 system	 for	
mitochondrial	 and	 nuclear	 DNA.	 In	 contrast	 to	 the	 universal	 genetic	 code,	
mitochondria	uses	four	different	nucleotide	triplets	and	different	modified	bases	at	
the	 wobble	 position	 (Suzuki	 et	 al.,	 2011).	 A	 second	 theory	 postulates	 that	
mitochondrially	 encoded	 proteins	 are	 too	 hydrophobic	 to	 be	 transported	 through	
the	 cytosol	 and	 imported	 into	 mitochondria	 (Björkholm	 et	 al.,	 2015).	 This	
hypothesis	 is	 in	 line	with	 the	 fact	 that	mitochondrial	 proteins	 are	 rapidly	 inserted	
into	the	IMM	upon	their	translation	(Mai	et	al.,	2017).	The	third	theory	proposes	that	
having	 additional	 genetic	 source	 in	 mitochondria	 would	 grant	 mitochondria	 the	
advantage	 to	 locally	 modulate	 assembly	 and	 quantity	 of	 respiratory	 chain	
complexes	by	redox	regulation	of	gene	expression	(Maier	et	al.,	2013;	Allen,	2015).		
	 The	oxidative	phosphorylation	 system	 is	 composed	of	 five	 complexes	with	
specialized	 functions	 embedded	 in	 the	 IMM	 (Figure	 1.2),	 these	 include:	 the	
NADH:ubiquinone	reductase	(Complex	I,	COI),	the	succinate	dehydrogenase	(COII),	
the	 quinol-cytochrome	 c	 reductase	 (COIII),	 the	 cytochrome	 c	 oxidase	 (COIV),	 and	
the	FoF1-ATP	synthase	(COV)	(Signes	and	Fernandez-Vizarra,	2018).	
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	 The	production	of	ATP	begins	with	 the	 formation	of	 the	 reducing	electron	
carriers	NADH	and	FADH2	through	catabolism	of	pyruvate	or	fatty	acids	in	the	TCA	
cycle	 or	 beta-oxidation	 (Spinelli	 and	 Haigis,	 2018).	 These	 carriers	 then	 deliver	
electrons	 to	 COI	 and	 COII	 (by	 using	 NADH	 and	 FADH2,	 respectively),	 which	 are	
channeled	within	 the	 complexes	 to	 their	 respective	CoQ	binding	 site.	 CoQ	enters	
the	 binding	 site,	 undergoes	 two	 one-electron	 reductions	 steps,	 and	 then	 acts	 a	
mobile	 electron	 carrier	 to	 deliver	 electrons	 to	 COIII	 (Wang	 and	 Hekimi,	 2016).	
Through	 the	Q-cycle	mechanism,	COIII	 accepts	 the	electrons	 from	CoQ	which	are	
then	used	to	reduce	the	electron	carrier	cytochrome	c	(cyt	c)	(Trumpower,	1990).	At	
this	 stage,	 COIV	 orchestrates	 the	 oxidation	 cyt	 c	 followed	 by	 the	 reduction	 of	
oxygen	 into	 water	 (Wikström	 et	 al.,	 2018).	 This	 series	 of	 reactions	 taking	 place	
between	COI	through	COIV	is	referred	to	as	the	electron	transport	chain	(ETC).	An	
additional	feature	of	ETC	is	the	coupling	of	electron	transfer	to	the	translocation	of	
protons	at	COI,	COII,	and	COIV.	An	increasing	concentration	of	protons	in	the	IMS	
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generates	 a	 proton	 motive	 force	 (Nicholls	 and	 Ferguson,	 2013b).	 The	 prevailing	
model	 of	 how	 COV	 synthesizes	 ATP	 is	 through	 a	 binding-change	 mechanism	
(Boyer,	1975).	 In	 this	model,	COV	uses	 the	proton	motive	 force	 to	 translocate	one	
proton	 at	 a	 time	 from	 the	 IMS	 into	 the	 matrix.	 Proton	 translocation	 causes	
mechanical	rotation	of	the	COV-Fo	subunit	followed	by	conformation	changes	in	the	
COV-F1	 subunits	 (Boyer,	 1993;	 Abrahams	 et	 al.,	 1994;	 Wang	 and	 Oster,	 1998;	
Cherepanov	 et	 al.,	 1999).	 The	 COV-F1	 conformational	 changes	 (open,	 tight,	 and	
loose)	 are	 coupled	 to	 proton	 translocation,	 and	 allow	 for	 ADP+Pi	 binding,	 ATP	
synthesis,	 and	 ATP	 release	 (S#trajbl	 et	 al.,	 2003).	 Hence,	 the	 production	 of	 ATP	
depends	on	the	coupling	of	redox	reactions	and	proton	translocation	to	accomplish	
oxidative	phosphorylation	(Mitchell,	1961).		
	
1.4	Mitochondrial	DNA	composition		
A	small	proportion	of	genes	were	retained	during	the	reductive	evolutionary	course	
of	 the	 present-day	 mammalian	 mtDNA	 (Falkenberg	 et	 al.,	 2007).	 Mammalian	
mtDNA,	 like	 its	 bacterial	 ancestors,	 is	 protein-coated	 and	packaged	 (Fisher	 et	 al.,	
1992).	The	main	protein	 in	mammals	that	can	achieve	packaging	of	mtDNA	is	 the	
mammalian	 transcription	 factor	 activator	 A	 (TFAM)	 (Kaufman	 et	 al.,	 2007).	
Approximately	 1000	 TFAM	 molecules	 bind	 randomly	 to	 mtDNA	 and	 the	
combination	 of	 cooperative	 and	 cross-strand	 binding	 results	 in	 complete	
compaction	 of	 mtDNA	 to	 form	 a	 nucleoid	 (Kukat	 et	 al.,	 2015).	 A	 mammalian	
nucleoid	has	a	diameter	of	about	100	nm	and	has	an	ellipsoidal	shape	 	 (Figure	1.1)	
(Brown	et	al.,	2011;	Kukat	et	al.,	2011).		
	 Mouse	mtDNA	is	a	circular	double-stranded	molecule	roughly	16.3	kilobases	
in	length	(Bibb	et	al.,	1981).	The	two	DNA	strands	are	denoted	as	heavy-strand	(H-
strand,	 higher	 guanine	 content)	 and	 light-strand	 (L-strand)	 based	 on	 their	
separation	in	alkaline	cesium	chloride	density	gradients	(Berk	and	Clayton,	1974).		
	 The	mitochondrial	genome	has	coding	and	non-coding	regions	(Figure	1.3).	
The	majority	of	mtDNA	is	coding.	In	mammalian	mtDNA	there	are	37	genes;	most	
found	on	the	H-strand	(coding	for	12	proteins,	14	tRNAs,	and	2	rRNAs),	making	the	
L-strand	 the	minor	 coding	 strand	 (coding	 for	 1	 protein	 and	 8	 tRNAs)	 (Bibb	 et	 al.,	
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1981).	 The	 main	 non-coding	 region	 of	 mtDNA	 is	 small	 and	 contains	 several	
regulatory	elements	for	mtDNA	transcription	and	replication.		
	 Secondary	 structures	 can	 also	 form	 in	 mtDNA.	 As	 a	 consequence	 of	
terminated	mtDNA	replication	at	the	control	region,	a	500-620-nucleotide	fragment	
(7S	 DNA)	 remains	 bound	 to	 the	 L-strand	 while	 the	 H-strand	 is	 displaced;	 thus,	
leading	to	the	formation	of	a	displacement	 loop	(D-loop)	(Robberson	and	Clayton,	
1972;	Berk	and	Clayton,	1974;	Bogenhagen	and	Clayton,	1978).	Moreover,	RNA:DNA	
hybrids	 (R-loops)	 can	 form	 close	 to	 the	 control	 region	 during	 transcription	 of	
mtDNA	(Wanrooij	et	al.,	2012;	Akman	et	al.,	2016).		
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1.5	Mitochondrial	DNA	transcription		
Expression	of	the	mitochondrial	genome	is	essential	for	the	assembly	and	activity	of	
the	 respiratory	 chain	 (Larsson	 et	 al.,	 1998;	 Kühl	 et	 al.,	 2016).	 Transcription	 of	
mtDNA	 is	achieved	by	 the	mitochondrial	RNA	polymerase	 (POLRMT)	 (Kühl	et	al.,	
2014).	 POLRMT	 is	 a	 single-unit	 polymerase	 that	 is	 distantly	 related	 to	 the	
bacteriophage	T7	RNA	polymerase	(Ringel	et	al.,	2011).		However,	unlike	the	T7	RNA	
polymerase,	 POLRMT	 is	 incapable	 of	 initiating	 or	 performing	 elongation	 of	
transcription	 alone.	 POLRMT	 requires	 the	 following	 auxiliary	 proteins:	 TFAM,	 the	
mitochondrial	transcription	factor	B2	(TFB2M),	and	the	mitochondrial	transcription	
elongation	factor	(TEFM)	(Gustafsson	et	al.,	2016).		
	 The	 regulatory	 elements	 for	mitochondrial	 transcription	 are	 located	 in	 the	
non-coding	 region	 (NCR)	 of	 mtDNA.	 These	 elements	 are	 the	 L-strand	 promoter	
(LSP)	 and	 H-strand	 promoter	 (HSP)	 and	 from	 here	mitochondrial	 transcription	 is	
initiated	(Falkenberg	et	al.,	2007).	The	current	model	of	initiation	states	that	DNA-
bound	 TFAM	 recruits	 POLRMT	 via	 its	 N-terminus	 to	 the	 promoter,	 leading	 to	 a	
structural	change	in	POLRMT	(Figure	1.4).	The	structural	change	in	POLRMT	allows	
for	binding	of	TFB2M	to	POLRMT	forming	a	fully	assembled	initiation	complex	and	
leads	 to	 promoter	 melting	 (Hillen	 et	 al.,	 2017;	 Posse	 and	 Gustafsson,	 2017;	
Ramachandran	et	al.,	2017).	After	 initiation	PORLMT	enters	 the	elongation	phase,	
whereby	 TEFM	binding	 to	 POLRMT	promotes	 transcription	 processivity	 (Posse	 et	
al.,	2015).	MTERF1	was	previously	proposed	to	act	as	a	termination	factor	for	sense	
rRNA	gene	transcription,	but	knockout	mouse	models	have	shown	that	its	function	
instead	is	to	terminate	antisense	transcription	(Martin	et	al.,	2005;	Terzioglu	et	al.,	
2013).		
	 The	product	of	mitochondrial	transcription	is	a	single	primary	near	genome-
length	transcript	containing	no	introns	(Gustafsson	et	al.,	2016).	This	long	transcript	
is	cleaved	to	release	2	rRNAs,	22	tRNAs,	and	11	mRNAs	(Anderson	et	al.,	1981;	Ojala	
et	al.,	1981).	Two	of	the	mRNAs	are	bicistronic	and	encode	two	proteins	each	(ATP8	
&	ATP6;	ND4L	&	ND4).	The	nascent	transcripts	are	stabilized	by	the	LRPPRC-SLIRP	
protein	complex	and	translated	by	the	mitochondrial	 ribosome	(Ruzzenente	et	al.,	
2012;	Lagouge	et	al.,	2015).	Translated	proteins	are	then	inserted	into	the	IMM	and	
assembled	into	respiratory	complexes	(Szyrach	et	al.,	2003).		
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1.6	Mitochondrial	DNA	replication	
Maintaining	 or	 increasing	mtDNA	 levels	 in	 early	 development	 and	 in	 post-mitotic	
tissues	requires	replication	of	mtDNA.	While	most	studies	find	replication	of	mtDNA	
independent	of	 nuclear	DNA	 replication,	 there	 are	 contrasting	 reports	whether	or	
not	 its	 coordinated	with	 cell	 division	 (Bogenhagen	 and	 Clayton,	 1977;	 Chatre	 and	
Ricchetti,	2013).	Continuous	replication	of	mtDNA	ensures	that	sufficient	numbers	
of	 copies	 are	 present	 to	 meet	 the	 energetic	 demands	 of	 the	 cell.	 In	 contrast,	
dysfunctional	 mtDNA	 replication	 results	 in	 mtDNA	 depletion	 and	 can	 also	 cause	
deletion	 of	 mitochondrial	 genomic	 regions	 or	 accumulation	 of	 point	 mutations	
(Viscomi	and	Zeviani,	2017).		
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	 The	 core	 mtDNA	 replication	 machinery	 (the	 replisome,	 Figure	 1.5)	 is	
composed	 of:	mitochondrial	 RNA	 polymerase	 (POLRMT),	 the	mitochondrial	 DNA	
helicase	 twinkle	 (TWNK),	 the	 mitochondrial	 DNA	 polymerase	 γ	 (Polγ),	 and	 the	
single-stranded	 DNA	 binding	 protein	 1	 (SSBP1)	 (Gustafsson	 et	 al.,	 2016).	 Loss	 of	
POLRMT,	 Polγ,	 and	 TWNK	 are	 embryonic	 lethal	 in	 mice	 (Hance	 et	 al.,	 2005;	
Milenkovic	 et	 al.,	 2013;	 Kühl	 et	 al.,	 2016).	Other	 proteins	 are	 also	 involved	 in	 this	
process,	 such	 as	 the	mitochondrial	 genome	maintenance	 exonuclease	 1	 (MGME1)	
that	 processes	 the	 5’	 mtDNA	 ends	 generated	 during	 replication,	 and	 the	
ribonuclease	H1	(RNASEH1)	that	removes	the	RNA	primer	used	to	 initiate	mtDNA	
replication	(Cerritelli	et	al.,	2003;	Uhler	et	al.,	2016).		
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	 Polγ	is	the	sole	mitochondrial	DNA	polymerase	that	can	synthesize	mtDNA.	
Other	DNA	polymerases	present	are	suggested	to	be	present	in	mitochondria,	e.g.	
PrimPol,	Polβ,	Polθ,	Polζ,	but	they	cannot	substitute	for	 loss	of	Polγ	(Hance	et	al.,	
2005;	 Humble	 et	 al.,	 2013).	 The	 mammalian	 Polγ	 is	 present	 as	 a	 heterotrimeric	
complex	consisting	of	one	A-subunit	and	two	B-subunits	(Carrodeguas	et	al.,	2002).	
PolγA	 is	 the	 catalytic	 subunit	 with	 3’	 to	 5’	 exonuclease	 activity	 and	 proofreading	
capabilities	 (Trifunovic	et	al.,	2004;	Macao	et	al.,	2015).	The	PolγB	dimer	serves	to	
enhance	 the	 catalytic	 activity	 of	 PolγA	 while	 also	 promoting	 processivity	
(Carrodeguas	et	al.,	2002;	Farge	et	al.,	2007).		
	 The	DNA	helicase	TWNK	 is	present	 as	 a	hexamer	 (Fernández-Millán	et	 al.,	
2015).	Studies	suggest	TWNK	may	be	anchored	to	the	IMM	and	may	even	serve	as	a	
platform	for	mtDNA	replication	(Rajala	et	al.,	2014;	Gerhold	et	al.,	2015a).	The	main	
function	of	TWNK	 is	 to	unwind	dsDNA	at	 the	 replication	 fork	because	POLRMT	 is	
unable	 to	 interact	 with	 dsDNA	 (Spelbrink	 et	 al.,	 2001;	 Wanrooij	 and	 Falkenberg,	
2010).		
	 The	mitochondrial	SSBP1	is	present	as	multiple	tetramer	on	single-stranded	
mtDNA	(Yang	et	al.,	1997).	The	main	role	of	SSBP1	is	to	stabilized	the	long	stretches	
of	 single-stranded	mtDNA	 and	 to	 prevent	 the	 formation	 of	 secondary	 structures	
(Tiranti	 et	 al.,	 1993).	 SSBP1	 can	 influence	 mtDNA	 replication	 in	 two	 ways,	 by	
stimulating	 the	 helicase	 activity	 of	 TWNK	 and	 by	 increasing	 the	 processivity	 of	
PolγA	(Farr	et	al.,	1999;	Korhonen	et	al.,	2003a).		
	 The	 prevailing	 model	 for	 mtDNA	 replication	 is	 the	 strand	 displacement	
model	whereby	initiation	of	mtDNA	replication	begins	within	the	non-coding	region	
(Brown	et	al.,	2005).	The	regulatory	elements	for	mitochondrial	DNA	replication	are	
found	on	different	regions	in	the	mitochondrial	genome.	The	NCR	holds	the	origin	
of	H-strand	(OH),	while	origin	of	L-strand	(OL)	can	be	found	in	the	middle	of	the	W-
A-N-C-Y	tRNA	cluster.	Initiation	requires	an	RNA	primer	synthesized	by	POLRMT	at	
the	 LSP.	 PolγA	 utilizes	 the	 3’	 end	 of	 this	 primer	 to	 initiate	 replication	 at	 the	OH.	
About	 95	%	 of	 the	 initiation	 events	 are	 terminated	 prematurely	 and	 it	 is	 unclear	
what	 regulates	 this	 termination	 event	 (Doda	 et	 al.,	 1981).	 The	 TWNK	 helicase	 is	
loaded	 on	 the	 lagging	 strand	 of	DNA	 to	 unwind	 the	DNA	duplex	 and	 the	 lagging	
strand,	which	will	be	replicated	later,	is	coated	with	SSBP1	(Korhonen	et	al.,	2003b).	
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After	the	replisome	passes	the	OL,	a	stem-loop	structure	is	created	on	the	nascent	
H-strand	and	POLRMT	uses	 this	 stem-loop	 to	 initiate	synthesis	of	a	25-nucleotide	
primer.	PolγA	utilizes	the	RNA	primer	and	proceeds	with	synthesis	of	the	L-strand	
(Figure	 1.5).	 The	 replication	 cycles	 ends	 with	 two	 complete	molecules	 of	 double-
stranded	mtDNA	(Falkenberg,	2018).		
	 	As	 mentioned,	 the	 replisome	 factors	 influence	 each	 other’s	 activity.	 For	
example,	SSBP1	is	important	for	TWNK	helicase	activity	and	both	PolγB	and	SSBP1	
enhance	PolγA	processivity	 (Farr	et	al.,	 1999;	Korhonen	et	al.,	2003a;	Farge	et	al.,	
2007).	 In	 an	 in	 vitro	 system,	 no	 DNA	 synthesis	 can	 take	 place	 in	 the	 absence	 of	
TWNK,	regardless	of	the	presence	of	Polγ	and	SSBP1	(Farge	et	al.,	2008).	Moreover,	
low	levels	of	Polγ	were	shown	to	lead	to	uncoupling	of	the	L-strand	synthesis	(Roos	
et	al.,	2013).		In	mice,	conditional	knockouts	of	TWNK	leads	to	a	reduction	in	mtDNA	
copy	number	by	80	%	(Milenkovic	et	al.,	2013;	 Ignatenko	et	al.,	2018).	 In	contrast,	
overexpression	 of	 TWNK	 in	 mice	 can	 increase	 mtDNA	 levels	 (Tyynismaa	 et	 al.,	
2004).	Yet,	overexpression	of	PolγB	in	cell	lines	does	not	change	mtDNA	levels	and	
in	Drosophila	overexpression	caused	mtDNA	depletion	(Lefai	et	al.,	2000;	Spelbrink	
et	 al.,	 2000).	 Altogether,	 it	 is	 evident	 that	 proper	 stoichiometry	 of	 the	 replisome	
factors	is	important	for	maintenance	of	mtDNA.		
	
1.7	Mitochondrial	DNA	point	mutations	
The	 mitochondrial	 genome	 can	 contain	 point	 mutations.	 Mutations	 can	 be	
generated	 de	 novo	 or	 can	 be	 maternally	 inherited.	 A	 mouse	 model	 expressing	 a	
proofreading	defective	 version	of	PolγA	 (mtDNA	mutator	mouse)	 showed	 that	de	
novo	mutations	are	generated	during	errors	in	mtDNA	replication	and	high	levels	of	
mutations	can	cause	premature	aging	(Trifunovic	et	al.,	2004).	It	was	proposed	that	
oxidative	 damage	 could	 also	 generate	 mutations.	 Recent	 studies	 in	 mice	 having	
deficiencies	 in	mtDNA	repair	and	 increased	oxidative	stress	 revealed	no	change	 in	
the	mtDNA	point	mutation	load	(Kauppila	et	al.,	2018).	Notably,	aged	wildtype	mice	
display	no	increase	in	mutations	compared	to	younger	mice	(Ameur	et	al.,	2011).				
	 Mitochondria	 are	 maternally	 inherited,	 as	 is	 their	 genetic	 material.	 Two	
mechanisms	are	 in	place	during	early	embryogenesis	 that	helps	preserve	wildtype	
copies.	 First,	 a	 strong	 purifying	 selection	 against	mutations	within	 protein-coding	
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genes	occurs	 in	 the	germ	 line	 (Stewart	et	 al.,	 2008).	Second,	 the	 large	number	of	
mtDNA	 molecules	 in	 the	 oocyte	 is	 derived	 from	 a	 small	 number	 of	 maternal	
mtDNAs.	The	unclear	mechanism	whereby	only	a	subset	of	the	pool	of	mtDNAs	in	
the	mother	 is	 transferred	 to	 the	offspring	 is	 referred	 to	as	 the	mtDNA	bottleneck	
(Cao	et	al.,	2007).	Pathogenic	mutations	of	mtDNA	that	do	get	past	the	germ-line	
purifying	 selection	may	undergo	clonal	expansion	 in	 somatic	 cells	 and	can	 lead	 to	
disease.	Within	a	population	of	mtDNA,	there	can	be	wildtype	copies	of	mtDNA	and	
copies	carrying	mutations,	a	condition	known	a	heteroplasmy.	In	fact,	low	levels	of	
mtDNA	heteroplasmy	is	observed	 in	healthy	 individuals	at	different	ages	(Li	et	al.,	
2010;	 Payne	 et	 al.,	 2013).	 Increasing	 levels	 of	 heteroplasmy	 can	 cause	 clinical	
symptoms	 if	 the	 fraction	 of	 mutated	 mtDNA	 exceeds	 the	 threshold	 for	 causing	
respiratory	chain	dysfunction.	In	the	mouse	brain,	20	%	of	nerve	cells	with	deficient	
respiratory	 chain	 function	 is	 sufficient	 to	 cause	 clinical	 symptoms	 of	 late-onset	
neurodegeneration,	 whereas	 >60	 %	 of	 deficient	 cells	 leads	 to	 severe	
neurodegeneration	and	premature	death	of	the	animal	(Dufour	et	al.,	2008).			
	
1.8	Mitochondrial	DNA	deletions	 	
Single	 large	deletions	of	mtDNA	can	range	from	5-7	to	kilobases	 in	 length	(Holt	et	
al.,	1988;	Schon	et	al.,	1989).	The	formation	of	deleted	molecules	is	believed	to	arise	
from	 slippage	 during	 mtDNA	 replication.	 The	 earliest	 observations	 of	 mtDNA	
deletions	 were	 made	 in	 patients	 with	 myopathies	 and	 progressive	 external	
ophthalmoplegia	 (PEO)	 (Holt	et	al.,	 1988;	Ozawa	et	al.,	 1988;	Zeviani	et	al.,	 1989;	
Moraes	et	al.,	1989;	Shoubridge	et	al.,	1990;	Suomalainen	et	al.,	1992).	Low	levels	of	
mtDNA	 deletions	 were	 also	 reported	 from	 postmortem	 heart	 and	 brain	 tissue	 of	
adult	 humans,	 suggesting	 deletions	 could	 play	 a	 role	 in	 ageing	 (Cortopassi	 and	
Arnheim,	1990).	However,	a	recent	study	with	mice	lacking	Mgme1	showed	no	signs	
of	premature	aging	or	respiratory	chain	dysfunction	despite	having	higher	levels	of	
linear	 deleted	mtDNA	molecules	 than	 the	mtDNA	mutator	mouse,	 a	model	 with	
pathological	symptoms	similar	to	age-related	diseases	(Trifunovic	et	al.,	2004;	Matic	
et	al.,	2018).	This	finding	indicates	that	point	mutations	rather	than	deletions	drive	
the	observed	pathology	in	mtDNA	mutator	mice.		
	 	
Introduction		
	 	 	 	13	
1.9	Mitochondrial	DNA	depletion	
A	 balance	 between	 mtDNA	 synthesis	 and	 degradation	 maintains	 a	 stable	 copy	
number	of	mtDNA.	Mitochondrial	DNA	depletion	syndromes	are	characterized	by	a	
reduction	 in	mtDNA	 levels,	 roughly	 down	 to	 30	%	 of	 normal	 levels,	 which	 affect	
mitochondrial	function	in	liver,	skeletal	muscle,	and	nerve	cells	(Rötig	and	Poulton,	
2009).	 In	 animal	 models,	 mutation	 or	 absence	 of	 proteins	 involved	 in	 mtDNA	
replication,	dNTP	synthesis,	and	mitochondrial	 fusion	can	cause	mtDNA	depletion	
(Chen	 et	 al.,	 2010;	 Hance	 et	 al.,	 2005;	 Zhou	 et	 al.,	 2008).	 Patients	 with	 mtDNA	
depletion	 syndromes	 can	 have	 mutations	 in	 genes	 that	 are	 involve	 in	 mtDNA	
maintenance,	 such	 as	 Polγ,	 TWNK,	RNASEH1,	 and	MGME1	 (Viscomi	 and	Zeviani,	
2017).	Furthermore,	mitochondria	rely	on	cytosolic	dNTPs	and	the	salvage	pathway	
for	 a	 constant	 supply	 of	 dNTPs	 required	 for	 mtDNA	 synthesis.	 Mutations	 in	 two	
major	 deoxyribonucleoside	 kinases	 of	 the	 mitochondrial	 salvage	 pathway,	 i.e.	
thymidine	 kinase	 (Tk2)	 and	 deoxyguanosine	 kinase	 (Dguok),	 lead	 to	 mtDNA	
depletion	 (Mandel	 et	 al.,	 2001;	 Saada	 et	 al.,	 2001).	 Another	 cause	 for	 mtDNA	
depletion	is	the	inability	of	mutant	mitochondria	to	fuse	their	membranes.	Patients	
with	optic	atrophy	protein	1	(Opa1)	mutations	have	decreased	mtDNA	copy	number	
(Spiegel	 et	 al.,	 2016).	 Moreover,	 mitofusin1-2	 and	Opa1	 tissue-specific	 knockout	
animals	 also	 display	 severely	 reduced	 levels	 of	 mtDNA	 (Chen	 et	 al.,	 2010;	
Papanicolaou	et	al.,	2012;	Tezze	et	al.,	2017).	How	mitochondrial	fusion	is	linked	to	
mtDNA	maintenance	remains	an	open	question.	
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1.10	Mitochondrial	DNA	distribution		
The	 discovery	 of	mtDNA	was	 reported	 in	 1963	 and	 relied	 on	 electron	microscopy	
analysis	of	mitochondria	from	chick	embryos	(Nass	and	Nass,	1963).	Since	then	we	
have	learned	that	the	mitochondrial	genome	can	be	found	in	hundreds	to	thousands	
of	 copies	 per	 cell	 and	 that	 mtDNA	 is	 distributed	 throughout	 the	 mitochondrial	
network	(Satoh	and	Kuroiwa,	1991;	Kukat	et	al.,	2011).	In	fibroblasts,	nucleoids	are	
distributed	 evenly	 within	 a	 mitochondrion	 and	 small	 differences	 in	 nucleoid-to-
nucleoid	 distances	 are	 observed	 between	 perinuclear	 and	 periphery	 nucleoids	
(Figure	1.6).	Very	 little	 is	known	about	the	mechanism	behind	mtDNA	distribution	
as	well	as	the	identity	of	all	key	proteins.	
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	 A	 recent	 study	 of	 this	 process,	 suggests	 that	 newly	 synthesized	 mtDNA	
molecules	are	segregated	at	mitochondria-ER	contact	sites	(Lewis	et	al.,	2016).	This	
model	 argues	 that	 the	 OMM	 may	 serve	 as	 organizational	 platform	 for	 mtDNA	
distribution.	 Indeed,	 the	GTPase	 dynamin-related	 protein	 1	 (DRP1),	which	 divides	
mitochondria	by	constricting	the	OMM,	was	necessary	to	prevent	mtDNA	clustering	
(Ban-Ishihara	et	al.,	2013).	Inside	mitochondria,	several	mtDNA-associated	proteins	
were	 also	 described	 to	 take	 part	 in	 mtDNA	 segregation.	 For	 example,	 the	
mitochondrial	 topoisomerase	 3α	 (TOP3α)	 which	 decatenates	 newly	 synthesized	
mtDNA	molecules	(Nicholls	et	al.,	2018).		Other	proteins	like	the	leucine	zipper	and	
EF-hand	 containing	 transmembrane	 protein	 1	 (LETM1),	 the	 ATPase	 family	 AAA	
domain	containing	3A	protein	(ATAD3A),	and	the	RNASEH1	protein	have	been	also	
associated	with	mtDNA	clustering	but	the	mode	of	action	remains	unknown	(Desai	
et	al.,	2017;	Durigon	et	al.,	2018;	Akman	et	al.,	2016).		
	 Interestingly,	mtDNA	distribution	may	also	rely	on	cholesterol	homeostasis.	
Human	 fibroblasts	 treated	 with	 either	 an	 inhibitor	 of	 cholesterol	 synthesis	
(pravastatin)	 or	 an	 intracellular	 cholesterol	 transport	 inhibitor	 (U18666A)	 for	 one	
week	 showed	 increased	mtDNA	 clustering	 (Desai	 et	 al.,	 2017).	 This	 suggests	 that	
mtDNA	 may	 depend	 on	 cholesterol	 for	 its	 segregation.	 A	 cholesterol-DNA	
interaction	 is	 supported	 by	 a	 study	 finding	mtDNA	 co-sediments	with	 cholesterol	
(Gerhold	 et	 al.,	 2015b).	 Additionally,	 nutrient	 availability	 may	 also	 play	 a	 role	 in	
mtDNA	distribution.	In	control	fibroblasts,	withdrawal	of	pyruvate	for	48	hours	was	
sufficient	 to	 induce	 mtDNA	 clustering	 (Durigon	 et	 al.,	 2018).	 Moreover,	
supplementing	 cells	 with	 ketone	 bodies	 instead	 of	 glucose	 and	 pyruvate	 also	
induced	 mtDNA	 clustering	 (Durigon	 et	 al.,	 2018).	 Further	 studies	 are	 needed	 to	
examine	if	nutrient	availability	and	cholesterol	synthesis	are	linked.	It	would	also	be	
important	 understand	 how	 various	 proteins	 implicated	 in	mtDNA	 distribution	 are	
united	in	a	common	mechanism.	
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1.11	Mitochondrial	dynamics			
The	mitochondrial	network	is	a	dynamic	structure.	Through	coordinated	actions	of	
membrane	 fusion	 and	 fission,	mitochondria	 are	 able	 to	 remodel	 their	 shapes	 and	
sizes	and	also	their	distribution	within	the	cell	(Figure	1.7).	The	precise	definition	of	
mitochondrial	 fission	 is	 the	 division	 of	 one	 mitochondrion	 into	 two	 daughter	
mitochondria;	 the	 opposite	 action,	 the	 union	 of	 two	 mitochondria	 in	 to	 one,	 is	
representative	 of	 a	 mitochondrial	 fusion	 event	 (Tilokani	 et	 al.,	 2018).	 The	
mammalian	 proteins	 that	 govern	 mitochondria	 morphology	 are	 dynamin-related	
GTPase:	 mitochondrial	 constriction	 is	 carried	 out	 by	 the	 dynamin-related/-like	
protein	1	(DRP1)	and	dynamin	2	(DNM2);	OMM	fusion	is	directed	by	mitofusin	1	and	
2	(MFN1,	MFN2)	and	IMM	fusion	is	mediated	by	OPA1	(Smirnova	et	al.,	1998;	Lee	et	
al.,	2016;	Chen	et	al.,	2003;	Griparic	et	al.,	2004).		
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	 In	 cultured	 cells,	 a	 balance	 between	 mitochondrial	 fusion	 and	 fission	
maintains	a	dispersed	tubular	network	(Figure	1.8,	Yu	and	Pekkurnaz,	2018).	When	
the	fission	activity	is	not	properly	controlled,	the	tubular	structure	disintegrates	into	
many	 fragmented	 mitochondria.	 The	 formation	 of	 hyperfused	 mitochondria	 can	
occur	 when	 the	 fusion	 activity	 is	 unopposed.	 In	 neurons,	 mitochondria	 can	 be	
observed	as	being	 fused	 in	 the	soma	and	as	 individual	units	 in	 the	axons	 (Misgeld	
and	Schwarz,	2017).	In	muscle	tissue	mitochondria	are	typically	organized	between	
the	myofibrils	 as	 individual	 spheres.	 A	 recent	 study	 of	 skeletal	muscle	 has	 shown	
that	 mitochondria	 can	 be	 remodeled	 to	 meet	 the	 metabolic	 state	 of	 the	 fiber	
through	 mitochondrial	 fusion	 (Mishra	 et	 al.,	 2015).	 Overall,	 morphological	
transitions	 of	 mitochondria	 play	 a	 key	 role	 in	 mitochondrial	 content	 mixing	 of	
protein	and	lipids,	recycling	of	mitochondria,	apoptosis,	metabolic	adaptations,	and	
immunity.		
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1.12	Mitochondrial	fission		
Much	 of	 our	 understanding	 about	 mammalian	 mitochondrial	 fission	 comes	 from	
seminal	work	 in	 budding	 yeast	 (Bleazard	 et	 al.,	 1999).	 The	 fission	GTPases,	DRP1	
and	 DNM2,	 are	 evolutionary	 conserved	 from	 yeast	 to	 mammals.	 Both	 of	 these	
proteins	are	found	in	the	cytosol	and	are	recruited	not	only	to	mitochondria	but	also	
peroxisomes	and	endocytic	vesicles	(Tilokani	et	al.,	2018).	The	mitochondrial	fission	
factor	 (MFF)	 and	 mitochondrial	 dynamics	 proteins	 (MiD49/51)	 are	 tail-anchored	
proteins	 that	 mediate	 recruitment	 of	 DRP1	 to	 the	 OMM	 under	 basal	 conditions	
(Figure	1.9,	Otera	et	al.,	2010;	Palmer	et	al.,	2011).		
	
	
	
	 The	multi-step	process	of	mitochondrial	fission	is	believed	to	begin	with	ER	
pre-constriction	of	mitochondria	 (Figure	 1.10,	 Farmer	et	 al.,	 2018),	 decreasing	 the	
diameter	 of	 mitochondria	 from	 500	 nm	 to	 150	 nm	 (Legesse-Miller	 et	 al.,	 2003;	
Friedman	et	al.,	2011).	This	pre-constriction	of	mitochondria	allows	for	recruitment	
of	 DRP1	 by	 the	 adaptor	 proteins	 MFF	 or	 MiD49/51,	 followed	 by	 DRP1	
oligomerization	 in	 a	 ring-like	 structure	 (Ingerman	et	 al.,	 2005;	 Losón	et	 al.,	 2013).	
Lastly,	DRP1	constricts	mitochondria	down	to	about	55	nm	in	diameter,	a	suitable	
size	 for	 DNM2	 assembly	 and	 oligomerization	 that	 finalizes	 scission	 of	 the	
mitochondrion	(Lee	et	al.,	2016).		
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1.13	Mitochondrial	fusion	
The	 first	 mitochondrial	 fusion	 protein	 was	 described	 in	 Drosophila	 and	 is	
evolutionary	conserved	from	yeast	to	humans	(Hales	and	Fuller,	1997;	Hermann	et	
al.,	 1998;	 Santel	 and	 Fuller,	 2001).	 In	 mammals	 there	 are	 three	 large	
transmembrane	GTPase	proteins	that	mediate	mitochondrial	fusion:	MFN1,	MFN2,	
and	OPA1.	In	heart	tissue,	the	RNA	expression	of	human	MFN2	is	the	highest	(98.9	
RPKM)	 compared	 to	 OPA1	 (17.2	 RPKM)	 and	 MFN1	 (9.7	 RPKM).	 The	 sequence	
similarity	between	MFN1	and	MFN2	is	about	77	%		(Figure	1.11)	and	they	can	form	
homotypic	 and	 heterotypic	 complexes	 with	 each	 other	 (Santel	 and	 Fuller,	 2001;	
Chen	et	al.,	2003).	In	addition	to	mitochondrial	fusion,	MFN2	has	secondary	roles	in	
mitochondria-ER	 tethering	 and	 maintenance	 of	 coenzyme	 Q	 (de	 Brito	 and	
Scorrano,	2008;	Mourier	et	al.,	2015).	OPA1	is	present	in	two	primary	isoforms,	the	
S-isoform	is	produced	by	proteolytic	cleavage	of	the	L-isoform	inside	mitochondria	
(Ishihara	 et	 al.,	 2006).	 The	 L-isoform	 was	 recently	 shown	 to	 heterotypically	
cooperate	 with	 cardiolipin	 in	 the	 IMM	 and	 this	 interaction	 was	 sufficient	 for	
mitochondrial	 fusion	 in	proteoliposomes	 (Ban	et	al.,	2017).	However,	 for	complete	
fusion	of	OMM	and	IMM,	OPA1	functionally	requires	MFN1	(Cipolat	et	al.,	2004).		
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	 Classical	 membrane	 fusion	 requires	 tethering,	 docking,	 and	 merging	 of	
membranes	(Bonifacino	and	Glick,	2004).	The	current	model	of	mitochondrial	fusion	
describes	 the	 initial	 step	as	 the	 tethering	of	mitofusins	on	opposing	mitochondria	
(Figure	 1.12).	 Exactly	 which	 domain	 in	 mitofusins	 is	 used	 for	 tethering	 is	 under	
debate,	 which	 centers	 on	whether	 the	 C-terminal	 coil-coil	 heptad	 repeat	 2	 (HR2)	
domain	or	the	GTPase	domain	is	the	main	tethering	unit	(Koshiba	et	al.,	2004;	Cao	
et	al.,	2017).	A	recent	study	suggest	that	the	C-terminal	domain	of	mitofusins	faces	
the	IMS	and	is	redox-regulated	to	drive	fusion	(Mattie	et	al.,	2017).	After	tethering,	
cycles	of	GTPase	hydrolysis	 promotes	docking	of	membranes	 and	 initial	 fusion	of	
the	OMM	 (Brandt	 et	 al.,	 2016).	 This	 is	 followed	by	 inner	membrane	 anchoring	by	
OPA1-cardiolipin.	 Lastly,	 the	Williams-Beuren	 syndrome	 critical	 region	 16	 protein	
(WBSCR16)	was	 recently	 described	 to	 act	 as	 an	OPA1	nucleotide	 exchange	 factor	
that	drives	the	OPA1	GTPase	activity	required	for	merger	of	the	IMMs	(Huang	et	al.,	
2017).		
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1.14	Research	aims	
	
1)	To	determine	the	link	between	mitochondria	fusion	and	mtDNA	maintenance	
The	 connection	 between	 mitochondrial	 dynamics	 and	 mtDNA	 maintenance	 is	
poorly	 understood.	 In	 the	 budding	 yeast,	 maintenance	 of	 mtDNA	 is	 absolutely	
dependent	on	OMM	fusion,	whereas	the	situation	is	less	drastic	in	mammals	(Jones	
and	 Fangman,	 1992;	 Rapaport	 et	 al.,	 1998;	 Chen	 et	 al.,	 2010).	 The	 absence	 of	
mitochondrial	 fusion	 in	animal	models	 leads	to	a	strong	reduction	 in	mtDNA	copy	
number	and	has	been	associated	with	mtDNA	mutagenesis	and	deletions	(Chen	et	
al.,	2010;	Papanicolaou	et	al.,	2012).	However,	reduced	mitochondrial	fusion	activity	
or	impaired	fission	does	not	affect	mtDNA	maintenance	(Ishihara	et	al.,	2009;	Chen	
et	 al.,	 2010;	 Del	 Dotto	 et	 al.,	 2017).	 To	 address	 the	 link	 between	 mtDNA	
maintenance	 and	 mitochondrial	 fusion	 proteins,	 molecular	 and	 biochemical	
characterization	 of	 mtDNA	 gene	 expression	 and	 maintenance	 was	 performed	 in	
heart	double	Mfn1-2	knockout	animals	and	mouse	embryonic	fibroblasts.		
	
2)	To	determine	whether	mitochondria	fusion	plays	a	role	in	mtDNA	distribution	
Although	 the	 even	 distribution	 of	 mtDNA	 within	 a	 cell	 was	 observed	 over	 two	
decades	 ago,	 we	 still	 don’t	 fully	 understand	 the	 mechanism.	 We	 used	 super-
resolution	microscopy	 of	 tissues	 from	heart	 double	Mfn1-2	 knockout	 animals	 and	
knockout	 tissue	 culture	 cells	 to	determine	how	proteins	 involved	 in	mitochondrial	
dynamics	could	influence	mtDNA	distribution.	
	
	 	
Results		
	 	 	 	23	
2.0	RESULTS	
	
2.1	Generation	of	Mfn1	and	Mfn2	conditional	heart	double	knockout	mice	
The	C57BL/6	mouse	strain	was	first	generated	in	the	1920’s	by	Clarence	Little	in	the	
Jackson	Laboratory	and	the	substrain	6N	later	established	in	the	National	Institutes	
of	 Health	 (Kiselycznyk	 and	 Holmes,	 2011).	 This	mouse	 strain	 was	 chosen	 for	 this	
project	as	it	is	widely	used	in	metabolic	and	mitochondrial	studies	(Trifunovic	et	al.,	
2004;	 Nikkanen	 et	 al.,	 2016).	 The	 genes	 encoding	 for	 Mfn1	 and	 Mfn2	 were	
genetically	modified	 to	 carry	 loxP	 sites	 flanking	exon	3	of	 the	Mfn1	 and	exon	5	of	
Mfn2.	 Mice	 with	 Mfn1loxP/loxP	 or	 Mfn2loxP/loxP	 genes	 were	 generated	 by	 Taconic	
Biosciences	and	previously	described	in	(Lee	et	al.,	2012).		
	 To	 generate	 double	 mitofusin1-2	 loxP-flanked	 homozygous	 mice	 (dMfn),	
Mfn1loxP/loxP	 and	Mfn2loxP/loxP	 animals	were	 crossed.	 It	was	previously	 reported	 that	
whole	body	mitofusin	1-2	knockout	animals	are	embryonic	lethal	(Chen	et	al.,	2010;	
Papanicolaou	et	al.,	2012).	Therefore,	we	chose	to	conditionally	knockout	(KO)	both	
mitofusins	in	heart	tissue,	where	mitochondria	are	abundant	and	mitofusins	highly	
expressed.	The	muscle	creatine	kinase	promoter	(Ckmm)	was	chosen	to	control	the	
expression	 of	 the	 Cre-recombinase	 (Cre)	 gene	 in	 heart	 and	 skeletal	muscle.	Mfn1	
and	Mfn2	 conditional	 heart	 double	 knockout	mice	 (dMfn	KO)	 were	 generated	 by	
crossing	Mfn1loxP/loxP,	Mfn2loxP/loxP,	Cre	 -/-	 and	Mfn1loxP/loxP,	Mfn2loxP/+,	Cre	 -/+	animals.	
Pups	were	born	at	the	expected	mendelian	ratios	(Figure	2.1A	and	B).	
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2.2	Loss	of	Mfn1	and	Mfn2	in	heart	tissue	was	verified	
Gene	deletion	was	verified	by	assessing	mitofusin1	and	2	 transcript	 levels	 in	heart	
tissue.	 Mitofusin1	 and	 2	 transcripts	 in	 heart	 tissue	 were	 dramatically	 reduced	 in	
dMfn	KO	animals	 compared	 to	 controls	 (Figure	 2.2A).	 Additionally,	 gene	 deletion	
was	verified	by	western	blot	analysis.	The	steady-state	protein	levels	of	mitofusin	1	
were	 absent,	 while	 traces	 of	 mitofusin	 2	 were	 detected	 dMfn	 KO	 mitochondria	
(Figure	2.2B).	The	residual	mitofusin	transcripts	and	protein	levels	observed	may	be	
explained	 by	 the	 fact	 that	 heart	 tissue	 contains	 other	 cell	 types	 besides	
cardiomyocytes,	 such	 as	 endothelial	 cells	 and	 fibroblast	 (Pinto	 et	 al.,	 2016).	
Together	these	data	confirmed	the	generation	of	Mfn1	and	Mfn2	conditional	heart	
double	knockout	mice.		
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2.3	Physiological	characterization	of	dMfn	KO	animals	
Pups	 of	 the	 different	 genotypes	 were	 indistinguishable	 up	 to	 two	 weeks	 of	 age,	
when	a	minor	decrease	in	body	size	was	observed	in	dMfn	KO	animals.	At	five	weeks	
of	age,	dMfn	KO	animals	showed	no	difference	in	heart	weight	compared	to	control	
littermates	 (Figure	 2.3A).	 However,	 the	 same	 animals	 had	 nearly	 50	%	 less	 body	
weight	(Figure	2.3B).	The	heart	weight	to	body	weight	ratio	showed	that	the	dMfn	
KO	animals	had	cardiomyopathy	(Figure	2.3C).	Most	dMfn	KO	animals	survived	until	
postnatal	 age	 of	 5-6	 weeks	 and	 likely	 died	 from	 heart	 failure	 or	 arrhythmia.	
Transmission	 electron	 microscopy	 analysis	 of	 heart	 sections	 at	 5	 weeks	 of	 age	
revealed	 an	 increase	 in	 mitochondrial	 mass	 in	 dMfn	 KO	 animals	 (Figure	 2.4A).	
Mitochondria	 were	 also	 disorganized,	 no	 longer	 displaying	 a	 classical	 linear	
arrangement	 between	 the	 myofibrils	 (Figure	 2.4B).	 At	 higher	 magnifications,	
aberrant	mitochondrial	ultrastructure	could	be	observed	(Figure	2.4B).	
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2.4	dMfn	KO	animals	exhibit	mitochondrial	respiratory	dysfunction		
Mitochondrial	 respiration	 is	 essential	 for	 the	 conversion	 of	 ADP	 into	 ATP,	 the	
cellular	energy	currency	(Figure	2.5A).	Moreover,	mitochondrial	fusion	proteins	have	
been	 implicated	 in	 maintaining	 mitochondrial	 respiration	 (Mishra	 et	 al.,	 2014;	
Mourier	et	al.,	2015).	To	examine	the	consequences	of	 loss	of	outer	mitochondrial	
fusion,	 extensive	 bioenergetic	 characterization	 was	 performed.	 The	 steady-state	
levels	of	various	respiratory	subunits	as	determined	by	western	blot	were	reduced	in	
dMfn	 KO	 heart	 mitochondria	 (Figure	 2.5B).	 Proteomic	 analysis	 of	 isolated	 heart	
mitochondria	revealed	many	other	respiratory	subunits	decreased	in	dMfn	KOs,	the	
majority	 belonging	 to	 complex	 I	 (Figure	 2.6).	 Proteins	 involved	 in	 the	 intra-
mitochondrial	 CoQ	 synthsis	 pathway	 proteins	 BN-PAGE	 analysis	 of	 heart	
mitochondria	solubilized	in	DDM	showed	individual	OXPHOS	complexes	decreased	
in	dMfn	KO,	with	the	exception	of	complex	II	(Figure	2.5C).	Similar	to	other	mouse	
models	 displaying	mitochondrial	 respiratory	 defects	 (Kühl	 et	 al.,	 2016;	Mourier	 et	
al.,	2014),	the	ATP5A-containing	free	F1	part	of	complex	V	was	detected	in	dMfn	KO	
heart	 mitochondria	 (Figure	 2.5C).	 Additional	 BN-PAGE	 analysis	 of	 heart	
mitochondria	 solubilized	 in	 digitonin	 revealed	 reduced	 levels	 of	 respiratory	 chain	
supercomplexes	and	respirasomes	(I+III2+IV1)	in	dMfn	KO	animals	(Figure	2.5D).	
	 Functional	 assessment	of	 the	mitochondrial	 respiratory	 complexes	 showed	
impaired	enzymatic	activity	in	dMfn	KO	heart	mitochondria,	at	the	level	of	complex	
I	and	V	(Figure	2.7A).	High-resolution	respirometry	with	substrates	that	will	deliver	
electrons	 to	 complex	 I	 (pyruvate,	 glutamate,	 malate)	 or	 complex	 II	 (succinate	 +	
rotenone)	demonstrated	a	significant	loss	of	respiration	under	phosphorylating	and	
uncoupled	conditions	in	dMfn	KO	heart	mitochondria	(Figure	2.7B).	The	impairment	
of	respiration	limited	mitochondrial	ATP	production	in	dMfn	KO	heart	mitochondria	
(Figure	2.7C).	Interestingly,	in	dMfn	KO	heart	mitochondria	the	yield	of	ATP	relative	
to	 oxygen	 consumption	 reached	 a	 similar	 ratio	 as	 controls	 (Figure	 2.7D).	 This	
suggests	 that	 the	OXPHOS	 defects	were	 not	 due	 to	 uncoupling	 of	mitochondria,	
because	 there	was	 no	 change	 in	 non-phosphorylating	 respiration	 (Figure	 2.7B)	 or	
per	 ATP	 produced	 and	 per	 oxygen	 consumed	 (Figure	 2.7D).	 In	 summary,	 loss	 of	
mitochondrial	fusion	in	heart	tissue	impairs	OXPHOS	capacity	but	does	not	alter	the	
proton	conductance	of	the	IMM.	
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2.5	dMfn	KO	heart	mitochondria	have	mevalonate	pathway	defects	
Coenzyme	Q	(CoQ)	is	a	hydrophobic	electron	carrier	between	complex	I-III	and	II-III	
of	 the	 respiratory	 chain.	 Previous	 research	 on	 single	Mfn1	 and	Mfn2	 knockouts	
animals	 and	 MEFs	 uncovered	 that	 MFN2	 is	 required	 for	 OXPHOS	 activity	 by	
maintaining	mitochondrial	CoQ	levels	(Mourier	et	al.,	2015).	Although	loss	of	MFN1	
leads	 to	 a	 decrease	 in	 proteins	 associated	 with	 CoQ	 synthesis,	 the	 CoQ	 levels	
remained	 unaltered	 (Mourier	 et	 al.,	 2015).	 To	 determine	 whether	 loss	 of	 both	
mitofusins	 exacerbates	 the	 CoQ	 phenotype	 of	 single	mitofusin	 KOs,	we	 assessed	
hydrogen	 peroxide	 production	 and	 CoQ	 abundance	 in	 fusion-deficient	 heart	 and	
MEFs.	
	 Mitochondrial	 peroxidic	 yield	 in	 dMfn	 KO	 heart	 mitochondria	 under	
phosphorylating	conditions	was	similar	 to	control	 (Figure	2.8A	and	B).	 In	contrast,	
under	 non-phosphorylating	 conditions	 peroxidic	 yield	 was	 increased	 in	 dMfn	 KO	
heart	 mitochondria	 (Figure	 2.8A	 and	 B).	 As	 complex	 I	 is	 a	 major	 site	 for	 ROS	
production,	reverse	electron	flow	from	complex	II	to	I	was	assessed.	dMfn	KO	heart	
mitochondria	were	 found	 to	 generate	 less	 hydrogen	 peroxide	 by	 reverse	 electron	
flow	(Figure	2.8C	and	D).	This	finding	suggests	that	the	CoQ	levels	may	be	affected.	
Next,	 the	 abundance	 of	 CoQ9	 and	 CoQ10	 were	 determined	 by	 UPLC-MS/MS	 in	
dMfn	 KO	 heart	 mitochondria.	 Mutant	 animals	 had	 nearly	 50	 %	 CoQ9,	 the	 most	
abundant	 form	 of	 CoQ	 in	 mice	 (Figure	 2.9A).	 This	 finding	 was	 corroborated	 in	
cultured	cells.	Both	dMfn	KO	and	Opa1	KO	MEFs	showed	CoQ9/10	depletion,	 to	a	
similar	 degree	 as	 Mfn2	 KO	 MEFs	 (Figure	 2.9B).	 Proteomic	 analysis	 comparing	
control	and	dMfn	KO	SILAC-labeled	cells	revealed	several	biological	processes	and	
pathways	 involved	 in	 cellular	 functions	 up	 regulated	 in	dMfn	KO	MEFs	 (cell	 cycle,	
cytoskeleton	organization).	The	majority	of	proteins	downregulated	were	linked	to	
mitochondrial	 function,	 corroborating	 the	 OXPHOS	 defect	 observed	 in	 dMfn	 KO	
heart	mitochondria	(Figure	2.9C).	 Interestingly,	several	proteins	(IDI1,	FDPS,	MVD,	
and	 MVK)	 that	 require	 the	 mevalonate	 pathway	 backbone	 (terpenoid,	 sterol,	
cholesterol	synthesis)	were	also	down	regulated	in	dMfn	KO	MEFs	(Figure	2.9C	and	
D).	 In	 summary,	 loss	 of	 mitofusin1-2	 is	 associated	 with	 CoQ	 depletion	 linked	 to	
defects	 in	 its	biosynthetic	pathways.	However,	 impaired	mitochondrial	 respiration	
was	driven	primarily	by	loss	of	respiratory	components	rather	than	CoQ	depletion.		
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2.6	Loss	of	OMM	fusion	does	not	increase	mtDNA	deletions	or	point	mutations	
A	prevailing	 theory	 in	 the	 field	 is	 that	mitochondrial	 fusion	plays	a	 role	 in	mtDNA	
stability	(Chen	et	al.,	2010;	Viscomi	and	Zeviani,	2017).	To	examine	the	integrity	of	
mtDNA,	 a	 sensitive	 read-out	 for	 mtDNA	 deletions	 was	 performed	 Illumina	
sequencing.	With	this	technique	we	were	able	to	analyze	the	frequency	of	mtDNA	
breakpoints,	 a	 signature	 of	 mtDNA	 deletions.	 We	 found	 no	 difference	 in	 the	
incidence	of	mtDNA	deletions	between	control	and	dMfn	KO	animals	(Figure	2.10A	
and	B).	In	comparison,	high	levels	of	mtDNA	rearrangements	were	detected	in	the	
deletor	mouse	(Figure	2.10C),	which	harbors	a	patient	mutation	in	the	DNA	helicase	
twinkle	(A360T)	that	 leads	to	accumulation	of	mtDNA	deletions	(Tyynismaa	et	al.,	
2005).	Moreover,	mtDNA	mutation	 load	analysis	revealed	no	significant	difference	
between	 control	 and	 dMfn	 KO	 heart	 tissue	 (Figure	 2.10D).	 Together,	 these	 data	
suggest	that	OMM	fusion	is	not	required	to	ensure	the	integrity	of	mtDNA	in	heart	
tissue.	
	
2.7	Loss	of	OMM	fusion	results	in	mtDNA	depletion	
Loss	 of	 OMM	 or	 IMM	 fusion	 has	 been	 associated	 with	 a	 dramatic	 decrease	 in	
mtDNA	copy	number	 (Chen	et	al.,	2010;	Papanicolaou	et	al.,	2012).	Southern	blot	
analysis	of	mtDNA	in	heart	tissue	showed	mtDNA	levels	depleted	by	50	%	in	dMfn	
KO	animals	(Figure	2.11A	and	B).	This	reduction	in	mtDNA	was	confirmed	by	qPCR	
analysis	 of	 heart	 tissue,	where	 a	 similar	 reduction	 in	mtDNA	 levels	was	 observed	
(Figure	 2.11C).	 Furthermore,	 mtDNA	 depletion	 was	 far	 more	 drastic	 in	 dMfn	 KO	
MEFs	 as	 determined	 by	 qPCR	 and	 image	 analysis	 of	mtDNA	 foci	 (Figure	 12B-D).	
These	 results	 indicate	 that	 mitochondrial	 fusion	 plays	 a	 prominent	 role	 in	
maintaining	mtDNA	levels.		
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2.8	Loss	of	OMM	fusion	leads	to	nucleoid	clustering		
Hundreds	 to	 thousands	of	nucleoids	can	be	 found	 in	a	different	cell	 types	and	are	
typically	 found	 evenly	 distributed	 (Kukat	 et	 al.,	 2011).	 The	 mechanism	 and	 the	
complete	 set	 of	 proteins	 involved	 in	 nucleoid	 distribution	 remain	 elusive.	 To	
determine	 if	 mitochondrial	 fusion	 plays	 a	 role	 in	 mtDNA	 distribution,	 an	
immunofluorescence	approach	was	 implemented	 to	examine	nucleoid	distribution	
in	heart	and	MEFs.	Confocal	microscopy	of	heart	sections	immunostained	with	anti-
DNA	antibodies	showed	nucleoid	 foci	 in	high	abundance	and	evenly	distributed	 in	
control	animals	(Figure	2.12A).	In	contrast,	nucleoids	were	visibly	reduced	and	often	
found	 as	 enlarged	 foci	 in	 dMfn	 KO	 heart	 sections	 (Figure	 2.12A).	 These	 enlarged	
nucleoid	foci	were	more	prominent	in	dMfn	KO	MEFs	(Figure	2.12B).		
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	 Confocal	microscopy	has	a	theoretical	resolution	limit	of	about	200	nm,	thus	
the	 enlarged	 nucleoid	 foci	 observed	 through	 this	method	 is	 not	 representative	 of	
the	 actual	 size.	 Stimulated	 emission	 depletion	 (STED)	 microscopy	 enables	 a	
resolution	 limit	of	about	50	nm	with	standard	 immunostaining	procedures	and	we	
therefore	 performed	 STED	 microscopy	 to	 resolve	 the	 true	 diameter	 of	 these	
enlarged	 nucleoid	 foci	 in	 dMfn	 KOs.	 The	 diameter	 of	 nucleoids	 was	 previously	
determined	by	super-resolution	microscopy	to	be	about	100	nm	(Brown	et	al.,	2011;	
Kukat	et	al.,	2011).	Dual	confocal	and	STED	imaging	of	mtDNA	immunostained	with	
anti-DNA	 antibodies	 showed	 that	 small	 nucleoid	 foci	 as	 seen	 by	 confocal	
microscopy	 were	 single	 nucleoid	 foci	 also	 by	 STED	microscopy	 (Figure	 2.13A).	 In	
contrast,	 enlarged	 nucleoid	 foci	 observed	 by	 confocal	 microscopy	 were	 resolved	
into	 multiple	 clustered	 nucleoids	 by	 STED	 microscopy	 (Figure	 2.13A).	 Thus,	
implementation	 of	 super-resolution	 microscopy	 allowed	 us	 to	 see	 the	 actual	
number	of	nucleoids	and	to	distinguish	between	clustered	and	single	nucleoids.		
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	 The	 appearance	 of	 nucleoid	 clustering	 in	 dMfn	 KO	 MEFs	 was	 further	
corroborated	by	chemically	staining	mtDNA	with	picogreen	(Figure	14A	and	B).	The	
pattern	 obtained	 by	 picogreen	 staining	 of	 nucleoids	 was	 identical	 to	 the	 pattern	
obtained	 by	 anti-DNA	 antibody	 staining,	 whereby	 clustered	 nucleoids	 could	 be	
resolved	into	multiple	single	nucleoids	STED	microscopy.		
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	 The	 appearance	 of	 clustered	 nucleoids	 in	 dMfn	 KOs	 prompted	 us	 to	
determine	if	other	fusion-deficient	models	display	clustering.	Interestingly,	only	the	
absence	 of	 OMM	 fusion	 induced	 mtDNA	 clustering,	 because	 the	 mtDNA	 foci	
appeared	 normal	 in	 IMM	 fusion-deficient	 MEFs	 (Figure	 2.14A	 and	 B).	 Further	
analysis	showed	single	Mfn1	KOs	displaying	a	similar	nucleoid	diameter	as	control	
MEFs	(Figure	2.15A	and	B).	
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	Moreover,	 single	Mfn2	 KO	 showed	 a	 small,	 but	 significant,	 increase	 in	 nucleoid	
diameter	with	 picogreen	 staining	 and	 confocal	 imaging	 (Figure	 2.15A	 and	 B).	 For	
control	 and	 all	 fusion-deficient	 models	 the	 STED-determined	 nucleoid	 diameter	
when	labeled	with	picogreen	or	anti-DNA	antibodies	was	calculated	to	be	about	100	
nm	 (Figure	 2.15A	 and	 B).	 Analysis	 of	 the	 confocal/STED	 diameter	 ratio	 indicated	
that	 dMfn	KO	MEFs	 contained	 a	 higher	 degree	 of	 nucleoid	 clustering	 than	 other	
fusion-deficient	 cell	 models	 (Figure	 2.15C	 and	 D).	 This	 finding	 was	 further	
emphasized	 in	 the	 gaussian	 distribution	 of	 STED-determined	 nucleoid	 diameters	
(Figure	 2.16A),	 where	 nearly	 40	%	 of	 nucleoids	 in	 dMfn	 KO	MEFs	were	 clustered	
(Figure	2.16B).	These	findings	suggest	that	OMM	fusion	proteins	play	an	important	
role	in	nucleoid	distribution,	whereas	IMM	fusion	has	no	such	effect.	
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2.9	Loss	of	OMM	fusion	does	not	affect	mtDNA	compaction	
Immunofluorescence	 analysis	 revealed	 that	 dMfn	 KO	 MEFs	 display	 nucleoid	
clustering	 without	 alteration	 in	 nucleoid	 diameter.	 However,	 this	 former	 set	 of	
analysis	does	not	address	directly	the	state	of	the	mtDNA	topology	in	the	nucleoids.	
Through	a	combined	biochemical	and	molecular	approach,	we	investigated	whether	
the	enlarged	nucleoids	could	be	explained	by	the	presence	of	physically	interlocked	
mtDNA	molecules.	Total	DNA	from	heart	tissue	was	resolved	in	its	native	state	on	
an	agarose	gel	and	subjected	to	Southern	blotting	to	visualize	mtDNA	topologies.	
We	 treated	 control	 DNA	 with	 various	 enzymes	 to	 validate	 the	 identity	 of	 each	
topological	 species;	 SacI	 cuts	 mtDNA	 once	 and	 produces	 a	 linear	 fragment,	
Nt.BbvCI	nicks	dsDNA,	topoisomerase	I	relaxes	supercoils,	topoisomerase	II	uncoils	
catenanes,	 and	 gyrase	 forms	 supercoiled	 circles	 (Figure	 2.17A).	 	 In	 the	 control,	
mtDNA	 is	 primarily	 present	 as	 relaxed	 circles,	while	 the	 other	 topological	 species	
are	 in	 low	 abundance	 (Figure	 2.17A).	 With	 regards	 to	 dMfn	 KO	 animals,	 the	
topologies	of	mtDNA	were	similar	to	the	topologies	in	control	samples.	This	shows	
that	 nucleoid	 clustering	 is	 not	 due	 to	 physical	 tethering	 of	mtDNA	 as	 there	 is	 no	
increase	in	catenaned	species.			
	 Lastly,	 TFAM	 is	 the	 main	 mitochondrial	 protein	 that	 is	 always	 bound	 to	
mtDNA	and	it	packages	mtDNA	into	nucleoids.	Therefore,	we	qualitatively	assessed	
nucleoids	for	the	presence	of	TFAM	to	rule	out	issues	in	mtDNA	compaction.	Fixed	
cultured	 MEFs	 were	 immunostained	 against	 DNA	 and	 TFAM	 and	 imaged	 by	
confocal	microscopy.	In	control	and	fusion-deficient	MEFs,	we	observed	that	TFAM	
as	 expected	 is	 present	 on	 every	 molecule	 of	 mtDNA	 (Figure	 2.17B).	 Moreover,	
enlarged	 nucleoids	 showed	 larger	 TFAM	 foci,	 in	 agreement	 with	 the	 fact	 that	
enlarge	 nucleoids	 are	 composed	 of	 multiple	 nucleoids.	 All	 together,	 these	 data	
suggest	OMM	fusion	does	not	affect	mtDNA	compaction,	but	rather	plays	a	role	in	
nucleoid	distribution.		
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2.10	Loss	of	OMM	fusion	does	not	affect	mt-transcription	activity	
The	basal	mt-transcription	initiation	machinery	composed	of	POLRMT,	TFB2M,	and	
TFAM	 is	 crucial	 for	 mitochondrial	 gene	 expression	 (Gustafsson	 et	 al.,	 2016).	
Mitochondrial	 DNA	 transcription	 and	 replication	 are	 coupled	 processed,	 whereby	
mt-transcription	 generates	 the	 RNA	 primer	 for	 mtDNA	 replication.	 Previously	
characterized	animals	models	with	defects	 in	mt-transcription	 in	heart	tissue	were	
associated	 with	 a	 loss	 of	 mtDNA	 (Larsson	 et	 al.,	 1998;	 Kühl	 et	 al.,	 2016).	 To	
investigate	the	origin	of	mtDNA	depletion	upon	loss	of	fusion,	mitochondrial	gene	
expression	was	assessed	in	fusion-deficient	heart	tissue	and	MEFs.		
	 Western	 blot	 analysis	 of	 isolated	 heart	 mitochondria	 found	 steady-state	
levels	 of	 TFAM	 and	 TFB2M	 that	 were	 similar	 to	 control	 levels,	 while	 POLRMT	
protein	levels	were	highly	increased	in	dMfn	KO	animals	(Figure	2.18).	Interestingly,	
despite	having	sufficient	transcription	machinery	proteins,	dMfn	KOs	compared	to	
control	animals	contained	less	mt-transcripts	from	both	the	light	and	heavy	strands	
as	 determined	 by	 northern	 blots	 (Figure	 2.19).	 However,	 the	 decrease	 in	
mitochondrial	 transcripts	 was	 not	 as	 profound	 as	 in	 heart	 specific	 Polrmt	 KO	
animals,	an	indication	that	mt-transcription	activity	is	not	fully	abolished.		
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	 To	 functionally	 assess	 total	 mt-transcription,	 an	 in	 organello	 assay	 using	
isolated	 heart	 mitochondria	 was	 performed	 to	 follow	 de	 novo	 synthesis	 of	 mt-
transcripts.	 Compared	 to	 controls,	dMfn	 KO	 heart	mitochondria	 produced	 overall	
considerably	 less	 mt-transcripts	 (Figure	 2.20A	 and	 C).	 Taking	 into	 account	 the	
mtDNA	depletion	in	dMfn	KOs,	the	activity	of	mt-transcription	per	mtDNA	template	
was	 similar	 between	 control	 and	 dMfn	 KO	 animals	 (Figure	 2.20B	 and	 D).	 These	
analyses	 show	 that	mt-transcription	 activity	 is	 unaffected	 and	 limited	 by	mtDNA	
copy	number.	
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	 This	 finding	was	 further	 investigated	 at	 the	 level	 of	 individual	 nucleoids	 in	
MEFs	 through	 immunofluorescence	approaches.	Fluorescence	 in	 situ	hybridization	
(FISH)	was	applied	to	detect	the	mtDNA-encoded	CoxI	mRNA	on	fixed	MEFs.	This	
FISH	probe	was	detected	only	in	mitochondria,	was	insensitive	to	DNAse	treatment,	
and	 highly	 specific	 for	 CoxI	mRNA	 (Figure	 2.21A).	 The	 CoxI	 mRNA	 FISH	 staining	
pattern	 was	 present	 as	 distinct	 foci	 in	 very	 close	 proximity	 to	 nucleoids	 (Figure	
2.21B).	CoxI	mRNA	was	abundant	in	control	MEFs,	while	dMfn	KO	MEFs	CoxI	mRNA	
was	 less	 abundant	 (Figure	 2.21B	 and	 C),	 consistent	 with	 Northern	 blot	 analysis.	
However,	 analysis	 of	 individual	 nucleoids	 revealed	 that	 nearly	 every	 nucleoid	was	
positive	for	CoxI	mRNA	in	both	control	and	dMfn	KO	MEFs	(Figure	2.21B	and	D).		
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	 Since	 FISH	 analysis	 of	 CoxI	 mRNA	 is	 not	 reflective	 of	 ongoing	 mt-
transcription,	de	novo	mt-transcript	production	was	evaluated	in	cultured	cells.	We	
incubated	 cells	 with	 the	 uridine	 analog	 Bromouridine	 (BrU)	 and	 its	 incorporation	
into	 nascent	 mRNA	 was	 assessed	 by	 immunofluorescence.	 The	 immuno-
fluorescence	 signal	 of	 BrU	 was	 detected	 in	 the	 nucleus	 and	 mitochondria.	 The	
staining	 pattern	 of	 BrU	within	mitochondria	was	 punctuated	 and	 always	 found	 in	
the	presence	of	the	mt-mRNA	binding	protein	LRPPRC	(Figure	2.22A).	 In	 line	with	
FISH	 analysis	 of	 CoxI	 mRNA,	 BrU	 incorporation	 was	 severely	 decreased	 in	 both	
OMM	and	IMM	fusion-deficient	dMfn	KO	and	Opa1	KO	MEFs	(Figure	2.22B	and	C).	
Moreover,	in	both	control	and	fusion-deficient	MEFs	the	majority	of	nucleoids	were	
positive	for	BrU,	suggesting	that	BrU	was	 incorporated	into	nascent	mitochondrial	
mRNA	 (Figure	 2.22B	 and	 D).	 Notably,	 clustered	 nucleoids	 in	 dMfn	 KO	 MEFs	
exhibited	higher	abundance	of	BrU-incorporated	mRNA	(Figure	2.22B).	Altogether,	
these	results	suggest	that,	although	mt-transcription	is	proportional	to	the	number	
mtDNA	 template,	 it	 is	 not	 impaired	 by	 loss	 of	 mitochondrial	 fusion	 and	 that	
clustered	nucleoids	also	are	transcribed.	
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2.11	Loss	of	mitochondrial	fusion	affects	replisome	composition		
Initiation	of	mtDNA	replication	 is	dependent	on	mt-transcription	to	 form	the	RNA	
primer	(Kühl	et	al.,	2016).	However,	our	findings	presented	above	exclude	impaired	
transcription	 as	 a	 cause	 for	 the	 observed	 mtDNA	 depletion	 in	 dMfn	 KO	 hearts.	
Faithful	replication	of	mtDNA	requires	a	dedicated	protein	replisome.	We	therefore	
proceeded	 to	 investigate	 replisome	 abundance	 and	 activity.	 The	 mitochondrial	
replisome	is	composed	POLRMT,	POLγ,	TWNK,	and	SSBP1.		
	 Western	blot	analysis	revealed	significant	changes	in	the	composition	of	the	
replisome	 in	 isolated	 mitochondria	 from	 dMfn	 KO	 and	 Opa1	 KO	 MEFs	 (Figure	
2.23A).	 In	 fusion-deficient	MEFs,	 the	steady-state	 levels	of	PolγA	were	reduced	by	
nearly	50	%	compared	to	controls,	while	the	levels	of	TWNK	were	not	significantly	
altered	(Figure	2.23B).	Since	a	western	blot	analysis	on	denatured	proteins	cannot	
evaluate	whether	replisome	proteins	are	engaged	with	mtDNA,	a	glycerol	gradient	
with	an	 iodixanol	pad	was	utilized	 to	enrich	 for	nucleoids	and	nucleoid-associated	
proteins	under	native	conditions	using	isolated	MEF	mitochondria	(Figure	2.23C).	In	
all	cell	types,	the	vast	majority	of	known	nucleoid-associated	proteins	were	enriched	
in	 fraction	 1	 of	 the	 gradient	 (Figure	 2.23D).	 Importantly,	 southern	 blot	 analysis	
showed	that	mtDNA	was	found	only	in	fraction	1.	Proteins	such	as	the	OMM	protein	
VDAC	 and	 matrix	 proteins	 LRPPRC	 and	 ATP5A	 were	 present	 in	 lighter-density	
fractions	 (Figure	 2.23D).	 Quantitative	 analysis	 of	 protein	 abundance	 relative	 to	
mtDNA	in	fraction	1	revealed	changes	in	the	stoichiometry	of	replisome	proteins.	In	
dMfn	 KO	 and	 Opa1	 KO	 MEFs,	 the	 stoichiometry	 of	 replisome	 interacting	 with	
mtDNA	were	 imbalanced,	 composed	 of	 less	 PolγA	 and	 increased	 levels	 of	 TWNK	
and	SSBP1	proteins	(Figure	2.23E	and	F).			
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	 	To	 further	 validate	 these	 findings,	 individual	 nucleoids	were	 examined	 for	
the	 presence	 of	 replisome	 proteins	 through	 immunocytochemistry	 and	 confocal	
microscopy.	 Immunostaining	of	SSBP1	and	mtDNA	 in	 control	 and	dMfn	KO	MEFs	
revealed	three	populations	of	SSBP1:	free	SSBP1,	SSBP1	partially	overlapping	with	
mtDNA,	and	SSBP	completely	overlapping	with	mtDNA.	 In	control	MEFs,	29	%	of	
SSBP1	 was	 present	 as	 distinct	 foci	 free	 of	 mtDNA	 and	 29%	 co-localizing	 with	
mtDNA	(Figure	2.24A	and	B).	In	contrast,	dMfn	KO	MEFs	exhibited	a	shift	towards	
more	 SSBP1	 co-localizing	with	mtDNA	 (38	%)	 resulting	 in	 less	 free	 SSBP1	 (20	%)	
(Figure	 2.24A	 and	 B).	 This	 finding	 is	 in	 agreement	 with	 other	 results	 showing	
enrichment	of	SSBP1	 in	nucleoid	 fractions	 in	 fusion-deficient	MEFs	 (Figure	2.23F).	
Similar	 immunofluorescence	 analyses	 were	 attempted	 for	 PolγA	 or	 TWNK;	
however,	numerous	commercially	available	antibodies	or	custom-made	antibodies	
failed	 to	 specifically	 detect	 endogenous	 PolγA	 or	 TWNK.	 Altogether,	 these	 data	
show	that	mitochondrial	fusion	plays	a	role	in	maintaining	a	balanced	replisome.		
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2.12	Mitochondrial	fusion	is	required	to	sustain	high	rates	of	mtDNA	replication		
In	order	 to	maintain	high	mtDNA	copy	number,	 a	 cell	must	 contain	a	mechanism	
that	 coordinates	 the	 balance	 between	 abortive	 and	 genome-length	 mtDNA	
replication.	In	addition	to	replication,	regulation	of	mtDNA	stability	is	an	important	
factor	 controlling	 copy	 number.	 To	 date,	 very	 little	 is	 known	 about	 how	mtDNA	
replication	 is	organized	and	regulated	 in	vivo.	Since	we	found	that	fusion-deficient	
MEFs	have	an	imbalance	in	replisome	factors,	we	assessed	whether	this	functionally	
perturbs	mtDNA	replication	activity.		
	 The	 ability	 to	 replicate	 mtDNA	 was	 investigated	 under	 conditions	 that	
activate	 mtDNA	 synthesis.	 This	 can	 be	 achieved	 by	 depletion	 of	 mtDNA	 with	
ethidium	bromide	(EtBr)	followed	by	monitoring	of	the	repopulation	of	mtDNA	over	
time.	 Control	 MEFs	 treated	 with	 EtBr	 for	 6	 days	 underwent	 a	 rapid	 depletion	 of	
mtDNA,	while	both	dMfn	and	Opa1	KO	MEFs	 lost	mtDNA	at	a	slower	 rate	 (Figure	
2.25A).	Moreover,	EtBr	treatment	caused	fragmentation	of	mitochondria	in	control	
cells	 (Figure	 2.25B)	 and	 in	 all	 genotypes	 about	 25%	 of	 the	 population	 showed	
complete	 loss	 of	 mtDNA	 (ρ0)	 (Figure	 2.25C).	 The	 residual	 amount	 of	 mtDNA	
remaining	after	6	days	of	EtBr	treatment	was	significantly	less	in	control	MEFs	(0.5	
%)	 compared	 to	dMfn	 and	Opa1	 KO	MEFs	 (5.3	%	 and	 3.0	%,	 respectively)	 (Figure	
2.25B).	Interestingly,	the	loss	of	mtDNA	in	Mfn1	and	Mfn2	KO	MEFs	was	similar	to	
control	MEFs	(1.0	%	and	0.3	%,	respectively)	(Figure	2.25D).	In	the	recovery	phase,	
EtBr	was	removed	from	the	culture	medium	in	order	to	assess	mtDNA	repopulation	
of	cells.	During	this	phase,	control	and	Mfn2	KO	MEFs	displayed	an	accelerated	rate	
of	mtDNA	 recovery	 (Figure	 2.25A).	 In	 contrast,	 dMfn	 and	 Opa1	 KO	MEFs	 lagged	
dramatically	 behind	 in	 mtDNA	 synthesis.	 In	 fact,	 control	 MEFs	 were	 more	
productive	with	far	less	mtDNA	templates,	reaching	a	150	fold	increase	of	mtDNA	in	
the	 repletion	 phase,	 whereas	 dMfn	 and	 Opa1	 KO	 MEFs,	 despite	 having	 more	
mtDNA	templates	after	 the	depletion	phase,	displayed	only	10-25	 fold	 increase	 in	
mtDNA	 copy	 number	 (Figure	 2.25E).	 Surprisingly,	 Mfn1	 KO	 MEFs	 also	 showed	
impaired	mtDNA	recovery	with	a	50	fold	increase	of	mtDNA	levels	in	the	repletion	
phase	(Figure	2.25E).			
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Lastly,	 to	 rule	 out	 changes	 in	 the	 cellular	 dNTP	 pools	 as	 a	 cause	 for	 the	 limited	
capacity	 for	 mtDNA	 replication	 in	 fusion-deficient	 MEFs,	 we	 determined	 the	
abundance	 of	 dNTP	 pools	 by	 UPLC-MS.	 As	 a	 negative	 control,	 cellular	 purines	
(dGTP	and	dATP)	 levels	were	mildly	depleted	by	treating	control	MEFs	with	2	mM	
hydroxyurea	 for	30	hours.	Hydroxyurea	 is	well	described	to	arrest	DNA	replication	
by	 inhibiting	the	 ribonucleotide	 reductase	enzyme	that	catalyzes	 the	 formation	of	
dNTPs	 and	 NTPs.	 Quantification	 of	 cellular	 dNTP	 pools	 revealed	 no	 change	 in	
dNTPs	in	all	fusion-deficient	cell	models,	although	Mfn1	and	Opa1	KO	MEFs	showed	
a	trend	for	increase	levels	(Figure	2.26A).	
	
	
	
	
2.13	OMM	fusion	is	necessary	for	postnatal	mtDNA	replication	in	the	heart	
In	order	 to	 establish	 the	 relevance	of	 the	observed	mtDNA	 replication	defect	 and	
replisome	imbalance	in	MEFs	in	a	physiological	context,	we	assessed	various	facets	
of	mtDNA	replication	in	dMfn	KO	animals.	We	examined	the	expansion	of	mtDNA	
copy	 number	 during	 postnatal	 heart	 development.	 In	 control	mice,	mtDNA	 levels	
gradually	 increased	 in	 the	 first	 few	weeks	 after	 birth	 and	 between	 the	 3rd	 and	 4th	
week	the	mtDNA	copy	number	is	substantially	 increased	by	almost	10-fold	(Figure	
2.27A).	In	contrast,	although	dMfn	KO	animals	are	born	with	similar	levels	of	mtDNA	
in	 heart,	 loss	 of	 mitochondrial	 fusion	 renders	 their	 mitochondria	 incompetent	 to	
synthesize	mtDNA	and	they	therefore	develop	severe	mtDNA	depletion	by	4	weeks	
of	 age	 (Figure	 2.27A).	 At	 this	 same	 age,	 dMfn	 KO	 heart	mitochondria	 display	 an	
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imbalance	 of	 replisome	 factors	 (Figure	 2.27B).	 Like	 fusion-deficient	 MEFs,	 the	
imbalance	 of	 replisome	 factors	 was	 characteristic	 by	 a	 decreased	 PolγA	 protein	
relative	to	TWNK	protein	levels	in	dMfn	KO	heart	mitochondria.		
	
	 	
	 The	 imbalance	 in	 replisome	 factors	 and	 inability	 to	 increase	mtDNA	 copy	
number	during	post-natal	development	suggested	a	possible	molecular	impairment	
of	mtDNA	replication.	Typically,	more	than	95	%	of	all	initiated	mtDNA	replication	
events	 are	 prematurely	 terminated	 (abortive)	 after	 about	 650	 nucleotides	 to	
generate	a	short	single-stranded	species	denoted	7S	DNA	(Gustafsson	et	al.,	2016).	
There	was	no	difference	in	steady-state	levels	of	7S	DNA	between	control	and	dMfn	
KO	animals	by	Southern	blot	(Figure	2.28A)	or	by	qPCR	analyses	(Figure	2.28B).	This	
finding	 was	 surprising	 since	 other	 mutant	 models	 exhibiting	 mtDNA	 depletion	
exhibit	 increased	(Mgme1	heart	KO)	or	decreased	(Polrmt	heart	KO)	7S	DNA	levels	
(Kühl	et	al.,	2016;	Matic	et	al.,	2018).		
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	 Next,	 to	 functionally	 assess	 mtDNA	 replication	 activity	 in	 isolated	 heart	
mitochondria	we	performed	in	organello	assays.	Heart	mitochondria	were	incubated	
with	a	radioactively	labeled	deoxynucleotide	for	two	hours,	which	is	the	estimated	
time	it	takes	for	one	molecule	of	mtDNA	to	be	replicated	(Berk	and	Clayton,	1974).		
Afterwards,	 mtDNA	 was	 isolated,	 subjected	 to	 Southern	 blotting,	 and	 newly	
replicated	mtDNA	 and	 7S	DNA	was	 visualized	 by	 capturing	 the	 ionizing	 radiation	
produced	by	the	 incorporated	radioactive-deoxynucleotide.	When	isolated	mtDNA	
is	not	boiled,	 7S	DNA	 remains	attached	 to	mtDNA	and	 is	 seen	 together	with	 full-
length	mtDNA	 on	 top	 of	 the	 gel.	 However,	 7S	 DNA	 single	 stranded	 DNA	 can	 be	
separated	by	boiling	isolated	mtDNA.	The	higher	molecular	weight	mtDNA	is	then	
observed	 on	 the	 top	 of	 the	 gel,	 whereas	 the	 smaller	 7S	 DNA	 fragments	migrate	
towards	 the	 bottom	 of	 the	 gel.	 Following	 mtDNA	 synthesis	 from	 initiation	 to	
completion,	 we	 found	 that	 most	 of	 the	 de	 novo	 mtDNA	 replication	 products	 in	
control	 heart	 mitochondria	 is	 7S	 DNA.	 Although	 dMfn	 KO	 heart	 mitochondria	
appear	 to	 generate	more	mtDNA	when	 comparing	 unboiled	 samples,	 analysis	 of	
boiled	samples	show	smear	of	 incomplete	 replication	products	surrounding	the	7S	
DNA	(Figure	2.29A	and	B).	This	finding	suggests	that	dMfn	KOs	are	able	to	initiate	
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mtDNA	 replication	 but	 fail	 to	 complete	 the	 replication	 cycles.	 Altogether,	 these	
data	 conclude	 that	 OMM	 fusion	 is	 necessary	 for	 maintaining	 the	 balance	 of	
replisome	 proteins,	 which	 allow	 for	 rapid	 mtDNA	 replication	 during	 postnatal	
development	of	the	heart.	
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3.0	DISCUSSION		
There	 are	 many	 copies	 of	 mitochondrial	 DNA	 in	 mammalian	 cells,	 which	 are	
expressed	and	maintained	in	order	to	ensure	a	functional	OXPHOS	system	(Larsson	
et	 al.,	 1994).	The	 regulation	of	mtDNA	maintenance	 is	multi-layered	and	 involves	
various	machinery	 acting	 on	mtDNA	 transcription,	mtDNA	 replication,	 nucleotide	
metabolism,	mtDNA	 stability,	 and	 organelle	 quality	 control	 (Viscomi	 and	Zeviani,	
2017).	To	add	to	the	complexity,	remodeling	of	the	mitochondrial	network	through	
fusion	 or	 fission	 of	 mitochondrial	 membranes	 can	 affect	 mtDNA	 integrity,	
maintenance,	and	its	distribution	(Mishra	and	Chan,	2014).	The	research	presented	
in	 this	 thesis	 reports	 on	 an	 unexpected	 link	 between	OMM	 fusion	 and	 replication	
and	distribution	of	mtDNA	in	mammalian	cells.		
	
On	mitochondrial	form	and	function			
It	 is	 generally	 assumed	 that	 the	 shape	 of	 the	mitochondrial	 network	 reflects	 the			
functional	state	of	mitochondria	(Ryan	and	Hoogenraad,	2007;	Westermann,	2012).	
Namely,	 a	 fragmented	 network	 is	 often	 interpreted	 as	 a	 sign	 of	 mitochondrial	
dysfunction,	while	a	tubular	network	 is	attributed	to	functional	mitochondria.	This	
has	been	shown	to	be	true	in	yeast	(Rapaport	et	al.,	1998;	Shepard	and	Yaffe,	1999).	
In	mammals	this	correlation	doesn’t	always	apply,	possibly	due	to	differences	in	the	
proteins	 regulating	mitochondrial	 dynamics.	We	 have	 shown	 that	 the	 absence	 of	
Mfn2,	Mfn1-2	or	Opa1	all	exhibited	fragmented	mitochondria	and	display	 impaired	
mitochondrial	 respiration,	 with	 the	 exception	 of	 Mfn1	 KOs.	 Interestingly,	 mild	
respiratory	 dysfunction	 can	 also	 be	 observed	 in	 hyper-tubular	 mitochondrial	
network	 caused	 by	 the	 loss	 of	Drp1	 in	MEFs	 (Parone	 et	 al.,	 2008;	 Ishihara	 et	 al.,	
2015).	 Hence,	 form	 does	 not	 necessary	 follow	 function	 when	 it	 comes	 to	
mitochondria	morphology.		
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On	the	bioenergetic	role	of	mitochondrial	fusion		
Through	 our	 studies	 we	 demonstrate	 that	 loss	mitochondrial	 fusion	 proteins	 can	
trigger	mitochondrial	respiratory	dysfunction	in	two	ways.	Interestingly,	heart	Mfn1	
KO	and	Mfn2	KO	animals	and	MEFs	exhibit	a	down-regulation	 in	 the	biosynthetic	
pathway	 for	 CoQ,	 but	 only	 loss	 of	 MFN2	 lead	 to	 CoQ	 depletion	 and	 respiratory	
dysfunction	not	 attributed	 to	 changes	 in	 respiratory	protein	 levels	 (Mourier	 et	 al.,	
2015;	Silva	Ramos	et	al.,	2016).	However,	MFN2	associated	OXPHOS	defects	have	
been	 reported	 in	 other	 tissues	 like	 brown	 adipose	 tissue	 and	 skeletal	 muscle	
(Sebastián	 et	 al.,	 2012;	 Boutant	 et	 al.,	 2017;	 Mahdaviani	 et	 al.,	 2017).	 It	 remains	
unclear	how	MFN2	contributes	to	the	maintenance	of	mitochondrial	CoQ	pools.	 In	
fact,	the	majority	of	CoQ	is	produced	 in	the	 IMM	but	can	be	found	 in	nearly	every	
cellular	 organelle.	 (Stefely	 and	 Pagliarini,	 2017).	 Thus,	 taking	 into	 consideration	
reports	describing	MFN2	as	a	mitochondria-ER	tether	(de	Brito	and	Scorrano,	2008)	
and	 studies	 finding	 newly	 synthesized	 CoQ10	 at	 mitochondrial	 associated	
membranes	and	the	ER	(Fernández-Ayala	et	al.,	2005),	it	may	be	possible	these	two	
processes	 are	 physically	 linked.	 If	 true,	 MFN2	 tethers	 may	 serve	 as	 important	
structural	 components	 for	 intra-organelle	 synthesis	 of	 CoQ.	 A	 recent	 study	 in	
budding	yeast	has	also	recognized	a	connection	between	CoQ	biosynthesis	and	the	
MFN2	 homolog	 Fzo1p,	 suggesting	 this	 relationship	 has	 been	 evolutionarily	
conserved	 (Stefely	 et	 al.,	 2016).	 Further	 studies	 are	 needed	 to	 understand	 how	
these	sites	are	 regulated,	whether	 these	sites	 facilitate	 import	of	 intermediates	or	
export	of	CoQ,	and	as	well	identifying	the	enzymes	and	substrates	present	at	these	
sites.		Alternatively,	MFN2	and	CoQ	levels	may	be	linked	through	glutathione	redox	
cycles	 (GSH/GSSH)	 that	activate	mitochondrial	 fusion	and	which	maybe	mediated	
by	semiquinone	ROS	production	(Wang	and	Hekimi,	2016;	Mattie	et	al.,	2017).	This	
possible	MFN2-CoQ	relationship	remains	to	be	investigated.	
	 The	second	way	mitochondrial	fusion	proteins	mediate	respiratory	capacity	
is	through	maintenance	of	mtDNA.	In	line	with	previous	studies,	the	complete	loss	
of	 fusion	(dMfn	KO	or	Opa1	KO)	affected	mtDNA	copy	number	 (Chen	et	al.,	2010,	
2011;	Papanicolaou	et	al.,	2012).	As	a	consequence,	we	found	that	ATP	production	
per	 oxygen	 consumed	 is	 limited	 to	 mtDNA	 levels.	 Although	 the	 absence	 of	
mitofusin1-2	or	OPA1	presented	CoQ	deficiency,	to	a	similar	extent	as	loss	of	MFN2,	
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the	 respiratory	 impairment	 was	 driven	 by	 the	 partial	 collapse	 of	 the	 OXPHOS	
system	due	to	mtDNA	depletion	rather	than	CoQ	loss.	This	has	several	implications.	
It	 suggests	 that	 the	 combined	 loss	of	MFN1	and	MFN2	does	not	have	an	additive	
effect	to	 further	reduce	CoQ	levels.	Rather,	 it	suggests	the	tethering	properties	of	
MFN2	play	an	important	role	in	the	synthesis	of	CoQ.	Another	conclusion	drawn	is	
that	CoQ	deficiency	can	occur	as	a	secondary	response	to	respiratory	dysfunction	as	
exemplified	 in	 Opa1	 KO	 MEFs.	 This	 finding	 is	 in	 agreement	 with	 other	 mutant	
animal	models	 displaying	 CoQ	 loss	 associated	with	OXPHOS	 defects	 (Kühl	 et	 al.,	
2017).	Moreover,	 since	both	 loss	of	OMM	and	 IMM	 fusion	 can	elicit	 near	 identical	
bioenergetic	 impairments	 and	 mtDNA	 loss,	 it	 is	 unlikely	 that	 secondary	 role	 of	
OPA1	 in	cristae	remodeling	 is	 the	key	mechanism	driving	OXPHOS	dysfunction	as	
previously	proposed	 (Cogliati	et	al.,	2013).	Unexpectedly,	 the	dMfn	KO	MEFs	used	
by	Cogliati	and	colleagues	showed	a	contrasting	bioenergetic	profile	and	no	growth	
defect	 on	glucose	 and	galactose	medium.	 It	 is	 unclear	why	 there	 is	 a	 discrepancy	
between	these	cell	lines	that	share	the	same	origin	(the	lab	of	David	Chan,	Caltech).	
However,	a	close	inspection	of	the	cristae	morphology	in	two	publications	from	this	
lab	show	dMfn	KO	MEFs	exhibiting	abnormal	cristae	 (Gomes	et	al.,	2011)	and	 in	a	
later	study	showing	dMfn	KO	MEFs	with	no	change	in		cristae	shape	(Cogliati	et	al.,	
2013).	This	suggests	a	shift	in	cell	population	likely	occurred	by	clonal	expansion	and	
could	 explain	 the	 bioenergetic	 discrepancy.	 In	 summary,	 mitochondrial	 fusion	
proteins	 can	 influence	 respiratory	 function	 by	 either	 supporting	 CoQ	 synthesis	 or	
maintenance	of	mtDNA.				
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On	mtDNA	distribution		
The	research	presented	in	this	thesis	show	that	OMM	fusion	proteins	are	important	
players	 to	 segregate	mitochondrial	 nucleoids.	Unexpectedly,	 nucleoid	 distribution	
was	not	dependent	on	IMM	fusion.	The	majority	of	nucleoids	in	Opa1	KO	MEFs	were	
distinctly	 present	 as	 single	 foci	 of	 similar	 size.	 This	 finding	 can	mean	 two	 things.	
First,	 it	 could	mean	 that	mtDNA	 is	 not	 distributed	 throughout	 the	mitochondrial	
network	by	IMM	remodeling.	This	is	supported	by	single	molecule	studies	of	TFAM	
that	 revealed	 constraint	 diffusion	 with	 the	mitochondrial	 matrix,	 suggesting	 that	
nucleoids	are	not	undergoing	long-range	redistribution	(Busch	et	al.,	2014).		Second,	
it	would	also	suggest	 that	even	mtDNA	distribution	throughout	 the	mitochondrial	
network	depends	on	proteins	on	the	OMM.	Indeed,	it	was	shown	that	loss	of	DRP1	
prevented	mitochondrial	division	and	induced	massive	aggregation	of	mtDNA	(Ban-
Ishihara	 et	 al.,	 2013;	 Ishihara	 et	 al.,	 2015).	 In	 comparison	 to	 Drp1	 KOs,	 mtDNA	
clustering	in	dMfn	KOs	was	moderate.			
	 In	 further	 support	 of	 the	 OMM	 as	 a	 mtDNA	 distribution	 center,	 newly	
synthesized	mtDNA	molecules	were	 found	 to	 be	 segregated	 at	 ER-OMM	 contact	
sites	(Lewis	et	al.,	2016).	Mitofusins	may	be	involved	in	this	process	by	establishing	
ER-mitochondria	 tethers.	 However,	 since	 loss	 of	 Mfn2	 only	 mildly	 induced	
clustering,	 it	 is	 still	 not	 clear	 if	 this	 is	 the	 underlying	 mechanism.	 Moreover,	 it	
remains	 to	 be	 investigated	 if	 losing	 ER-mitochondria	 contact	 sites	 would	 induce	
mtDNA	 clustering.	 One	 study	 on	 acute	 disruption	 of	 ER	 shape,	 that	 shifted	 the	
proportion	of	ER	tubules	into	sheet-like	structures,	reported	no	mtDNA	aggregation	
(Lewis	et	al.,	2016).	This	experimental	approach	however	might	not	have	disrupted	
contact	 sites.	 Additionally,	 since	 changes	 in	 cholesterol	 content	 can	 also	 induce	
mtDNA	clustering,	studies	looking	at	cholesterol	content	in	dMfn	KOs	would	also	be	
warranted	 because	 the	 biosynthetic	 pathway	 for	 cholesterol	 is	 down-regulated	 in	
this	model.	Overall,	from	these	and	previous	studies	it	is	becoming	evident	that	an	
important	mtDNA	distribution	platform	resides	on	the	OMM,	which	rely	on	fusion	
and	fission	proteins.		
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On	mtDNA	integrity		
We	demonstrate	 that	 the	profound	mtDNA	depletion	 is	not	explained	by	genome	
instability.	dMfn	heart	KO	animals	neither	showed	a	difference	in	mtDNA	mutation	
load	nor	did	they	exhibit	a	greater	abundance	of	mtDNA	deletions.	These	findings	
go	 against	 a	 popular	 theory	 that	 fusion	 stabilizes	 mtDNA	 by	 preventing	
mutagenesis.	 This	 hypothesis	 is	 based	 on	 a	 previous	 report	 showing	 that	 skeletal	
muscle	dMfn	KO	mice	accumulate	point	mutations	and	deletions	of	mtDNA	(Chen	
et	al.,	2010).	However,	 this	 theory	 is	unsatisfactory	because	 the	absolute	 levels	of	
point	 mutations	 and	 deletions	 were	 extremely	 low	 (2-3	 x10-6	 and	 1	 x10-6,	
respectively).	Assuming	 that	 about	~103	mtDNA	copies	are	present	per	nucleus	 in	
skeletal	muscle	cells,	then	only	1:103	of	the	nuclear	domains	in	skeletal	muscle	will	
contain	a	deletion	or	a	point	mutation	of	mtDNA.	These	low	levels	of	mtDNA	point	
mutations	 and	deletions	 are	 insufficient	 to	 account	 for	mtDNA	 loss	 or	 respiratory	
dysfunction.	 In	 comparison,	 the	 mutator	 mouse	 (POLGγ	 exonuclease	 mutant)	
harbors	 about	 1	 x10-3	 point	 mutations	 which	 is	 sufficient	 to	 cause	 OXPHOS	
dysfunction	(Trifunovic	et	al.,	2004).	It	is	unlikely	that	the	tissue-specific	expression	
levels	of	mitofusins	could	account	for	the	discrepancy	between	the	studies.	In	both	
heart	 and	 skeletal	muscle	 the	 RNA	 expression	 of	 Mfn1	 is	 low	 (7.7	 and	 5.5	 RPKM,	
respectively),	 while	 Mfn2	 is	 very	 high	 in	 both	 tissues	 (89.9	 and	 71.1	 RPKM,	
respectively).	Interestingly,	some	adult	patients	with	Mfn2	or	Opa1	mutations	were	
reported	to	have	mtDNA	deletions	(Lodi	et	al.,	2011;	Rouzier	et	al.,	2012).	Although	
the	 determination	 of	 mtDNA	 deletions	 in	 these	 patients	 was	 not	 based	 on	 DNA	
sequencing	but	rather	PCR,	this	finding	would	suggest	a	causal	link	between	aging	
and	formation	of	mtDNA	deletions.	Thus,	it	is	possible	that	fusion-deficient	animals	
do	not	live	long	enough	to	generate	and	accumulate	mtDNA	deletions,	while	human	
patients	do.	Further	studies	with	animal	models	carrying	human	mutations	in	fusion	
proteins	 would	 help	 to	 determine	 if	 mitochondria	 genome	 stability	 depends	 on	
mitochondrial	fusion	proteins	during	aging.	
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On	mtDNA	depletion	and	premature	death			 	
We	 report	 that	 conditional	 heart	 dMfn	 KO	 animals	 suffer	 from	 severe	 mtDNA	
depletion	and	die	prematurely	between	5-6	weeks	of	age.	This	is	in	stark	contrast	to	
single	mitofusin1	and	2	heart	KO	animals	that	have	no	change	mtDNA	copy	number	
and	have	a	normal	life	span	(Mourier	et	al.,	2015).	However,	the	lifespan	was	similar	
to	 dMfn	 skeletal	muscle	KO	animals	 that	 live	up	 to	6-8	weeks	 (Chen	et	 al.,	 2010).	
Other	mutant	mice	displaying	severe	mtDNA	loss	also	die	around	the	same	age	as	
dMfn	KO	animals,	such	as	Polrmt	heart	KO	animals	which	live	up	to	6	weeks	(Kühl	et	
al.,	 2016).	 Some	mutant	mice	 die	 earlier,	 like	 Tk2	 whole	 body	 KO	 animals	 die	 at	
around	2	weeks	of	age	 (Zhou	et	al.,	2008).	 Interestingly,	Opa1	 skeletal	muscle	KO	
animals	 die	 the	 earliest,	 9	 days	 after	 birth	 (Tezze	 et	 al.,	 2017).	 However,	 not	 all	
mutant	mice	displaying	mtDNA	depletion	die	within	the	first	month;	Tfam	heart	KO	
animals	die	between	10-12	weeks	of	age,	Twnk	heart	KO	animals	die	at	19	weeks,	
and	Mgme1	whole	body	KO	animals	do	not	die	prematurely	 (Hansson	et	al.,	2004;	
Milenkovic	 et	 al.,	 2013;	Matic	 et	 al.,	 2018).	 The	 early	 premature	 death	 of	 fusion-
deficient	 animals	 further	 emphasizes	 the	 important	 of	 these	 proteins	 in	 mtDNA	
maintenance.			
	
On	mtDNA	replication	
The	 link	between	mitochondria	 fusion	and	mtDNA	maintenance	was	 first	made	 in	
the	budding	yeast.	The	yeast	homolog	of	Opa1,	Mgm1,	was	named	mitochondrial	
genome	maintenance	because	loss	of	this	protein	caused	complete	loss	of	mtDNA	
(Jones	and	Fangman,	1992;	Guan	et	al.,	1993).	 In	mammals,	 IMM	and	OMM	fusion	
are	equally	 important	to	maintain	mitochondrial	DNA	copy	number.	 In	agreement	
with	 previous	 reports,	 the	 absence	 of	mitofusins	 in	mouse	 heart	 tissue	 leads	 to	 a	
strong	 reduction	 in	mtDNA	 copy	 number	 (Chen	 et	 al.,	 2010;	 Papanicolaou	 et	 al.,	
2012).	 In	our	studies	to	uncover	the	molecular	basis	of	mtDNA	depletion	upon	the	
loss	mitochondrial	 fusion,	we	were	able	 to	 rule	out	certain	 factors.	We	 found	that	
mitochondrial	 fusion	 is	dispensable	 for	mt-transcription.	Transcription	activity	was	
normal	 and	 reflective	 of	 total	 mtDNA	 template	 in	 dMfn	 KO	 animals	 and	 MEFs.	
Moreover,	mtDNA	clustering	had	no	effect	on	transcription	activity.	Since	Drp1	KO	
animals	exhibit	massive	nucleoid	clustering	without	affecting	mtDNA	levels,	we	can	
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infer	 that	 moderate	 nucleoid	 clustering	 would	 not	 prevent	 mtDNA	 from	 being	
replicated	 in	 dMfn	 KO	 animals.	 Additionally,	 replication	 of	 mtDNA	 would	 not	 be	
impaired	 by	 a	 lack	 of	 dNTPs,	 as	 these	were	 present	 in	 normal	 abundance.	 These	
findings	would	 strongly	argue	 that	 loss	of	mitochondrial	 fusion	 specifically	 affects	
mtDNA	replication	at	the	molecular	level.		
	 We	show	that	OMM	fusion	ensures	that	the	mtDNA	replication	is	functional	
by	 maintaining	 a	 balanced	 replisome.	 This	 is	 well	 in	 line	 with	 previous	 in	 vitro	
studies	 that	 have	 shown	 that	 a	 balanced	 replisome	 composition	 is	 essential	 for	
efficient	mtDNA	replication	(Farge	et	al.,	2007;	Fusté	et	al.,	2014;	Korhonen	et	al.,	
2004;	Roos	et	al.,	2013).	Consistent	with	these	data,	mtDNA	depletion	phenotypes	
have	also	been	reported	 in	vivo	when	replisome	proteins	have	been	overexpressed	
or	knocked-out	in	animals	(Hance	et	al.,	2005;	Humble	et	al.,	2013;	Lefai	et	al.,	2000;	
Martínez-Azorín	 et	 al.,	 2008;	Milenkovic	 et	 al.,	 2013;	Tyynismaa	et	 al.,	 2004).	The	
presence	of	an	imbalance	replisome	prevented	high	rates	of	mtDNA	synthesis	and	
resulted	 in	 the	 generation	 of	 incomplete	 replication	 products.	How	mitochondrial	
fusion	ensures	a	balance	replisome	remains	to	be	further	examined.	One	possibility	
can	be	that	content	mixing	induced	by	mitochondrial	fusion	may	increase	the	half-
life	 of	 replisome	 factors.	 In	 summary,	 we	 report	 an	 unexpected	 link	 between	
mitochondrial	 fusion	 and	mammalian	mtDNA	 replication,	 whereby	mitochondrial	
fusion	coordinates	and	promotes	high	rates	of	mtDNA	replication	by	maintaining	a	
balance	replisome.		
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5.0	MATERIAL	AND	METHODS		
	
5.1	GENERATION	AND	MAINTENANCE	OF	MICE		
	
5.1.1	Generation	of	mutant	mice	
Mice	 with	 loxP-flanked	 Mfn1	 and	 Mfn2	 genes	 were	 generated	 by	 Taconic	
Biosciences	and	previously	described	in	(Lee	et	al.,	2012).	These	mice	have	loxP	sites	
flanking	 exon	 3	 of	 the	Mfn1	 gene	 and	 exon	 5	 of	 the	Mfn2	 gene	 and	 a	 neomycin	
resistance	 cassette	 flanked	 by	 Frt	 sites	 was	 introduced	 to	 select	 for	 homologous	
recombination.	 The	 neomycin	 resistance	 cassette	 was	 removed	 by	 mating	
transgenic	mice	with	mice	 constitutively	 expressing	 Flp	 recombinase.	 Conditional	
Mfn1	and	Mfn2	heart	double	knockout	mice	were	generated	by	mating	Mfn1loxP/loxP	
and	Mfn2loxP/loxP	mice	with	mice	expressing	the	Cre-recombinase	protein	(Mfn1loxP/loxP	
and	Mfn2loxP/+,	Cre+/-)	 in	 heart	 and	 skeletal	muscle	under	 the	 control	 of	 the	muscle	
creatinine	 kinase	 protomer	 (Ckmm).	 Littermates	 or	 age-matched	 animals	 lacking	
the	Cre-recombinase	allele	were	used	as	controls.	For	certain	imaging	experiments,	
Mfn1loxP/loxP,	Mfn2loxP/+,	Cre+/-	mice	were	crossed	with	Mfn1loxP/loxP,	Mfn2loxP/loxP,	Cre-/-	
mice,	constitutively	expressing	a	mitochondria-targeted	yellow	florescence	protein	
protein	 (YFPTg/Tg)	 from	 the	 ROSA26	 locus.	 YFP	 reporter	 mice	 were	 previously	
described	in	(Sterky	et	al.,	2011).		
	
5.1.2	Mouse	husbandry	
All	 inbred	 C57BL/6N	 mice	 were	 housed	 in	 the	 animal	 facility	 at	 the	 Max	 Planck	
Institute	 for	 Biology	 of	Aging.	 The	mouse	 facility	maintained	 a	 12	 hour	 light/dark	
cycle	with	an	ambient	temperature	of	21°C.	All	mice	were	approved	and	permitted	
by	the	Landesamt	für	Natur,	Umwelt	and	Verbraucherschutz,	Nordrhein-Westfalen,	
Germany.	All	animal	work	was	performed	following	the	guidelines	of	the	Federation	
of	European	Laboratory	Animal	Science	Associations	(FELASA).	
	
5.1.3	Mouse	genotyping	
Two-week	old	pups	were	genotyped	by	isolating	DNA	from	ear	clippings;	see	phenol	
chloroform	 extraction	 for	 details.	 DNA	
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(PCR)	 to	 amplify	 a	 target	 genomic	 segment,	 see	 Table	 1	 for	 details.	 PCR	 primers	
were	designed	to	detect	the	both	wild	type	and	loxP-flanked	Mfn1	or	Mfn2	alleles,	
the	 Cre	 transgene,	 or	 the	 Yfp	 transgene.	 See	 Table	 2	 for	 PCR	 primers	 used	 for	
genotyping.	PCR	products	were	subjected	to	gel	electrophoresis	using	1	%	agarose	
gels	 (Thermo	 Fisher	 Scientific,	 16500-500)	 containing	 ethidium	 bromide	 and	
visualized	 using	 a	 U:Genius	 gel	 documentation	 system	 (Integrated	 Scientific	
Solutions	Inc.).		
	
Table	1:	PCR	reaction	mix	and	conditions	
Locus	 Reagents	 Volume	(μl)	 PCR	conditions	
Mfn1	or	
Mfn2	
DNA	 2	 95ºC,	3	minutes	
	
95ºC,	30	seconds	
60ºC,	30	seconds	
72ºC,	1	minutes	
(30	cycles)	
	
72ºC,	5	minutes	
5x	PCR	buffer	 6	
dNTP	mix		(1.25	mM	each)	 5	
For	primer	(10	pmol/μl)	 0.6	
Rev	primer	(10	pmol/μl)	 0.6	
Taq	polymerase	 0.15	
Water	 15.56	
Total	volume	 28	
	
Cre	
DNA	 1	 95ºC,	3	minutes	
	
95ºC,	30	seconds	
53ºC,	30	seconds	
72ºC,	45	seconds	
(30	cycles)	
	
72ºC,	5	minutes	
5x	PCR	buffer	 4	
dNTP	mix	(1.25	mM	each)	 3.2	
For	primer	(10	pmol/μl)	 0.6	
Rev	primer	(10	pmol/μl)	 0.6	
Taq	polymerase	 0.1	
Water	 10.5	
Total	volume	 20	
	
ROSA26	
DNA	 1	 95ºC,	3	minutes	
	
95ºC,	30	seconds	
55ºC,	30	seconds	
72ºC,	1	minutes	
(30	cycles)	
	
	
72ºC,	5	minutes	
5x	PCR	buffer	 4	
dNTP	mix	(1.25	mM	each)	 3.2	
Primer	1	(10	pmol/μl)	 0.4	
Primer	2	(10	pmol/μl)	 0.4	
Primer	3	(10	pmol/μl)	 0.4	
Taq	polymerase	 0.1	
Water	 10.5	
Total	volume	 20	
	
Table	2:	Primers	for	mouse	genotyping	
Locus	 Primers	 PCR	products	
Mfn1	
For,	5’	TCTCCCCACAACAGTTTTTACC	3’	
Rev,	5’	CAGCCTGTGCTACATGAAACC	3’	
Wild	type	allele,	342	bp		
loxP	allele,	499	bp		
Mfn2	
For,	5’	CTGATGGGGTAGAAGAGATGG	3’	
Rev,	5’	CTTCAAGGTCAGGCAAAGG	3’	
Wild	type	allele,	141	bp		
loxP	allele,	298	bp	
Cre	
For,	5’	CACGACCAAGTGACAGCAAT	3’	
Rev,	5’	AGAGACGGAAATCCATCGCT	3’	
Cre	allele,	371bp		
	
ROSA26	
Primer	1,	5’	AAAGTCGCTCTGAGTTGTTAT	3’	
Primer	2,	5’	GCGAAGAGTTTGTCCTCAACC	3’	
Primer	3,	5’	GGAGCGGGAGAAATGGATATG	3’	
Wild	type	allele,	583	bp		
loxP	allele,	300	bp	
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5.2	CELL	MODELS	AND	MAINTENANCE				
	
5.2.1	Cell	Lines	
Mfn1,	 Mfn2,	 Mfn1-2	 double	 knockout	 mouse	 embryonic	 fibroblasts	 (MEF)	 were	
originally	 generated	 and	 immortalized	 in	 the	 lab	 of	 Prof.	 Dr.	 David	 Chan	 at	 the	
California	Institute	of	Technology	(Chen	et	al.,	2003,	2005).	Based	on	the	published	
literature	related	to	generation	of	these	cell	 lines	(Chen	et	al.,	2003),	the	wild-type	
Mfn1	 and	Mfn2	 genomic	 locus	 were	 double	 crossover	 with	 a	 targeted	 construct	
resulting	 in	 the	generation	of	a	pre-mature	stop	codon	 in	exon	3	and	a	neomycin-
resistance	 cassette	 flanked	 by	 loxP	 sites	was	 inserted.	MEFs	were	 prepared	 from	
embryonic	day	10.5	and	immortalized	by	infection	with	retrovirus	expressing	Simian	
vacuolating	 virus	 40	 large	 T	 antigen.	 Control	 and	 Mfn1,	Mfn2,	 dMfn,	 and	 Opa1	
knockout	 MEFs	 were	 obtained	 as	 a	 gift	 from	 Prof.	 Dr.	 Thomas	 Langer	 and	 Dr.	
Mafalda	Escobar-Henriques	from	the	University	of	Cologne.		
	 		
5.2.2	Cell	Culture	
All	cells	were	maintained	at	37°C	with	5	%	CO2	in	DMEM	GlutaMax	media	containing	
25	mM	glucose	(Thermo	Fisher	Scientific,	31966-021)	and	supplemented	with	10	%	
fetal	 bovine	 serum	 (Thermo	 Fisher	 Scientific,	 10270-106),	 100	 U/ml	 penicillin	 and	
100	 μg/ml	 streptomycin	 (Thermo	 Fisher	 Scientific,	 15070-063),	 1x	 non-essential	
amino	 acids	 (Thermo	 Fisher	 Scientific,	 11140-050),	 and	 50	 μg/ml	 uridine	 (Sigma-
Aldrich,	 U3750).	 Cells	 were	 passaged	 when	 confluency	 in	 a	 flask	 reached	 90	 %.	
Typical	viability	of	cells	was	between	96-98	%.		
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5.3	BIOENERGETIC	METHODS	
	
5.3.1	Isolation	of	heart	mitochondria	for	bioenergetics	
Functional	 assessment	 of	mitochondria	 requires	 intact	mitochondrial	 membranes	
and	 the	 coupling	of	 the	 respiratory	 chain	 to	proton	 translocation	 across	 the	 inner	
mitochondrial	 membrane.	 High-quality	 mitochondria	 were	 isolated	 from	 mouse	
heart	by	gentle	hand-homogenization	followed	by	differential	centrifugation.	First,	
mice	were	sacrificed	by	cervical	dislocation,	skin	disinfected	with	70	%	ethanol,	the	
heart	 quickly	 extracted,	 and	washed	 in	 ice-cold	 PBS.	 Remaining	 blood	 inside	 the	
heart	 was	 gently	 squeezed	 out	 with	 forceps.	 Tissue	was	 then	minced	 and	 placed	
inside	 a	 5	 ml	 Potter	 S	 homogenizer	 (Sartorius)	 containing	 5	 ml	 of	 mitochondria	
isolation	 buffer	 (MIB,	 310	mM	 sucrose,	 20	mM	Tris-HCl,	 and	 1	mM	EGTA).	 Tissue	
was	hand	homogenized	 slowly	with	 two	different	pestles,	 a	 very	 loose	pestle	 first	
and	then	a	slightly	loose	pestle,	both	custom	made.	Homogenates	were	transferred	
into	 a	 13	 ml	 centrifuge	 tube.	 To	 separate	 mitochondria	 from	 nuclear	 and	
cytoplasmic	 fractions,	 homogenates	 were	 centrifuged	 for	 10	minutes	 at	 1,000x	 g	
and	 4°C.	 Supernatants	 were	 transferred	 into	 a	 new	 13	 ml	 centrifuge	 tube	 and	
mitochondria	 pelleted	 by	 centrifugation	 at	 4,500x	g	 for	 10	minutes	 at	 4°C.	 Crude	
mitochondria	 were	 resuspend	 gently	 with	 cut	 pipette	 tips	 in	MIB	 and	 transferred	
into	a	1.5	ml	microcentrifuge	tube.	During	experiments	mitochondria	were	kept	on	
ice	or	when	not	in	use	stored	at	-80°C.		
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5.3.2	High-resolution	respirometry:	Mitochondria	
Mitochondria	 respiration	 is	 measured	 by	 recording	 the	 oxygen	 consumption	 at	
complex	 IV,	 as	 oxygen	 is	 reduced	 into	 water.	 An	 Oroboros-2K	 equipped	 with	 a	
polarographic	oxygen	 sensor	 (Oroboros	 Instruments)	was	used	 for	high-resolution	
determination	of	respiration	in	isolated	mitochondria.		 	
	 The	 Oxygraph-2K	 was	 calibrated	 to	 atmospheric	 oxygen	 prior	 to	
measurement	 of	 biological	 samples	 according	 to	 manufactures	 instructions.	 On	
experimental	 days,	 chambers	 were	washed	 three	 times	with	water	 and	 2.1	ml	 of	
fresh	 respiration	 buffer	 (120	 mM	 sucrose,	 50	 mM	 KCl,	 20	 mM	 Tris-HCl,	 4	 mM	
KH2PO4,	 2	 mM	 MgCl2,	 and	 1	 mM	 EGTA,	 pH	 7.2)	 was	 incubated	 at	 37°C	 and	 air	
calibrated	 with	 constant	 stirring	 until	 oxygen	 and	 flux	 plots	 were	 stabilized.	 The	
following	parameters	were	set	for	the	instrument:	oxygen	gain	senor	set	to	2,	stirrer	
speed	set	to	750	rpm,	data	recording	intervals	set	to	2,	and	oxygen	slope	set	to	15.		
	 Mitochondrial	respiration	under	phosphorylating,	non-phosphorylating,	and	
uncoupled	states	was	performed	sequentially	on	30	μg	of	crude	heart	mitochondria.	
Complex	 I-driven	 respiration	 under	 phosphorylating	 conditions	 was	 assessed	 by	
adding	1	mM	ADP	(Sigma-Aldrich,	A2754),	10	mM	pyruvate	(Sigma-Aldrich,	P2256),	
5	mM	glutamate	(Sigma-Aldrich,	49449),	and	5	mM	malate	(Sigma-Aldrich,	M1000).	
Complex	 II-driven	 respiration	 under	 phosphorylating	 conditions	 was	 assessed	 by	
adding	1	mM	ADP,	 10	mM	succinate	 (Sigma-Aldrich,	S3674),	 and	10	nM	 rotenone	
(Sigma-Aldrich,	 R8875).	 The	 non-phosphorylating	 state	 was	 evaluated	 by	 the	
addition	of	2.5	μg/ml	oligomycin	(Sigma-Aldrich,	O4876).	The	maximum	respiratory	
capacity	of	mitochondria	was	reached	by	uncoupling	electron	transfer	from	proton	
translocation	 by	 successive	 addition	 of	 CCCP	 (Sigma-Aldrich,	 C2759)	 up	 to	 3	 μM.	
Respiratory	controls	(the	ratio	of	phosphorylating/non-phosphorylating	flux)	were	>	
than	 10	 for	 complex	 I-driven	 respiration	 and	 >5	 for	 complex	 II-driven	 respiration	
based	on	control	heart	mitochondria.		A	respiratory	control	ratio	>3	denotes	coupled	
mitochondria.		
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5.3.3	High-resolution	respirometry:	Whole	cells	
Mitochondrial	 respiration	 in	 whole	 cells	 is	 determined	 in	 a	 similar	 matter	 as	 for	
isolated	mitochondria	using	an	Oxygraph-2K.	MEFs	were	maintained	for	5	to	6	days	
in	DMEM	GlutaMax	containing	25	mM	glucose	and	supplemented	with	1	%	dialyzed	
fetal	 bovine	 serum	 (Sigma-Aldrich,	 A3382001),	 100	 U/ml	 penicillin	 and	
streptomycin,	 1x	 non-essential	 amino	 acids,	 and	 50	 μg/ml	 uridine.	 MEFs	 were	
passaged	once	during	this	equilibration	phase.	On	experimental	days,	MEFs	 in	 log	
phase	 were	 washed	 with	 PBS,	 trypsinized	 with	 1	 ml	 of	 0.25	 %	 Trypsin-EDTA	
(Thermo	Fisher	Scientific,	25200056),	diluted	with	culture	medium,	cells	pelleted	by	
centrifugation	at	800xg	for	5	minutes,	and	resuspended	in	800	μl	of	culture	medium.	
A	 cell	 count	 from	 a	 1:10	 dilution	 was	 performed	 using	 a	 Vi-Cell	 XR	 cell	 analyzer	
(Beckman	Coulter).		
	 Mitochondrial	respiration	under	phosphorylating,	non-phosphorylating,	and	
uncoupled	states	was	performed	sequentially	using	1	million	viable	cells.	See	High-
resolution	 respirometry:	 Mitochondria	 for	 details	 on	 Oxygraph	 preparation.	 Before	
the	 addition	 of	 respiratory	 substrates,	 cells	 were	 permeabilized	 with	 0.02	 mg/ml	
Digitonin	 (Sigma-Aldrich,	300410)/ethanol	 (4	μl	 from	10	mg/ml	stock).	Complex	 II-
driven	 mitochondrial	 respiration	 under	 phosphorylating	 conditions	 was	 assessed	
with	2.3	mM	ADP	(10	μl	from	0.5	M	stock),	19.5	mM	succinate	(20	μl	from	1	M	stock),	
and	4.8	mM	glycerol-3-phosphate	(20	μl	 from	0.5	M	stock,	Sigma-Aldrich,	G7886).	
The	 non-phosphorylating	 state	 was	 evaluated	 by	 the	 addition	 of	 0.25	 μg/ml	
oligomycin	 (1	 μl	 from	 500	μg/ml	 stock)	 and	 the	maximum	 respiratory	 capacity	 of	
mitochondria	was	reached	by	successive	addition	of	CCCP	up	to	0.3	μM	(1	μl	steps	
using	0.1	mM	CCCP	stock).	Respiratory	controls	(the	ratio	of	phosphorylating/non-
phosphorylating	 flux)	 were	 >5	 for	 complex	 II-driven	 respiration	 based	 on	 control	
cells.		
	
5.3.4	Mitochondrial	ATP	production	
Through	 the	 oxidative	 phosphorylation	 system	 ADP	 and	 phosphate	 can	 be	
converted	 into	 ATP,	 a	 chemical	 form	 of	 cellular	 energy.	 Mitochondrial	 ATP	
production	can	be	measured	in	isolated	mitochondria	after	substrate	feeding	using	
a	 commercially	 available	 ATPlite	 1step	 kit	 (PerkinElmer,	 6016736).	 The	 oxygen	
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consumption	and	ATP	synthesis	 rates	 in	 isolated	heart	mitochondria	 (65	μg)	were	
simultaneously	 measured	 via	 complex	 I-driven	 respiration	 (1	 mM	 ADP,	 10	 mM	
pyruvate,	 5	mM	glutamate,	 and	 5	mM	malate)	 or	 complex	 II-driven	 respiration	 (1	
mM	ADP,	 2	mM	succinate,	 and	 10	nM	 rotenone).	 To	determine	 the	ATP	 content,	
aliquots	 were	 collected	 every	 20	 seconds,	 precipitated	 in	 7	 %	 HClO4	and	 25	 mM	
EDTA,	centrifuged	at	16,000x	g	for	10	minutes,	and	neutralized	with	2	M	KOH	and	
0.3	M	MOPS.	The	ATPlite	1step	kit	was	used	following	manufacture’s	instructions	to	
measure	the	ATP	abundance.	The	non-oxidative	ATP	synthesis	rate	was	determined	
in	a	parallel	experiment	using	oligomycin.	
	
5.3.5	Respiratory	Chain	Enzyme	Activities	
Enzymatic	 activity	 of	 respiratory	 chain	 complexes	 in	 isolated	 mitochondria	 was	
assessed	 through	 spectrophotometric	 analysis	 and	 through	 respirometry	 analysis.	
Complex	 I,	 II,	 and	 citrate	 synthase	 activity	 was	 determined	 using	 a	
spectrophotometer	 (UV-3600;	 Hitachi)	 at	 37°C	 using	 15-50	 μg	 of	 heart	 isolated	
mitochondria	 in	 1	 ml	 of	 phosphate	 buffer	 (50	 mM	 KH2PO4,	 pH	 7.4).	 Complex	 I,	
NADH	dehydrogenase,	activity	was	determined	in	the	presence	of	0.25	mM	NADH,	
0.25	mM	decylubiquinone,	and	1	mM	KCN	at	340	nm	(ε	=	6220	M-1cm-1).	Rotenone	
was	 added	 to	 control	 for	 complex	 I	 specific	 activity.	 Complex	 II,	 succinate	
dehydrogenase,	activity	was	determined	in	the	presence	of	40	mM	succinate,	35	μM	
dichlorophenolindophenol	(DCPIP),	and	1	mM	KCN	at	600	nm	(ε	=	21,000	M-1cm-1).	
Citrate	synthase	activity	was	determined	in	the	presence	of	0.1	mM	acetyl-CoA,	0.5	
mM	oxaloacetate,	and	0.1	mM	5,5’-dithiobis-2-nitrobenzoic	acid	(DTNB)	at	412	nm	
(ε	 =	 13,600	 M-1cm-1).	 Complex	 IV	 activity	 was	 assessed	 on	 65	 μg	 of	 isolated	
mitochondria	 in	 2	 ml	 of	 MIB.	 Oxygen	 consumption	 was	 recorded	 using	 an	
Oxygraph-2K	 in	 the	 presence	 of	 0.2	 mM	 TMPD,	 1	 mM	 ascorbate,	 and	 0.5	 μM	
Antimycin	A.	Once	respiratory	flux	was	stabilized	KCN	(2	mM	final)	was	injected	into	
chamber.	 Complex	 IV	 activity	 was	 calculated	 as	 the	 difference	 between	
TMPD/ascorbate	flux	minus	residual	flux	after	KCN	addition.		
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5.4	PROTEIN	BIOCHEMISTRY		
	
5.4.1	Isolation	of	heart	mitochondria		
Mice	were	sacrificed	by	cervical	dislocation,	skin	disinfected	with	70	%	ethanol,	the	
heart	quickly	extracted,	and	washed	in	ice-cold	PBS.	The	remaining	blood	inside	the	
heart	 was	 gently	 squeezed	 out	 with	 forceps.	 Tissue	was	 then	minced	 and	 placed	
inside	a	5	ml	Potter	S	homogenizer	 (Sartorius)	containing	5	ml	of	MIB.	Tissue	was	
homogenized	 using	 a	 Homgen	 plus	 homogenizer	 (Schuett-biotech)	 with	 a	 fitting	
pestle	performing	16	strokes	at	300	rpm.	Homogenates	were	transferred	 into	a	13	
ml	centrifuge	tube	and	centrifuged	for	10	minutes	at	1,000x	g	and	4°C.	Supernatants	
were	 transferred	 into	 a	 new	 13	ml	 centrifuge	 tube	 and	mitochondria	 pelleted	 by	
centrifugation	at	10,000x	g	 for	10	minutes	at	4°C.	Crude	mitochondria	were	gently	
resuspend	 in	 MIB	 and	 transferred	 into	 a	 1.5	 ml	 microcentrifuge	 tube.	 During	
experiments,	mitochondria	were	kept	on	ice	or	when	not	in	use	stored	at	-80°C.		
5.4.2	Isolation	of	MEF	mitochondria		
Isolation	 of	 mitochondria	 from	 cells	 was	 achieved	 by	 hypotonic	 cell	 disruption,	
homogenization	 with	 a	 syringe	 and	 followed	 by	 differential	 centrifugation,	 as	
previous	described	 in	 (Lee	and	Bogenhagen	2016)	with	minor	modifications.	Cells	
were	grown	on	 square	dishes	 (Thermo	Fisher	Scientific,	 166508)	 for	2-3	days	with	
standard	medium.	Cells	were	scraped	with	 ice-cold	PBS	and	centrifuged	at	500x	g	
for	 5	minutes	 at	 4°C.	Cells	were	 resuspended	 in	 3	ml	 of	 1x	mitochondria	 isolation	
buffer	 for	 cells	 (MSH,	 210	 mM	 mannitol,	 70	 mM	 sucrose,	 2	 mM	 EDTA,	 20	 mM	
HEPES	(KOH)	pH	8.0,	0.2	mg/ml	BSA,	2	mM	DTT,	and	1x	protease	inhibitors	(Sigma-
Aldrich,	 04693159001),	 and	 plasma	 membrane	 was	 permeabilized	 with	 0.04	 %	
Digitonin	 (12	 μl	 from	 10	%	Digitonin	 stock)	 for	 2-3	minutes	 on	 ice.	 Digitonin	was	
diluted	by	adding	7	ml	of	1x	MSH	buffer	and	cells	pelleted	at	1,200x	g	for	5	minutes	
at	4°C.	Cells	were	resuspended	in	3	ml	1x	MSH	and	lyzed	using	a	25-G	needle	(Braun,	
4657519)	for	about	12	strokes.	After	lysis	an	additional	7	ml	of	1x	MSH	was	added	to	
the	samples.	Homogenates	were	centrifuged	at	900xg	for	5	minutes	at	4°C	using	a	
swing-out	rotor.	Supernatant	was	collected	in	a	new	15	ml	tube	and	centrifugation	
step	repeated	another	2x	to	remove	as	much	of	the	nuclear	and	cytoplasmic	debris.	
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Supernatants	 were	 then	 centrifuged	 at	 15,000x	 g	 for	 15	minutes	 at	 4°C	 to	 pellet	
mitochondria.		
	 Mitochondria	 were	 washed	 with	 3	 ml	 of	 isolation	 buffer	 with	 potassium	
chloride	 (1x	MSH,	1	M	KCl)	 to	 further	 remove	nuclear	DNA	and	cytoplasmic	 rRNA	
contamination.	 Mitochondria	 were	 pelleted	 by	 centrifugation	 at	 15,000x	 g	 for	 15	
minutes	 at	 4°C	 and	 resuspended	 in	 1	 ml	 of	 nuclease	 buffer	 (1	 mM	 ADP,	 5	 mM	
glutamic	 acid,	 5	mM	malate,	 10	mM	NaOH,	 0.25	mg/ml	 BSA,	 1x	MSH	 buffer,	 1x	
protease	 inhibitors,	 10	 mM	 MgCl2,	 60	 mM	 KCl,	 1	 mM	 K2HPO4,	 2	 mM	 DTT)	
containing	25	μl	DNAseI	 (2	mg/ml	 stock,	Sigma,	10104159001),	2	μl	Turbo	DNAse	
(1x	stock,	Thermo	Fisher	Scientific,	AM2238),	and	5	μl	of	RNAse	A	(Qiagen,	19101).	
Samples	were	incubated	for	20	minutes	at	37°C	with	500	rpm	on	an	orbital	shaker.	
Reaction	was	stop	by	with	25	mM	EDTA	(50	μl	of	0.5	M	stock).		
	 Mitochondria	were	subject	to	an	additional	purification	step	through	sucrose	
gradient	 sedimentation.	DNAse/RNAse	 treated	mitochondria	were	 layered	on	 top	
of	 a	 sucrose	 gradient.	 A	 sucrose	 gradient	 was	 prepared	 in	 an	 Ultraclear	 tube	
(Beckman	Coulter,	344059)	and	composed	of	two	layers.	The	upper	layer	contained	
6	ml	of	1M	sucrose	(1	M	sucrose,	20	mM	HEPES	pH	8.0,	2	mM	EDTA,	2	mM	DTT,	and	
1x	protease	 inhibitor	cocktail)	and	the	 lower	 layer	was	3	ml	of	1.7M	sucrose	 (1.7	M	
sucrose,	 20	mM	HEPES	 (KOH)	 pH	 8.0,	 2	mM	EDTA,	 2	mM	DTT,	 and	 1x	 protease	
inhibitors).	Samples	were	centrifuged	at	25,000	rpm	for	25	minutes	at	4°C	using	a	
SW-41	Ti	rotor.	Mitochondria	were	collected	from	the	1.7	M	/	1	M	sucrose	interface	
into	a	1.5	ml	microcentrifuge	tube,	diluted	with	2-3	volumes	of	0.5x	MSH	buffer,	and	
centrifuged	at	10,000x	g	 for	10	minutes	at	4°C.	Mitochondria	were	washed	with	1x	
MSH	 buffer	 and	 centrifuged	 again.	 Lastly,	 mitochondria	 were	 resuspended	 in	 1x	
MSH	buffer	(50	μl	per	square	plate).	During	experiments	mitochondria	were	kept	on	
ice	or	when	not	in	use	stored	at	-80°C.	
	 	
5.4.3	DC	Protein	Assay	
Protein	 concentrations	 of	 isolated	mitochondria	 from	whole	 tissue	 and	whole	 cell	
extracts	 were	 determined	 using	 the	 commercially	 available	 DC	 (detergent	
compatible)	protein	assay	from	Bio-Rad	(5000111).	Each	sample	was	prepared	 in	a	
clear	96-well	Flat-bottom	plate	(Greiner	bio-one,	655101)	as	duplicates.	A	standard	
Material	and	Methods		
	 	 	 	86	
protein	curve	ranging	from	5	μg	to	30	μg	was	prepared	using	a	10	μg/μl	BSA	stock	
(New	England	BioLabs,	B9000S).	First,	0.5	μl	of	reagent	S	(surfactant	solution)	was	
combined	with	1	ml	of	reagent	A	(alkaline	copper	tartrate	solution).	Then,	25	μl	of	
reagent	A/S	was	pipetted	to	each	well.	Next,	1	μl	of	undiluted	sample	was	added	to	
a	designated	well.	The	plate	was	gentle	vortexed,	200	μl	of	reagent	B	(Folin	reagent)	
was	 added	 to	 each	 well,	 and	 incubated	 at	 room	 temperature	 for	 15	 minutes.	
Absorbance	was	recorded	at	750	nm	with	an	Infinite	M200	Pro	plate	reader	(Tecan).	
A	 linear	 regression	 analysis	 was	 performed	 on	 protein	 standards	 and	 used	 to	
calculate	protein	concentration	of	experimental	samples.		
5.4.4	Western	Blot		
The	abundance	of	 target	proteins	 can	be	analyzed	 in	a	homogenate	or	extract	by	
immunoblotting	with	specific	antibodies	that	recognized	a	protein	of	interest.	Heart	
tissue	and	whole	cells	were	first	by	lyzed	in	RIPA	buffer	(150	mM	NaCl,	1.0	%	NP-40	
(Sigma-Aldrich,	 I8896)	 or	 Triton	 X-100	 (Sigma-Aldrich,	 T8787),	 0.5	 %	 sodium	
deoxycholate	(Sigma-Aldrich,	D6750),	0.1	%	SDS	(Roth,	CN302),	50	mM	Tris	pH	8.0).	
After	 lysis,	 protein	 concentration	was	determined	using	DC	protein	 assay	 and	25-
100	 μg	 of	 protein	 was	 resuspended	 in	 2x	 NuPAGE	 LDS	 Sample	 Buffer	 (Thermo	
Fisher	Scientific,	NP0007)	with	0.1	M	DTT.	Isolated	mitochondria	were	prepared	by	
first	removing	the	storage	buffer	(MIB)	by	centrifugation	at	10,000xg	for	5	minutes	
at	4°C,	followed	by	resuspension	in	2x	NuPAGE	LDS	Sample	Buffer	with	0.1	M	DTT.	
Proteins	were	separated	by	SDS-PAGE	in	4-12	%	Bis-Tris	precast	gels	using	a	XCell	
SureLock	cell	 (Thermo	Fisher	Scientific).	Proteins	were	transferred	onto	a	0.45	μm	
PVDF	membrane	(GE	Healthcare,	1060023),	or	in	some	cases	0.45	μm	nitrocellulose	
membranes	(GE	Healthcare,	10600002),	with	1x	transfer	buffer	(38.6	mM	Tris,	47.8	
mM	 glycine,	 20	 %	 methanol)	 using	 a	 Criterion	 blotter	 (Bio-Rad).	 After	 transfer,	
membranes	were	washed	 in	 1x	TBS	and	 then	blocked	 in	 3	%	milk/TBS	 for	 1	hour.	
Primary	antibodies	were	applied	overnight	at	4°C.	Membranes	were	then	washed	3x	
with	TBST	(0.1	%	Tween	20	(Sigma-Aldrich,	P9416)	/TBS)	for	5	minutes,	1x	with	TBS	
for	 5	 minutes,	 and	 HRP-conjugated	 secondary	 antibodies	 applied	 at	 room	
temperature.	 See	 Table	 3	 for	 complete	 list	 of	 primary	 and	 secondary	 antibodies	
used.	Afterwards,	membranes	were	washed	again	3x	with	TBST	and	1x	with	TBS.	
Material	and	Methods		
	 	 	 	87	
Detection	of	HRP-conjugated	secondary	antibodies	was	achieved	using	Amersham	
ECL	western	blotting	detection	reagent	(GE	Healthcare,	RPN2106)	and	Amersham	
Hyperfilm	ECL	 (GE	Healthcare,	 28906836).	 For	 certain	 experiments,	 after	 primary	
antibody	 incubation	 PVDF	 membranes	 were	 decorated	 with	 near-infrared	
fluorescence-conjugated	 secondary	 antibodies	 (1:30,000	 in	 BSA,	 Table	 3)	 for	 30	
minutes	at	room	temperature,	washed	3x	with	TBST	and	1x	with	TBS,	and	followed	
by	fluorescence	signal	detection	with	an	Odyssey	imaging	system.	
	
Table	3:	Primary	and	secondary	antibodies	used	for	immunoblotting	
Protein	target		 Host	 Source		 Catalogue	#	 Dilution	
Anti-β-Actin	 Mouse	 Abcam		 ab8226	 1:500	
Anti-MFN1		 Rabbit	 Abcam	 ab104274	 1:500	
Anti-MFN2	 Mouse	 Abcam	 ab56889	 1:500	
Anti-OXPHOS	cocktail		 Mouse	 Abcam	 ab110413	 1:1000	
Anti-POLγA	 Rabbit	 Abcam	 ab12899	 1:250	
Anti-TFAM		 Rabbit	 Abcam	 ab131607	 1:1000	
Anti-VDAC		 Mouse	 Abcam	 ab14734	 1:1000	
Anti-SSBP1	 Rabbit	 Sigma	 HPA002866	 1:500	
Anti-TWNK	 Rabbit	 Custom-made,	AfP	 Milenkovic	et	al.,	2013	 1:100	
Anti-TFB2M	 Rabbit	 Custom-made,	AfP	 Metodiev	et	al.	2009	 1:100	
Anti-POLRMT	 Rabbit	 Custom-made,	AfP	 Kühl	et	al.,	2014	 1:100	
Anti-LRPPRC	 Rabbit	 Custom-made,	AfP	 Ruzzenente	et	al.,	2012	 1:100	
Anti-NDFUA9		 Mouse	 Thermo	Fisher	Scientific	 459100	 1:1000	
Anti-ATP5A		 Mouse	 Abcam	 ab14748	 1:1000	
Anti-MTCO1	 Mouse	 Abcam	 ab14705	 1:1000	
Anti-COIII	Core2		 Mouse	 Abcam	 ab14705	 1:1000	
Anti-SHD	70kDa	Fp	subunit		 Mouse	 Thermo	Fisher	Scientific	 459200	 1:1000	
Anti-rabbit	IgG	-	HRP	 Donkey	 GE	Healthcare	 NA9340V	 1:10,000	
Anti-mouse	IgG	-HRP	 Sheep	 GE	Healthcare	 NXA931	 1:10,000	
IRDye	800	conj.	anti-rabbit	 Donkey	 Licor	 925-32213	 1:30,000	
IRDye	800	conj.	anti-mouse	 Donkey	 Licor	 925-32212	 1:30,000	
Alexa	Fluor	680	anti-mouse	 Goat	 Thermo	Fisher	Scientific	 A27057	 1:30,000	
Alexa	Fluor	680	anti-rabbit	 Goat	 Thermo	Fisher	Scientific	 A21076	 1:30,000	
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5.4.5	Blue	Native	PAGE	Analyses	
Analysis	of	protein	complexes	under	native	conditions	was	achieved	by	Blue	Native	
PAGE	electrophoresis,	as	previously	described	with	minor	modifications	(Jha	et	al.,	
2016).	 Isolated	mitochondria	 (50	μg)	were	prepared	by	 first	 removing	 the	 storage	
buffer	(MIB)	by	centrifugation	at	10,000x	g	for	5	minutes	at	4°C.	Mitochondria	were	
then	 solubilized	 on	 ice	 for	 15	 minutes	 in	 16	 μl	 of	 1x	 NativePAGE	 sample	 buffer	
(Thermo	Fisher	Scientific,	BN20032)	containing	1	%	DDM	or	2	%	Digitonin.	Insoluble	
material	was	pelleted	by	 centrifugation	 at	 20,000x	g	 for	 30	minutes	 at	 4°C.	Next,	
12	 μl	 of	 supernatant	 was	 collected	 and	 mixed	 with	 0.5	 μl	 of	 NativePAGE	
5	%	G-250	sample	additive	 (Invitrogen,	BN20041).	High	molecular	weight	markers	
were	 prepared	 following	 manufactures	 instructions	 (GE	 Healthcare,	 17-0445-01).	
Samples	 were	 separated	 on	 a	 3-12	 %	 NativePAGE	 Bis-Tris	 gel	 (Thermo	 Fisher	
Scientific,	 BN1001BOX).	 Initially,	 a	 dark	 blue	 cathode	 buffer	 (1x	 NativePAGE	
running	 buffer	 and	 0.5x	 cathode	 additive;	 Invitrogen,	 BN2001	 and	 BN2002)	 was	
added	to	the	inner	chamber	of	a	XCell	SureLock	cell	and	ran	for	30	minutes	at	150	
volts.	Then,	the	dark	blue	cathode	was	removed	by	aspiration	and	exchanged	with	
light	blue	cathode	buffer	(1x	NativePAGE	running	buffer	and	0.1x	cathode	additive)	
and	separation	was	continued	at	150	Volts	until	the	blue	front	reach	the	bottom	of	
the	gel.	The	anode	buffer	(placed	in	the	outside	chamber	of	the	XCell	SureLock	cell)	
consisted	of	1x	NativePAGE	 running	buffer.	DDM-treated	samples	were	subjected	
to	 standard	 immunoblotting.	 To	 this	 end,	 proteins	were	 transferred	 onto	 a	 PVDF	
membrane	 with	 BN-transfer	 buffer	 (47.9	 mM	 Tris	 and	 38.7	 mM	 glycine)	 for	 90	
minutes	 at	 400	 mA	 and	 4°C.	 Afterwards,	 residual	 Coomassie	 was	 removed	 by	
washing	with	methanol	prior	applying	primary	antibodies.	
5.4.6	Glycerol	Gradient	Fractionation	and	Immunoblotting	
Analysis	 of	 mitochondrial	 DNA-protein	 complexes	 can	 be	 achieved	 by	 glycerol	
gradient	sedimentation	followed	by	western	and	southern	blotting.	This	protocol	is	
adapted	 from	 (Lee	 and	 Bogenhagen	 2016)	 with	 minor	 modifications.	 Crude	
mitochondria	 (250	 μg),	 which	 were	 DNaseI	 (Sigma-Aldrich,	 10104159001)	 and	
RNase	A	(Qiagen,	19101)	-treated	and	purified	by	sucrose	gradient	were	used.	The	
mitochondrial	storage	buffer	(MIB)	was	removed	by	centrifugation	at	10,000x	g	for	
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5	 minutes	 at	 4°C.	 Mitochondria	 were	 then	 lyzed	 on	 ice	 in	 83.3	 μl	 (3	 μg/μl),	
mitochondrial	 lysis	buffer	 (MLB,	2	%	Triton	X-100,	 100	mM	HEPES	 (KOH)	pH	8.0,		
100	mM	NaCl,	 10	mM	 EDTA,	 10	mM	DTT,	 1x	 Protease	 inhibitor	 cocktail	 without	
EDTA)	for	15	minutes	and	two	8.3	μl	aliquots	(about	25	μg	protein),	from	the	total	
lysate,	 were	 collected	 as	 input	 samples	 for	 western	 and	 southern	 blotting.	 The	
remaining	total	lysate	was	carefully	layered	on	top	of	the	casted	glycerol	gradient.	A	
15-40	%	 glycerol	 gradient	 containing	 a	 20	%	 glycerol	 /	 30	%	 iodixanol	 pad	 at	 the	
bottom	of	gradient	was	casted.	First,	5.5	ml	of	15	%	glycerol	buffer	(15	%	glycerol	in	
1x	MLB)	was	added	onto	a	14x89	mm	Ultraclear	 tube	 (Beckman	Coulter,	344059).	
Then,	 5.5	ml	 of	 40	%	glycerol	 buffer	 (40	%	glycerol	 in	 1x	MLB)	was	 added	with	 a	
syringe	 from	 the	 bottom	 of	 the	 tube,	 pushing	 the	 15	%	 glycerol	 buffer	 upwards.	
Lastly,	 500	 μl	 of	 20	 %	 glycerol	 /	 30	 %	 iodixanol	 mixture	 was	 also	 added	 with	 a	
syringe	to	the	bottom	of	the	tube.	Ultracentrifuge	tubes	were	closed	with	SW	41	Ti	
long	 caps	 (Beranek	 Laborgeräte,	 105-514-6)	 and	 gradient	 casted	 using	 a	 gradient	
master	(model	107,	Biocomp)	with	the	following	settings:	2	minutes	and	31	seconds	
run	 time,	81.65	angle,	and	 speed	set	 to	14.	Mitochondrial	 lysates	were	 layered	on	
top	 of	 the	 gradient,	 gradients	 balanced,	 and	 centrifuged	 at	 151,000x	g	 at	 4°C	 for	
4	 hours.	 Gradient	 was	 manually	 fractionated	 in	 750	 μl	 increments	 from	 top	 to	
bottom	using	a	1	ml	pipette.	Fractions	were	filled	up	to	1	ml	and	divided	in	half	for	
protein	precipitation	and	DNA	isolation.		
	 Proteins	were	precipitated	overnight	at	-20°C	with	12	%	trichloroacetic	acid	
(Millipore	 1.00807.1000)	 and	0.02	%	 sodium	deoxycholate.	 The	next	 day,	 samples	
were	centrifuged	at	20,000x	g	for	20	minutes	at	4°C.	Pellets	were	washed	with	1	ml	
of	 acetone	 (Millipore	 1.00014.1000),	 incubated	 on	 ice	 for	 15	 minutes,	 and	
centrifuged	20,000x	g	for	20	minutes	at	4°C.	After	a	second	acetone	wash,	protein	
pellets	 were	 dried	 at	 room	 temperature	 and	 solubilized	 in	 16	 μl	 of	 2x	 NuPAGE	
loading	 buffer	 containing	 0.1	 M	 DTT.	 See	 Western	 blot	 for	 further	 details	 on	
immunoblotting.	
	 Mitochondrial	DNA	was	 isolated	by	phenol	 chloroform	extraction.	To	each	
500	 μl	 fraction,	 60	 μl	 of	 1	 M	 Tris	 pH	 8,	 40	 μl	 3	 %	 SDS,	 and	 60	 μl	 of	 10	 mg/ml	
Proteinase	K	was	 added	 and	 incubated	 overnight	 at	 56°C.	 Then	 600	μl	 of	 phenol	
chloroform	was	added	and	centrifuged	at	5,000x	g	 for	5	minutes.	The	upper	phase	
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was	aspirated	into	a	2	ml	microcentrifuge	tube	and	60	μl	of	8	M	potassium-acetate	
plus	2	μl	of	GlycoBlue	(Thermo	Fisher	Scientific,	AM9515)	was	added	and	mixed	by	
vortex.	Then	1.5	ml	of	pure	ethanol	was	added	and	samples	incubated	overnight	at		
-20°C.	 Samples	 were	 tabletop	 centrifuged	 at	 max	 speed	 for	 30	 minutes	 at	 4°C,	
pellet	 dried.	 DNA	 was	 resuspend	 in	 15	 μl	 digestion	 buffer	 (1x	 Smartcut	 buffer)	
containing	 1	 μl	 of	 SacI-HF	 restriction	 enzyme	 (NEB,	 R3156S)	 and	 incubated	 for		
1	hour	at	37°C.		Digested	samples	were	prepared	for	agarose	gel	electrophoresis	by	
adding	 4	 μl	 of	 6x	 DNA	 loading	 dye.	 See	Southern	 blot	 for	 further	 details	 on	 how	
mtDNA	was	visualized.	
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5.5	MOLECULAR	BIOLOGY	METHODS		
	
5.5.1	Northern	blot	
Total	RNA	was	extracted	from	frozen	ground	heart	tissue	using	the	ToTALLY	RNA	
isolation	 kit	 (Ambion,	 AM1910)	 or	 TRIzol	 reagent	 (Thermo	 Fisher	 Scientific,	
15596026).	Extracted	RNA	was	subjected	to	DNase	treatment	following	instructions	
from	 TURBO	 DNA-free™	 kit	 (Thermo	 Fisher	 Scientific,	 AM1907).	 RNA	 sample	
loading	buffer	(Sigma,	R1386)	was	added	to	RNA	(1-2	μg),	denatured	for	20	minutes	
at	65°C,	 loaded	onto	a	1	or	1.8	%	 formaldehyde-MOPS	agarose	gel,	and	 ran	 for	2	
hours	 at	 120	 volts.	 Migration	 of	 RNA	 through	 the	 gel	 was	 checked	 with	 a	 UV	
transilluminator.	 RNA	 was	 transferred	 overnight	 onto	 a	 15	 x	 15	 cm	 Hybond-N+	
membrane	(GE	Healthcare,	RPN203B).	The	membrane	was	first	incubated	in	MiiliQ	
water	 for	 15	minutes,	 and	 both	 gel	 and	membrane	were	 incubated	 in	 20x	 saline-
sodium	citrate	(SSC)	buffer	for	20	minutes	prior	to	transfer	assembly.		
	 Gel	 to	membrane	 transfer	 assembly	was	as	 follows.	A	 large	glass	dish	was	
filled	with	20x	SSC	and	a	salt	bridge	using	blotting	paper	(15	x	20	cm)	was	place	on	
top	of	 the	dish	with	the	upper	and	 lower	ends	of	 the	blotting	paper	submerged	 in	
20x	SSC.	Two	pieces	of	 blotting	paper	 (15	 x	 15	 cm),	 pre-soaked	 in	 20x	SSC,	were	
placed	on	top	of	the	salt	bridge.	Air	bubbles	were	rolled	out	and	the	gel	placed	face	
down	on	top	of	the	blotting	papers.	Air	bubbles	were	rolled	out	and	the	Hybond-N+	
membrane	was	placed	on	top	of	the	gel,	 the	top	right	corner	was	cut.	Air	bubbles	
were	rolled	out	and	another	two	pieces	of	wet	blotting	paper	were	placed	on	top	of	
the	membrane.	Next,	a	stack	of	paper	towels	was	placed	on	top,	followed	by	15	x	15	
cm	glass	plate	and	a	filled	1	L	glass	bottle.	RNA	was	left	to	transfer	overnight.	After	
transfer,	 the	 transfer	 system	was	dismantled	 and	membrane	was	washed	with	2x	
SSC	for	5	minutes,	and	dried	at	room	temperature.	
	 Membrane	was	UV	cross-linked	with	a	UVC500	crosslinker	 (GE	Healthcare)	
for	3	minutes,	followed	by	blocking	in	20	ml	of	PerfectHyb	Plus	Hybridization	buffer	
(Sigma,	 H7033)	 for	 1	 hour	 at	 65°C	 prior	 to	 being	 hybridized	 with	 various	 probes.	
Mitochondrial	probes	used	for	visualization	of	mRNA	and	rRNA	levels,	Table	4,	were	
restriction	 fragments	 labeled	 with	 α-32P-dCTP	 and	 a	 Prime-It	 II	 Random	 Primer	
Labeling	Kit	(Agilent	technologies,	300385).	First,	mRNA	or	rRNA	probe	(30	ng)	was	
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mixed	with	random	primers	and	primers	denatured	at	95°C	for	5	minutes,	followed	
by	 2	 minutes	 on	 ice,	 Table	 5.	 Then,	 probes	 were	 mixed	 radioactive	 α-32P-dCTP	
(Hartmann	 Analytic),	 non-radioactive	 dNTPs	 and	 DNA	 polymerase.	 Sample	 was	
incubated	for	30	minutes	at	37°C,	Table	6.		
	 The	 probe	 was	 purified	 with	 G-50	 columns	 following	 manufactures	
instructions	 (IllustraTM	 Probe	 Quant	 TM	 G-50	 Micro	 Columns,	 GE	 Healthcare,	
28903408).	 Afterwards,	 50	 μl	 of	 purified	 probe	 was	 added	 to	 the	 hybridization	
buffer	 used	 for	 blocking	 the	 membrane	 and	 incubated	 overnight	 at	 65°C.	
Afterwards,	membranes	were	first	washed	with	20	ml	of	2x	SSC/0.1	%	SDS	and	then	
with	20	ml	0.2x	SSC/0.1	%	SDS	for	20	minutes	at	65°C.	Membrane	was	sealed	in	a	
plastic	bag	and	exposed	to	a	phosphor	screen	and	developed	using	a	Typhoon	FLA	
7000	(GE	healthcare)	or	exposed	to	autoradiography	films	for	visualization	of	mRNA	
and	rRNA.		 	
	 Different	tRNAs	and	7S	rRNA	were	detected	using	specific	oligonucleotides	
end-labeled	 with	 γ-32P-dATP	 following	 a	 similar	 protocol	 as	 for	mRNA	 and	 rRNA	
with	the	following	differences.	Membranes	were	blocked	with	10	ml	of	PerfectHyb	
Plus	Hybridization	buffer	for	1	hour	at	42°C.	T4	Polynucleotide	Kinase	end-labeling	
reaction	 for	 tRNA	probes	was	 prepared	 as	 shown	 in	Table	 7	 and	 incubated	 for	 30	
minutes	at	37°C.	
	 tRNA	probe	was	purified	with	a	G-25	column	(IllustraTM	MicroSpinTM	G-25	
Columns,	 27532501)	 following	 manufactures	 instructions.	 Afterwards,	 50	 μl	 of	
purified	probe	was	added	to	 the	hybridization	buffer	used	 for	blocking	membrane	
and	incubated	overnight	at	42°C.	Lastly,	membranes	were	washed	and	membranes	
exposed	as	described	above.		
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Table	4:	Mitochondrial	probes	for	Northern	and	Southern	blot	
Target	 Probe	 Oligonucleotide	Sequence	
mRNA	 NdI	
ACGCAAAATCTTAGGGTACATACAACTACGAAAAGGCCCTAACATTGTTGGTCCATACG
GCATTTTACAACCATTTGCAGACGCCATAAAATTATTTATAAAAGAACCAATACGCCCT
TTAACAACCTCTATATCCTTATTTATTATTGCACCTACCCTATCACTCACACTAGCATTAA
GTCTATGAGTTCCCCTACCAATACCACACCCATTAATTAATTTAAACCTAGGGATTTTAT
TTATTTTAGCAACATCTAGCCTATCAGTTTACTCCATTCTATGATCAGGATGAGCCTCAA
ACTCCAAATACTCACTATTCGGAGCTTTACGAGCCGTAGCCCAAACAATTTCATATGAA
GTAACCATAGCTATTATCCTTTTATCAGTTCTATTAATAAATGGATCCTACTCTCTACAA
ACACTTATTACAACCCAAGAACACATATGATTACTTCTGCCAGCCTGACCCATAGCCAT
AATATGATTTATCTCAACCCTAGCAGAAACAAAC	
mRNA	 CoxI	
GTTCATTATTTTTGGTTGGTTGTCTTGGGTTAGCATTAAAGCCTTCACCTATTTATGGAG
GTTTAGGTTTAATTGTTAGTGGGTTTGTTGGTTGTTTAATGGTTTTAGGGTTTGGTGGA
TCGTTTTTAGGTTTAATAGTTTTTTTAATTTATTTAGGGGGGATGTTGGTTGTGTTTGGA
TATACGACTGCTATAGCTACTGAGGAATATCCAGAGACTTGGGGATCTAACTGATTAAT
TTTGGGTTTTTTAGTATTGGGGGTGATTATAGAGGTTTTTTTAATTTGTGTGCTTAATTA
TTATGATGAAGTTGGAGTAATTAATCTTGATGGTTTGGGAGATTGGTTGATGTATGAGG
TTGATGATGTTGGAGTTATGTTGGAAGGAGGGATTGGGGTAGCGGCAATATATAGTTG
TGCTACTTGAATGATGGTAGTGCTGGGTGATCTTTGTTTGCGGGTATTTTTATT	
mRNA	 CoxII	
GGTCTACAAGACGCCACATCCCCTATTATAGAAGAGCTAATAAATTTCCATGATCACAC
ACAATAATTGTTTTCCTAATTAGCTCCTTAGTCCTCTATATCATCTCGCTAATATTAACA
ACAAAACTAACACATACAAGCACAATAGATGCACAAGAAGTTGAAACCATTTGAACTAT
TCTACCAGCTGTAATCCTTATCATAATTGCTCTCCCCTCTCTACGCATTCTATATATAATA
GACGAAATCACAACCCCGTATTAACCGTTAAAACCATAGGGCACCAATGATACTGAAGC
TACGAATATACTGACTATGAAGACCTATGCTTTGATTCATATATAATCCCAACAAACGA
CCTAAAACCTGGTGAACTACGACTGCTAGAAGTTGATAACCGAGTCGTTCTGCCAA	
mRNA	 Nd5	
ACAAGACATCCGAAAAATAGGAAACATCACAAAAATCATACCATTCACATCATCATGCC
TAGTAATCGGAAGCCTCGCCCTCACAGGAATACCATTCCTAACAGGGTTCTACTCAAAA
GACCTAATTATTGAAGCAATTAATACCTGCAACACCAACGCCTGAGCCCTACTAATTAC
ACTAATCGCCACTTCTATAACAGCTATGTACAGCATACGAATCATTTACTTCGTAACAAT
AACAAAACCGCGTTTTCCCCCCCTAATCTCCATTAACGAAAATGACCCAGACCTCATAA
ACCCAATCAAACGCCTAGCATTCGGAAGCATCTTTGCAGGATTTGTCATCTCATATAAT
ATTCCACCAACCAGCATTCCAGTCCTCACAATACCATGATTTTTAAAAACCACAGCCCTA
ATTATTTCAGTATTAGGATTCCTAATCGCACTAGAACTAAACAACCTAACCATAAAACT
ATCAATAAATAAAGCAAATCCATATTCATCCTTCTCAACTTTACTGGGGTTTTTCCCATC
TAT	TATTCACCGCATTACACC		
mRNA	
Cytb	
	
AGTAGACAAAGCCACCTTGACCCGATTCTTCGCTTTCCACTTCATCTTACCATTTATTAT
CGCGGCCCTAGCAATCGTTCACCTCCTCTTCCTCCACGAAACAGGATCAAACAACCCAA
CAGGATTAAACTCAGATGCAGATAAAATTCCATTTCACCCCTACTATACAATCAAAGAT
ATCCTAGGTATCCTAATCATATTCTTAATTCTCATAACCCTAGTATTATTTTTCCCAGACA
TACTAGGAGACCCAGACAACTACATACCAGCTAATCCACTAAACACCCCACCCCATATT
AAACCCGAATGATATTTCCTATTTGCATACGCCATTCTACGCTCAATCCCCAATAAACTA
GGAGGTGTCCTAGCCTTAATCTTATCTATCCTAATTTTAGCCCTAATACCTTTCCTTCAT
ACCTCAAAGCAACGAAGCCTAATATTCCGCCCAATCACACAAATTTTGTACTGAATCCT
AGTAGCCAACCTACTTATCTTAACCTGAATTGGGGGCCAACCAGTAGAACACCCATTT		
mRNA	 12S	
TACACATGCAAACCTCCATAGACCGGTGTAAAATCCCTTAAACATTTACTTAAAATTTAA
GGAGAGGGTATCAAGCACATTAAAATAGCTTAAGACACCTTGCCTAGCCACACCCCCAC
GGGACTCAGCAGTGATAAATATTAAGCAATAAACGAAAGTTTGACTAAGTTATACCTCT
TAGGGTTGGTAAATTTCGTGCCAGCCACCGCGGTCATACGATTAACCCAAACTAATTAT
CTTCGGCGTAAAACGTGTCAACTATAAATAAATAAATAGAATTAAAATCCAACTTATAT
GTGAAAATTCATTGTTAGGACCTAAACTCAATAACGAAAGTAATTCTAGTCATTTATAA
TACACGACAGCTAAGACCCAAACTGGGATTAGATACCCCACTATGCTTAGCCATAAACC
TAAATAATTAAATTTAACAAAACTATTTGCCAGAGAACTACTAGCCATAGCTTAAAACT
CAAAGGACTTGGCGGTACTTTATATCCATCTAGAGGAGCCTGTTCTATAATCGATAAAC
CCCGCTCTACCTCACCATCTCTTGCTAA		
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mRNA	 18S	
	
GGTCTACAAGACGCCACATCCCCTATTATAGAAGAGCTAATAAATTTCCATGATCACAC
ACTAATAATTGTTTTCCTAATTAGCTCCTTAGTCCTCTATATCATCTCGCTAATATTAACA
ACAAAACTAACACATACAAGCACAATAGATGCACAAGAAGTTGAAACCATTTGAACTAT
TCTACCAGCTGTAATCCTTATCATAATTGCTCTCCCCTCTCTACGCATTCTATATATAATA
GACGAAATCAACAACCCCGTATTAACCGTTAAAACCATAGGGCACCAATGATACTGAA
GCTACGAATATACTGACTATGAAGACCTATGCTTTGATTCATATATAATCCCAACAAAC
GACCTAAAACCTGGTGAACTACGACTGCTAGAAGTTGATAACCGAGTCGTTCTGCCAA		
tRNA	 tRNAPhe	 CATTTTCAGTGCTTTGCTTTGTTATTA		
tRNA	 tRNALeu1	 AAGTCTTACGCAATTTCCTGGCTCTG	
tRNA	 tRNAPro	 TCAAGAAGAAGGAGCTACT	
tRNA	 tRNAGlu	 AACTGCGACCAATGACATGAAAAATC	
RNA	 7S	RNA	 GACATATAATATTAACTATCAAACCCTATGTCCTGATCAATTCTA		
DNA	 7S	DNA	
AGTACATAAATTTACATAGTACAACAGTACATTTATGTATATCGTACATTAAACTATTTT
CCCCAAGCATATAAGCTAGTACATTAAATCAATGGTTCAGGTCATAAAATAATCATCAA
CATAAATCAATATATATACCATGAATATTATCTTAAACACATTAAACTAATGTTATAAGG
ACATATCTGTGTTATCTGACATACACCATACAGTCATAAACTCTTCTCTTCCATATGACT
ATCCCCTTCCCCATTTGGTCTATTAATCTACCATCCTCCGTGAAACCAACAACCCGCCCA
CCAATGCCCCTCTTCTCGCTCCGGGCCCATTAAACTTGGGGGTAGCTAAACTGAAACTT
TATCAGACATCTGGTTCTTACTTCAGGGCCATCAAATGCGTTATCGCCCATACGTTCCCC
TTAAATAAGACATCTCGATGGTATCGGGTCTAATCAGCCCATGACCAACATAACTGTGG
TGTCATGCATTTGGTATCTTTTTATTTTGGCCTACTTTCATCAACATAGCCGTCAAGGCA
TGAAAGGACAGCACACAGTCTAGACGCACCTACGGTGAAGAATCATTAGTCCGCAAAA
CCCAATCACCTAAGGCTAATTATTCATGCTTGTTAGACATAAATGCTACTCAATACCAAA
TTTTAACTCTCCAAACCCCCCACCCCCTCCTCTTAATGCCAAACCCCAAAAACACTAAGA
ACTTGAAAGACATATAATATTAACTATCAAACCCTATGTCCTGATCAATTCTAGTAGTTC
CCAAAATATGACTTATATTTTAGTACTTGTAAAAATTTTACAAAATCATGTTCCGTGAAC
CAAAACTCTAATCATACTCTATTACGCAATAAACATTAACAA	
DNA	 pAM1	 Whole	mitochondrial	genome	sequence		
	
	
Table	5:	Random	primers	preparation	
Chemical	 Volume	
Random	9-mer	primers	 10	μl	
30	ng	mRNA	or	rRNA	probe	 1	μl	
DEPC	water	 23		μl	
	
	
Table	6:	Probe	synthesis	reaction	 	
Chemical	 Volume	
Probe	with	random	primers	mix	 34	μl	
5x	dCTP	buffer	(with	all	dNTPs	except	dCTPs)		 10	μl	
Exo	(-)	Klenow	polymerase	5	U/μl		 1	μl	
50	μCi	α-32P-CTP		 5	μl	
	
	
Table	7:	tRNA	end-labeling	reaction	
Chemical	 Volume	
10x	Polynucleotide	buffer	(NEB)	 2	μl	
T4	Polynucleotide	Kinase	(NEB)	 1	μl	
10	μM	primers	 2	μl	
30	μCi	γ-32P-ATP	 3	μl	
DEPC	water	 12	μl	
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5.5.2	Phenol	Chloroform	Extraction		
Total	 DNA	 from	 ear	 clippings	 was	 isolated	 by	 phenol	 chloroform	 extraction.	 Ear	
clippings	were	digested	in	200	μl	of	TNES	buffer	(100	mM	Tris	pH	8,	200	mM	NaCl,	5	
mM	EDTA	pH	8,	and	0.2	%	SDS)	in	the	presence	of	1	mg/ml	Proteinase	K	for	1	hour	
at	56°C	with	vigorous	shaking.	After	complete	digestion	of	tissue,	200	μl	of	phenol-
chloroform	(Carl	Roth,	A156.1)	was	added,	samples	vortexed,	centrifuged	at	5,000xg	
for	3	minutes,	and	upper	layer	aspirated	into	a	new	1.5	ml	microcentrifuge	tube.	To	
precipitate	 DNA,	 20	 μl	 of	 8M	 potassium-acetate	 was	 added	 to	 each	 sample,	
vortexed,	and	followed	by	addition	of	1	ml	of	pure	ethanol.		Samples	were	mixed	by	
inversion	 and	 overnight	 storage	 at	 -20°C	 for	 overnight.	 DNA	 was	 pelleted	 by	
centrifugation	at	max	speed	for	20	minutes	at	4°C.	Supernatant	was	discarded,	DNA	
pellet	air-dried,	and	DNA	resuspended	in	250	μl	TE	(10	mM	Tris-HCl	pH	8.0,	1	mM	
EDTA	pH	8.0)	buffer.					
	
5.5.3	Southern	Blot	
Total	DNA	was	extracted	from	pulverized	heart	tissue	using	phenol/chloroform;	see	
DNA	isolation	from	mouse	tissue	for	detail	on	this	step.	DNA	(5	μg)	was	digested	with	
SacI	 (20U,	New	England	Biolabs,	 R3156)	 overnight	 at	 37°C	 to	 digest	 nuclear	DNA	
and	linearize	mitochondria	DNA,	Table	8.	DNA	was	precipitated	and	resuspend	in	24	
μl	of	TE	buffer.	Afterwards,	6	μl	of	6x	DNA	 loading	dye	was	added	 (New	England	
Biolabs,	B7024S)	 and	DNA	 separated	on	 a	 0.8	%	agarose	gel	 containing	ethidium	
bromide,	running	at	40	volts	for	about	16	hours.	Agarose	gel	was	then	subjected	to	
treatment	with	0.2	M	HCl	for	20	minutes,	two	washes	with	water	for	5	minutes	each,	
20	minutes	incubation	with	denaturating	solution	(1.5	M	NaCl	and	0.5	M	NaOH),	two	
washes	with	water	 for	 5	minutes	 each,	 20	minutes	 incubation	with	 neutralization	
solution	(1.5	M	NaCl	and	0.5	M	Tris-HCl	pH	7.4),	 then	both	Hybond-N+	membrane	
(15	x15	cm)	and	gel	were	incubated	in	water	for	10	minutes,	followed	by	20	minutes	
incubation	 in	 20x	 SSC	 prior	 to	 gel	 transfer	 assembly.	 DNA	 was	 transferred	 on	 a	
Hybond-N+	membrane;	see	Northern	blot	 for	details	on	transfer.	Membranes	were	
then	UV	cross-linked,	blocked	in	PerfectHyb	Plus	Hybridization	buffer	as	described	
for	 Northern	 blot.	 Radioactivity-labeled	 probes	 recognizing	 mtDNA	 (pAM1)	 and	
nuclear	DNA	(18S)	were	prepared	as	described	for	probes	for	mRNA	and	rRNA,	see	
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Northern	blot	and	tables	5	and	6.	Membrane	was	sealed	in	a	plastic	bag	and	exposed	
to	a	phosphor	screen	and	developed	using	a	Typhoon	FLA	7000	(GE	healthcare)	or	
exposed	to	autoradiography	films	for	visualization	of	DNA.		
	
Table	8:	Restriction	digest	of	DNA	
Chemical	 Volume	
Total	DNA	(200	ng	-	5	μg)	 	X	μl	
10x	CutSmart	buffer	 2	μl	
SacI-HF	20U	 1	μl	
DEPC	water	 Up	to	20	μl	
	
5.5.4	D-loop	Southern	Blot	
Southern	 blotting	 on	 isolated	 mtDNA	 allows	 for	 comparison	 of	 7S	 DNA	 levels.	
Mitochondria	 were	 isolated	 as	 described	 in	 Isolation	 of	 heart	 mitochondria	 for	
biochemistry.	 Isolated	 heart	 mitochondria	 (from	 an	 entire	 heart	 sample)	 were	
digested	and	DNA	extracted	by	phenol/chloroform,	 see	DNA	 isolation	 from	mouse	
tissue	 for	details.	 Isolated	mtDNA	was	then	RNase	A	(Qiagen,	19101)	 treated	for	1	
hour	 at	 37°C.	 Concentration	 of	 DNA	 was	 determined	 using	 a	 NanoDrop	 2000	
(Thermo	 Fisher	 Scientific).	 mtDNA	 (3	 μg)	 was	 then	 linearized	 by	 overnight	 SacI	
digestion	at	37°C.	See	Southern	blot	and	Tables	8	for	details	on	restriction	digestion,	
gel	 electrophoresis,	 transfer	 to	 membrane,	 and	 labeling	 DNA	 with	 radioactive	
probe.	 To	 detect	 mitochondrial	 7S	 DNA,	 a	 specific	 probe	 was	 designed	 which	
recognizes	full-length	mtDNA	and	7S	DNA.	Of	special	note,	during	the	α-32P-dCTP	
labeling	 of	 the	 7S	 DNA	 probe,	 the	 hybridization	 temperature	 was	 set	 to	 42°C,	
instead	of	65°C.	Membrane	was	sealed	in	a	plastic	bag	and	exposed	to	a	phosphor	
screen	 and	 developed	 using	 a	 Typhoon	 FLA	 7000	 (GE	 healthcare)	 or	 exposed	 to	
autoradiography	films	for	visualization	of	DNA.	
	
5.5.5	mtDNA	Topology	Analysis	
Mitochondrial	 DNA	 is	 organized	 as	 a	 circular	 dsDNA	 structure	 and	 can	 found	 in	
various	 topological	 confirmations	 under	 physiological	 conditions.	 These	 native	
confirmations	of	mtDNA	can	be	separated	by	gel	electrophoresis	and	visualized	by	
Southern	blot.	The	following	method	was	modified	from	Kolesar	et	al.,	2013.	Heart	
tissue	(20	mg)	was	minced	and	lyzed	in	600	μl	of	 lysis	buffer	(100	mM	Tris-HCl	pH	
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7.5,	100	mM	EDTA,	100	mM	NaCl,	0.5	%	SDS,	0.5	mg/ml	Proteinase	K)	at	55°C	for	3	
hours	followed	by	2	hours	incubation	on	ice	with	premixed	820	mM	lithium	chloride	
and	 270	 mM	 potassium-acetate	 to	 precipitate	 contaminants.	 Precipitate	 was	
removed	 from	 sample	 by	 centrifugation	 for	 10	 minutes	 at	 10,000	 rpm	 at	 room	
temperature.	Next,	DNA	was	precipitated	with	isopropanol	overnight.	The	pelleted	
DNA	 was	 washed	 with	 75	 %	 ethanol	 and	 resuspended	 in	 10	mM	 Tris-HCl,	 1	 mM	
EDTA	 pH	 8.0	 followed	 by	 quantification	with	Qubit	 dsDNA	BR	 assay	 kit	 (Thermo	
Fisher	Scientific,	Q32850).	As	controls,	different	topological	isomers	of	the	mtDNA	
were	identified	by	treatment	with	different	restriction	and	topological	enzymes.	To	
this	end,	total	DNA	(200	ng)	from	control	was	incubated	at	37°C	for	30	minutes	with	
the	following	enyzmes:	SacI	 (New	England	Biolabs,	R0156S;	20	U),	Nt.BbvCI	 (New	
England	Biolabs,	R0632S;	10	U),	Topoisomerase	I	(New	England	Biolabs,	M0301S;	5	
U),	 Topoisomerase	 II	 (USB	 Affymetrix,	 78303;	 20	 U),	 DNA	 gyrase	 (New	 England	
Biolabs,	 M0306;	 5	 U).	 Total	 DNA	 (200	 ng)	 from	 experimental	 samples	 was	 then	
resolved	in	a	0.4	%	agarose	gel	(15	x	15	cm)	without	ethidium	bromide	at	35	volts	for	
20	hours,	and	DNA	transferred	overnight	onto	Hybond-N+	membrane.	For	details	
on	DNA	transfer,	radioactive	labeling	of	pAM1	probe,	and	visualization	of	DNA	see	
Southern	blot.			
	
5.5.6	Quantitative	PCR	
The	 relative	 abundance	 of	 mRNA	 expression	 level	 and	 mtDNA	 molecules	 was	
determined	 by	 quantitative	 polymerase	 chain	 reaction	 (qPCR).	 For	 mtRNA	
expression	analysis	the	following	steps	were	taken.	Total	RNA	was	extracted	from	
pulverized	 heart	 tissue	 using	 RNeasy	 Mini	 kit	 (Qiagen,	 74104)	 according	 to	
manufactures	 instructions.	 Isolated	RNA	was	DNase	 treated	 following	 instructions	
from	TURBO	DNA-free	Kit	(Thermo	Fisher	Scientific,	AM2238).	RNA	concentration	
was	determined	using	a	NanoDrop	2000	(Thermo	Fisher	Scientific)	and	2	μg	of	RNA	
subjected	 to	 reverse	 transcription	 PCR	 (RT-PCR)	 for	 cDNA	 synthesis	 according	 to	
the	 High	 Capacity	 cDNA	 reverse	 transcription	 kit	 (Thermo	 Fisher	 Scientific,	
4368814).	 A	 standard	 curve	 was	 created	 using	 cDNA	 from	 samples	 and	 serial	
dilutions	at	1:2.	cDNA	from	samples	were	diluted	1:5	with	DNase-free	water	and	1	μl	
used	for	PCR.	A	single	9	μl	PCR	reaction	mix	consisted	of	1x	Taqman	mix	(4.8	ul	from	
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2x	stock),	0.5	μl	from	20x	Taqman	probe,	1	μl	of	cDNA,	and	water	(3.2	μl),	kept	on	
ice.	Triplicates	of	samples	were	loaded	on	a	364-well	plate	(Thermo	Fisher	Scientific,	
4309849)	and	sealed	with	adhesive	film	(Thermo	Fisher	Scientific,	4311971).	Plates	
were	centrifuged	 for	1	minute	at	1,200	 rpm.	A	QuantStudio	6	Flex	Real-Time	PCR	
system	 (Thermo	 Fisher	 Scientific)	 was	 used	 to	 perform	 real-time	 quantitative	
reverse	transcription	PCR	(qRT-PCR)	under	Absolute	Quantification	mode.	Taqman	
probes	 used	 for	 qPCR	 analysis	 of	 mRNA	 expression	 are	 listed	 in	 Table	 9.	 The	
quantity	 of	 transcripts	was	 normalized	 to	 β-2-microglobulin	 (B2M)	 as	 a	 reference	
gene	transcript.		
	
Table	9:	Taqman	probes		 	
Probe	 Species	 Target	 Assay	ID	 Reporter	 Source	
Mfn1	 Mouse	 cDNA	 Mm01289372_m1	 FAM	 Thermo	Fisher	Scientific	
Mfn2	 Mouse	 cDNA	 Mm00500120_m1	 FAM	 Thermo	Fisher	Scientific	
B2M		 Mouse	 cDNA	 Mm00437762_m1	 FAM	 Thermo	Fisher	Scientific	
ATP6	 Mouse	 mtDNA	 Mm03649417-g1	 FAM	 Thermo	Fisher	Scientific	
16S	 Mouse	 mtDNA	 Mm04260181_s1	 FAM	 Thermo	Fisher	Scientific	
7S	DNA	 Mouse	 7S	DNA	&	mtDNA	 Custom-order	 FAM	 Thermo	Fisher	Scientific	
β-actin	 Mouse	 nDNA	 Mm01205647_g1	 FAM	 Thermo	Fisher	Scientific	
18S	 Human	 nDNA	 Hs99999901_s1	 FAM	 Thermo	Fisher	Scientific	
	
	 The	 relative	 abundance	 of	 mtDNA	 and	 7S	 DNA	 was	 determined	 by	
quantitative	PCR	analysis.	Total	DNA	from	pulverized	heart	tissue	and	immortalized	
MEFs	was	extracted	using	the	DNeasy	Tissue	and	Blood	Kit	(QIAGEN,	69504)	based	
on	 manufacturer’s	 instructions.	 DNA	 concentration	 was	 determined	 using	 a	
NanoDrop	2000	(Thermo	Fisher	Scientific).	A	standard	curve	was	created	using	total	
DNA	 from	 samples	 and	 serial	 diluting	down	 to	 1:1,000.	The	a	 single	PCR	 reaction	
consisted	of	1x	Taqman	mix	(4.8	ul	from	2x	stock),	0.5	μl	from	20x	Taqman	probe,	5	
ng	of	DNA,	and	water	for	final	volume	of	9	μl.	Reactions	were	kept	on	ice.	Samples	
were	prepared	for	qPCR	as	describes	above.	Taqman	probes	used	for	qPCR	analysis	
of	 mtDNA	 copy	 number	 are	 listed	 in	 Table	 9.	 The	 quantity	 of	 mtDNA	 was	
normalized	to	nuclear	DNA.	To	quantify	mitochondrial	7S	DNA,	a	custom	Taqman	
probe	 recognizing	 mouse	 7S	 DNA	 was	 constructed	 through	 Thermo	 Fisher	
Scientific’s	custom	primer	and	probe	service.	The	mouse	7S	DNA	probe	sequences	
are	 the	 following:	 	 forward	 primer,	 CTAATGTTATAAGGACATATCTGTGTTATCT-
GACATAC;	 reverse	 primer,	 GGTTTCACGGAGGATGGTAGATTAA;	 FAM	 reporter	
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primer,	 ACCATACAGTCATAAACTCTT.	 The	 specificity	 of	 7S	 DNA	 probe	 was	
validated	using	models	known	to	have	changes	in	7S	DNA	levels.	The	abundance	of	
7S	DNA	was	determined	by	normalizing	 the	 values	of	7S	DNA	 to	ATP6,	 since	 the	
probe	will	recognize	both	7S	DNA	and	the	displaced	mtDNA	complementary	strand	
(Figure	5.1).	 	
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5.5.7	Mutation	Load	Analysis	
Total	 DNA	was	 extracted	 from	 hearts	 tissue.	 The	 somatic	mtDNA	mutation	 load	
was	 determined	 by	 post-PCR,	 cloning,	 and	 sequencing	 as	 described	 previously	
(Wanrooij	et	al.,	2012).	Primers	that	amplified	a	region	of	the	mtDNA	spanning	the	
3’	 end	of	mtNAD2	 through	approximately	 a	 third	of	mtCO1	 (nucleotide	pair	 4950-
5923	of	the	mouse	reference	mtDNA	sequence	GenBank	NC_005089).	The	resulting	
clones	were	 filtered	 to	 remove	 sequences	 derived	 from	 the	 known	mitochondrial	
Numts	sequences	within	the	nuclear	genome	of	the	mice.	
	
5.5.8	DNA	Sequencing		
DNA	 from	 isolated	 heart	 mitochondria	 was	 used	 to	 generate	 libraries	 for	
sequencing	 to	 detect	 mtDNA	 deletions.	 Total	 genomic	 DNA	 from	 the	 Deletor	
mouse	 was	 provided	 by	 Anu	 Suomalainen-Wartiovaara	 and	 used	 as	 a	 positive	
control	 for	the	detection	of	mtDNA	deletions	 (Tyynismaa	et	al.,	2005).	A	standard	
Illumina	 TrueSeq	 paired-end	 library	 was	 prepared	 with	 ~500	 base	 pair	 fragment	
inserts.	Paired-end	100	base	pair	sequencing	was	conducted	using	an	Illumina	HiSeq	
2500.	The	reads	were	mapped	to	the	genomic	sequence	without	the	mitochondria	
using	bowtie	 (VN:	2.1.0)	 to	 remove	nuclear-genomic	 sequences	 (Langmead	et	 al.,	
2009).	 The	 unmapped	 reads	 were	 then	 mapped	 to	 the	 mitochondrial	 sequence	
(GenBank	JF286601.1)	using	bwa	(n=0.04,	VN:	0.6.2-r126)	(Li	and	Durbin,	2010)	with	
unmapped	 reads	 undergoing	 an	 additional	 mapping	 round	 after	 trimming	
fastx_trimmer,	VN:	0.0.13.2)	to	ensure	higher	mapping	results.	Using	samtools	(Li	et	
al.,	2009)	(VN:	1.0:	samtools	–f1	–F14)	reads	where	the	two	paired	sequences	were	
observed	to	be	greater	than	600	base	pair	apart	were	identified	as	those	containing	
deletion	breakpoints.	These	reads	were	extracted	for	additional	analysis.		
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5.6	IN	ORGANELLO	ASSAYS	
5.6.1	de	novo	mtDNA	Transcription		
Heart	 mitochondria	 were	 isolated	 by	 differential	 centrifugation,	 see	 Isolation	 of	
heart	mitochondria	for	procedure	details.	For	each	biological	sample,	three	aliquots	
of	mitochondria	were	taken.	1)	300	μg	of	mitochondria	was	used	to	determine	the	
levels	 of	 mtDNA	 and	 7S	 DNA	 by	 Southern	 blot	 using	 [α-32P]-dCTP-labeled	 DNA	
probes	specific	 for	7S	DNA,	see	Southern	blot	 for	details.	2)	30	μg	of	mitochondria	
were	used	as	a	 loading	control	using	mouse	anti-VDAC	antibody,	see	Western	blot	
for	 details.	 3)	 300	 μg	 of	 mitochondria	 were	 used	 to	 radioactively	 label	 newly	
synthesized	 mt-RNA.	 First,	 mitochondria	 storage	 buffer	 was	 removed	 by	
centrifugation	at	9,000	rpm	for	4	minutes	at	4°C.	Mitochondria	were	washed	twice	
with	500	μl	in	organello	buffer	(25	mM	sucrose,	75	mM	sorbitol,	100	mM	KCl,	10	mM	
K2HPO4,	50	μM	EDTA,	5	mM	MgCl2,	10	mM	glutamate,	2.5	mM	malate,	10	mM	Tris–
HCl	 pH	 7.4,	 freshly	 added	 1	mM	ADP	 and	 1	mg/ml	 BSA	 essential	 fatty	 acid	 free).	
Mitochondria	were	then	pelleted	again	and	resuspend	in	1	ml	of	in	organello	buffer	
and	 50	 μCi	 of	 [α-32P]-UTP	 (Perkin-Elmer)	 was	 added.	 Samples	 were	 incubated	 at	
37°C	 for	 1	 hour	 with	 constant	 rotation.	 Afterwards,	 radioactive-UTP	 buffer	 was	
removed	by	pelleting	mitochondria	at	9,000	rpm	for	4	minutes	at	4°C	and	discarding	
the	 supernatant.	 A	 short	 for	 10-minute	 chase,	 to	 remove	 background	 signal,	 was	
performed	at	 37°C	with	mitochondria	 resuspended	 in	 500	μl	 of	 in	 organello	 buffer	
supplemented	with	2	mM	UTP.	After	chase	samples	were	centrifuged	at	9,000	rpm	
for	4	minutes	at	4°C	and	washed	twice	with	500	μl	of	washing	buffer	(10	mM	Tris–
HCl	 pH	 6.8,	 0.15	 mM	 MgCl2,	 10%	 glycerol).	 Mitochondrial	 RNA	 was	 isolated	 by	
resuspending	mitochondria	 in	 250	μl	washing	 buffer	 and	 750	 μl	 Trizol	 LS	 reagent	
(Invitrogen,	cat	#10296010)	and	incubated	for	5	minutes	at	room	temperature.	Next	
200	μl	of	chloroform	was	added,	vortex,	and	incubated	for	3	minutes.	Samples	were	
then	 centrifuged	 at	 12,000x	 g	 for	 15	 minutes	 at	 4°C.	 The	 upper	 aqueous	 phase	
containing	RNA	was	collected	and	transferred	to	a	new	1.5	ml	microcentrifuge	tube.	
RNA	 was	 precipitated	 with	 500	 μl	 of	 isopropanol	 and	 incubated	 for	 10	 minutes.	
Samples	 were	 centrifuged	 for	 10	 minutes	 at	 12,000x	 g	 at	 4°C.	 Supernatant	 was	
discarded.	RNA	can	be	seen	as	a	colorless	gel-like	pellet	after	centrifugation.	RNA	
Material	and	Methods		
	 	 	 	102	
was	washed	with	1	ml	of	75	%	ethanol,	vortexed,	and	centrifuged	at	7,500x	g	 for	5	
minutes	 at	 4°C.	 Supernatant	 was	 discarded	 and	 RNA	 pellet	 was	 air-dried	 for	 10	
minutes,	and	 resuspended	 in	10	μl	RNAse/DNase-free	water.	RNA	sample	 loading	
buffer	 (Sigma,	 R1386)	 was	 added	 and	 samples	 were	 incubated	 at	 65°C	 for	 10	
minutes.	A	15x15	cm	1	%	low-melting	agarose	(Biozym,	840001)	gel	prepared	with	
18	%	formaldehyde,	1x	MOPs	Northern	running	buffer	(in	DEPC	water)	was	casted	
and	thin-well	combed	used.	2-5	μl	of	RNA	were	 loaded	onto	the	gel	and	ran	at	90	
volts	until	RNA	loading	dye	reached	2/3	of	the	gel.	1x	MOPs	northern	running	buffer	
was	used	for	electrophoresis.	Afterwards,	the	gel	was	washed	twice	with	water	for	
15	minutes,	followed	by	20	minutes	incubation	with	20x	SSC.	In	parallel,	a	15x15	cm	
Hybond-N+	membrane	was	 also	 subjected	 to	 the	 same	 incubation	 periods	 as	 the	
gel.	 	 RNA	 from	 the	 agarose	 gel	 was	 transferred	 overnight	 onto	 a	 Hybond-N+	
membrane;	 see	 Northern	 blot	 for	 details	 on	 transfer	 set	 up	 and	 detection	 of	
radioactive	signals.			
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5.6.2	de	novo	mtDNA	Replication		
Heart	 mitochondria	 were	 isolated	 by	 differential	 centrifugation,	 see	 Isolation	 of	
heart	mitochondria	for	procedure	details.	300	μg	of	mitochondria	were	washed	with	
500	μl	of	ice-cold	 in	organello	buffer.	Mitochondria	were	pelleted	by	centrifugation	
at	9,000	rpm	for	4	minutes	at	4°C	and	resuspended	in	organello	buffer	containing	50	
μM	 of	 dCTP,	 dGTP,	 dTTP	 and	 20	 μCi	 of	 radioactive	 α-32P-dATP.	 Samples	 were	
incubated	 for	 2	 hours	 at	 37°C	 with	 constant	 rotation.	 After	 incubation	 with	
radioactive	dNTP,	mitochondria	were	centrifuged	at	9,000	rpm	for	4	minutes	at	4°C	
and	 washed	 3x	 with	 500	 μl	 of	 ice-cold	 washing	 buffer.	 Mitochondria	 were	
resuspended	in	50	μl	of	washing	buffer	and	4	μl	of	sample	(about	24	μg	of	protein)	
was	 taken	 as	 a	 VDAC	 loading	 control,	 see	 Western	 blot	 for	 details.	 Next,	
mitochondria	 were	 centrifuged	 again	 at	 9,000	 rpm	 for	 4	 minutes	 at	 4°C	 and	
resuspended	 in	 25	 μl	 of	 TNES	 buffer	 containing	 1.2	mg/ml	 of	 Proteinase	 K.	 DNA	
extracted	with	phenol/chloroform,	see	DNA	 isolation	 from	mouse	 tissue	 for	details.	
DNA	was	 resuspended	 in	 30	 μl	 TE	 buffer	 and	 5	 μl	 from	 6x	DNA	 loading	 dye	was	
added.	DNA	was	split	in	half:	one	sample	was	boiled	at	95°C	for	5	minutes	to	release	
7S	 DNA	 from	mtDNA,	 the	 other	 half	 was	 not	 boiled.	 DNA	was	 separated	 by	 gel	
electrophoresis	on	a	15x15	cm	0.8	%	agarose	gel	containing	no	ethidium	bromine	for	
15	hours	at	20	volts	or	at	90	volts	 for	220	minutes.	After	gel	electrophoresis	DNA	
was	 transferred	 onto	 a	 Hybond-N+	 membrane.	 See	 Northern	 blotting	 for	 details	
from	transfer	to	visualization	of	radioactive	signal.	When	radioactive	signal	reached	
about	50	net	counts	per	second	using	a	Geiger	counter,	steady-state	mtDNA	and	7S	
DNA	were	detected	using	α-32P-dATP-labeled	DNA	probes	specific	 for	7S	DNA.	de	
novo	 mtDNA	 replication	 images	 were	 quantified	 by	 densitometry	 analysis	 using	
ImageJ.	 The	 cumulative	 abortive	 mtDNA	 products	 were	 defined	 as	 the	 signal	
directly	above	and	below	the	7S	DNA	band.		
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5.7	IN	CELLULO	ASSAYS	
	
5.7.1	Growth	Curve		
The	growth	rate	of	log-phase	cells	was	assessed	for	consecutive	5	days.	The	growth	
rate	was	determined	in	either	glucose	or	galactose	containing	media,	Table	10.	For	
galactose	 growth	 curve	 only,	 cells	 were	 equilibrated	 to	 galactose	medium	 3	 days	
prior	to	seeding	for	experiment.	For	both	type	of	growth	curves,	cells	were	seeded	
on	six-well	plates,	each	well	 containing	27,000	cells	 in	3	ml	of	medium.	Cells	were	
collected	 every	 24	 hours	 by	 trypsinization	 with	 1	 ml	 of	 0.05	 %	 Trypsin-EDTA	
(Thermo	 Fisher	 Scientific,	 25300-054)	 and	 viable	 cells	 counted	 using	 a	 Vi-Cell	 XR	
analyzer	(Beckman	Coulter).			
	
Table	10:	Growth	Curve	media	composition		
Media	 Ingredient	 Source	
Galactose	
DMEM	1x	(+)	L-Glutamine,	(-)	D-
Glucose,	(-)	Sodium	Pyruvate	
Thermo	Fisher	Scientific,	11966025	
15	mM	Galactose	–	sterile	filtered	 Sigma	G5388-100G	
1mM	sodium	pyruvate	 Thermo	Fisher	Scientific,	11360-039	
10	%	FBS	 	
1	%	Penicillin/Streptomycin,		 Thermo	Fisher	Scientific,	15070-063	
1	%	non-essential	amino	acids	 Thermo	Fisher	Scientific,	11140-050	
50	μg/ml	uridine	–sterile	filtered	 Sigma-Aldrich,	U3750	
Glucose	
DMEM	GlutaMax,	25	mM	glucose	 Thermo	Fisher	Scientific,	31966-021	
10	%	FBS	 Thermo	Fisher	Scientific,	10270-106	
1	%	Penicillin/Streptomycin,		 Thermo	Fisher	Scientific,	15070-063	
1	%	non-essential	amino	acids	 Thermo	Fisher	Scientific,	11140-050	
50	μg/ml	uridine)	 Sigma-Aldrich,	U3750	
	
5.7.2	mtDNA	Depletion	and	Repopulation	
MEFs	(0.5	million	for	control,	Mfn1	KO,	and	Mfn2	KO;	1.5	million	for	dMfn	and	Opa1	
KO)	were	 cultivated	 in	 18	ml	 of	 DMEM	GlutaMax	 containing	 25	mM	 glucose	 and	
supplemented	 with	 10	 %	 FBS,	 100	 U/ml	 penicillin	 and	 streptomycin,	 1x	 non-
essential	 amino	 acids,	 and	 fresh	 100	 ng/ml	 ethidium	 bromine	 (Sigma-Aldrich,	
E8751).	After	6	days	of	cultivation	 in	the	presence	of	ethidium	bromine,	cells	were	
switched	 to	 medium	 containing	 no	 ethidium	 bromine	 for	 6	 days.	 Cells	 were	
passaged	every	2-3	days	during	both	 conditions.	Cell	 pellets	were	 stored	at	 -20°C	
until	 further	 processing.	 Total	 DNA	 was	 extracted	 using	 the	 DNeasy	 Tissue	 and	
Blood	Kit	 (QIAGEN)	and	mtDNA	levels	determined	by	qPCR,	see	Quantitative	PCR	
for	details.	
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5.8	MASS	SPECTROMETRY	
	
5.8.1	UPLC-MS/MS:	Coenzyme	Q	Analysis	
MEFs	were	grown	in	175	cm2	flasks	for	one	week	in	DMEM	GlutaMax	containing	25	
mM	glucose	and	supplemented	with	1	%	dialyzed	FBS	 (Sigma-Aldrich,	A3382001),	
100	U/ml	penicillin	and	streptomycin,	1	%	non-essential	amino	acids,	and	50	μg/ml	
uridine.	 Quinones	 were	 extracted	 from	 cell	 pellets	 or	 pulverized	 heart	 tissue	 by	
suspending	in	200	μl	of	1	mM	cupric	sulfate	followed	by	addition	of	200	μl	ethanol.	
Samples	 were	 sonicated	 and	 vortexed	 in	 the	 presence	 of	 400	 μl	 of	 hexane.	 The	
upper	phase	was	collected	and	placed	in	a	new	tube:	both	lower	and	upper	phases	
were	 dried	 using	 a	 SpeedVac	 apparatus	 at	 60°C	 for	 1-2	 hours.	 The	 lower	 phase	
pellet	was	used	to	determine	the	protein	concentration.	The	upper	phase	pellet	was	
further	 processed	 for	 CoQ	 determination	 by	 dissolving	 the	 pellet	 in	 200	 μl	
ethanol/methanol	 (9:1),	 vortexed,	 sonicated	 for	 2	minutes,	 filtrated	 through	 a	 0.2	
μm	modified	nylon	centrifugal	filter	(VWR,	82031-358)	with	an	eppendorf	centrifuge	
5424R	set	to	6°C	and	15,000	rpm,	and	lastly	diluted	1/25.	
	 For	 absolute	 quantification	 of	 Q9	 and	 Q10	 in	 positive	 ESI	 MRM	 (multi	
reaction	monitoring)	mode	an	Acquitiy	UPLC	(Waters)	was	connected	to	a	XevoTM	
TQ	(Waters).	An	Acquity	UPLC	BEH	C18	1.7	µm,	2.1	x	50	mm	column	was	used	at	
40°C.	Solvent	A	was	90	%	methanol	+	10	%	propanol	+	0.1	%	formic	acid	and	B	was	
45	%	acetonitril/acetone	+	10	%	propanol	+	0.1	%	formic	acid.	A	linear	gradient	from	
100	%	A	to	0	%	in	3	minutes	at	a	flow	rate	of	0.5	ml/minute	was	applied.	2	μL	were	
injected	three	times.	The	sample	manager	was	set	to	8°C	for	the	standards	and	the	
samples	were	 defrosted	 and	directly	 injected.	 The	 source	 temperature	was	 set	 to	
150°C,	desolvation	temperature	was	550°C	and	desolvation	gas	was	set	to	800	L/h,	
cone	 gas	 to	 50	 L/h.	 The	 capillary	 voltage	 was	 set	 to	 1.5	 kv.	 The	 following	 MRM	
transitions	were	used	for	Q9	m/z	795.58	to	196.95	(quantifier)	collision	30	V,	795.58	
to	95.02	(qualifier)	collision	50	V,	795.58	to	106.46	(qualifier)	collision	64V,	cone	was	
in	all	cases	31	V	for	Q10	m/z	863.67	to	196.94	(quantifier)	collision	energy	36	V,	m/z	
863.67	to	95.02	(qualifier)	collision	54	V,	m/z	863.67	to	80.97	(qualifier)	collision	66	V,	
cone	 was	 in	 all	 cases	 35	 V.	 MassLynx	 (Waters)	 software	 was	 used	 for	 data	
management	 and	 TargetLynx	 (Waters)	 software	 for	 data	 evaluation	 and	 absolute	
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quantification.	 All	 compounds	 were	 prepared	 fresh	 and	 dissolved	 in	
ethanol/methanol	(9:1).	For	Q9	and	Q10	an	external	standard	calibration	curve	was	
calculated	 using	 following	 concentrations:	 For	Q9	 from	 100	 to	 20,000	 ng/mL	 and	
Q10	from	4	to	3,500	ng/ml	 (all	of	 them	were	prepared	from	stock	solutions	of	100	
μg/ml).	 Correlation	 coefficient:	 r	 <	 0.990;	 response	 type:	 internal	 standard,	 area;	
curve	type	linear;	weighting	1/x.	The	peak	integrations	were	corrected	manually,	 if	
necessary.	 Quality	 control	 standards	 of	 each	 standard	 were	 used	 during	 sample	
analysis	and	showed	between	0.5	%	and	40	%	deviation	 respectively.	Blanks	after	
the	 standards,	 quality	 control	 and	 sample	 batch	 proved	 to	 be	 sufficient.	 No	
carryover	was	detected.	Q	values	were	normalized	 to	 the	 total	 amount	of	protein	
extracted	 from	 cells	 (lower	 phase	 during	 extraction).	 Protein	 samples	 were	
resuspend	 in	 20	 μl	 of	 reagent	 A	 of	 DC	 protein	 assay	 and	 protein	 concentration	
determined	as	described	in	DC	protein	assay.		
	
5.8.2	UPLC-MS/MS:	Cellular	dNTP	Analysis	
Method	was	adapted	from	Olafsson	et	al.,	2017.	Cells	were	grown	on	100	mm	dishes	
in	DMEM	GlutaMax	containing	25	mM	glucose	and	supplemented	with	10	%	FBS,	
100	U/ml	 penicillin	 and	 streptomycin,	 1x	 non-essential	 amino	 acids,	 and	 50	μg/ml	
uridine.	 As	 a	 negative	 dNTP	 control,	 a	 group	 of	 control	 cells	 were	 treated	 with	
hydroxyurea	 (Sigma-Aldrich,	 H8627)	 at	 2	 mM	 for	 30	 hours	 to	 mildly	 depleted	
purines.	 Extraction	 of	 dNTP	 from	 cells	 was	 performed	 as	 follows.	 Adherent	 cells	
were	 quickly	 washed	 with	 ice-cold	 PBS,	 detached	 by	 trypsinization	 with	 0.05	 %	
trypsin,	 resuspended	 in	 medium,	 and	 the	 total	 number	 of	 cells	 was	 determined	
using	 a	 Vi-cell	 XR	 cell	 analyzer	 (Beckman	 Coulter).	 Approximately	 2	 million	 cells	
were	 centrifuged	 at	 800x	 g	 for	 5	 minutes,	 washed	 with	 ice-cold	 PBS,	 and	
resuspended	 in	 1	 ml	 of	 ice-cold	 60	 %	 methanol.	 Samples	 were	 then	 vortexed	
rigorously,	frozen	for	30	minutes	at	-20°C,	and	sonicated	for	15	minutes	on	ice.	After	
sonication,	 samples	 were	 centrifuged	 at	 1000x	 g	 for	 5	 minutes	 at	 4°C	 and	
supernatants	 collected.	 Extraction	 solution	 was	 evaporated	 using	 an	 Eppendorf	
Concentrator	plus	at	room	temperature.		
	 Dried	pellets	were	solved	in	100	μl	of	Milli-Q	water,	vortexed	and	sonicated	
for	2	minutes.	After	sonication,	samples	were	vortexed	again	and	filtrated	through	a	
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0.2	μm	modified	nylon	centrifugal	filter	(VWR)	with	an	Eppendorf	centrifuge	5424R	
set	to	8°C	and	12000	rpm.	The	external	standard	calibration	curve	was	prepared	in	
concentrations	 from	 5	 to	 600	 ng/ml	 of	 the	 dNTPs.	 All	 solutions	 were	 daily	 fresh	
prepared	 from	 stock	 solutions	 of	 100	 μg/ml	 and	 dissolved	 in	Milli-Q	water.	 dNTP	
analysis	was	 conducted	 using	 a	Dionex	 ICS-5000	 (Thermo	Fisher	 Scientific)	Anion	
exchange	 chromatography	using	 an	Dionex	 Ionpac	AS11-HC	 column	 (2	mm	x	 250	
mm,	4	μm	particle	size,	Thermo	Fisher	Scientific,	082313)	at	30ºC.	A	guard	column,	
Dionex	 Ionpac	 AG11-HC	 b	 (2	 mm	 x	 50	 mm,	 4	 μm	 particle	 size,	 Thermo	 Fisher	
Scientific),	 was	 placed	 before	 the	 separation	 column.	 The	 eluent	 (KOH)	 was	
generated	 in-situ	by	a	KOH	cartridge	and	deionized	water.	At	a	 flow	rate	of	0.380	
mL/min	a	gradient	was	used	for	the	separation:	0-3	min	10	mM	KOH,	3-12	min	10-50	
mM,	12-19	min	50-100	mM,	19-21	min	100	mM,	21-25	min	10	mM.	A	2	mm	Dionex	
suppressor	AERS	500	was	used	for	the	exchange	of	the	KOH	and	operated	with	95	
mA	at	15°C.	The	suppressor	pump	flow	was	set	at	0.6	mL/min.	10	μL	of	sample	in	a	
full	 loop	 mode	 (overfill	 factor	 3)	 was	 injected.	 Autosampler	 was	 set	 to	 6°C.	 The	
Dionex	ICS-5000	was	connected	to	a	XevoTM	TQ	(Waters)	and	operated	in	negative	
ESI	 MRM	 (multi	 reaction	 monitoring)	 mode.	 The	 source	 temperature	 was	 set	 to	
150°C,	desolvation	 temperature	was	350°C	and	desolvation	gas	was	 set	 to	50	L/h,	
cone	 gas	 to	 50	 L/h.	 The	 following	MRM	 transitions	 were	 used	 for	 quantification:	
dGTP,	transition	505.98	→	408.00,	cone	30,	collision	20;	dATP,	transition	490.02	→	
158.89,	 cone	30,	 collision	26;	dTTP,	 transition	480.83	→	 158.88,	 cone	28,	 collision	
46;	dCTP,	transition	465.98	→	158.81,	cone	28,	collision	30.	The	software	MassLynx	
and	 TargetLynx	 (Waters)	were	 used	 for	 data	management	 and	 data	 evaluation	&	
quantification.	The	calibration	curve	presented	a	correlation	coefficient:	r2	>	0.990	
for	 all	 the	 compounds	 (response	 type:	 area;	 curve	 type	 linear).	 Quality	 control	
standards	were	tested	during	the	sample	analysis.	The	deviation	along	the	run	was	
between	0.5%	and	40	%	respectively.	Blanks	after	the	standards,	quality	control	and	
samples	did	not	present	significant	peaks.	dNTP	values	were	normalized	to	the	total	
number	of	cells	used	for	extraction.		
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5.8.3	LC-MS/MS:	Proteomic	Analysis		
Cells	were	subjected	to	stable	isotope	labeling	by	amino	acids	(SILAC)	as	previously	
described	Ong	 and	Mann,	 2006.	One	 set	 of	 cells	were	 grown	 in	 75	 cm2	 flasks	 for	
seven	 days	 with	 SILAC	 DMEM	 medium	 (Thermo	 Fischer	 Scientific,	 89985)	
supplemented	 with	 10	 %	 dialyzed	 FBS,	 100	 U/ml	 penicillin	 and	 streptomycin,	 1x	
non-essential	 amino	 acids,	 and	 50	μg/ml	 uridine	 in	 the	 presence	of	 either	 light	 or	
heavy	 arginine	 and	 lysine	 (13C6	 15N4-L-arginine-,	 13C6	 15N4-L-lysine,	 Thermo	 Fisher	
Scientific,	88434	and	88429).	Seven	days	were	sufficient	for	near	full	 incorporation	
of	 the	amino	acids	 into	proteins	 (>	98	%).	The	other	 set	of	 cells	was	grown	 in	 the	
same	 medium	 containing	 non-isotopic	 amino	 acids	 for	 seven	 days.	 Cells	 were	
passaged	during	labeling	phase	when	cell	confluency	reached	80-90	%.	After	seven	
days,	cells	were	pelleted	at	800xg	for	5	minutes	at	4°C	and	pellets	storage	at	-20°C.			
	 Pellets	of	labeled	and	non-labeled	control	or	dMfn	KO	MEFs	were	lyzed	with	
with	 100	 –	 200	 μl	 of	 MS-lysis	 buffer	 (6	 M	 guanidinium	 chloride,	 10	 mM	 Tris(2-
carboxyethyl)phosphine	hydrochloride,	40	mM	chloroacetamide	and	100	mM	Tris-
HCl)	 and	mixed	 1:1	 (three	 pairs	 of	 SILAC	 labeled	 control	mixed	 with	 non-labeled	
dMfn	KO	MEFs;	three	pairs	non-labeled	control	mixed	with	SILAC-labeled	dMfn	KO	
MEFs).	Samples	were	sonicated	with	a	needle	sonicator	(1	minute/100	%	amplitude)	
and	heated	twice	for	5	to	10	minutes	at	95°C.	Following	centrifugation	at	20,000x	g	
for	20	minutes	and	room	temperature,	supernatants	were	diluted	1:10	with	20	mM	
Tris	pH	8.3	 and	 centrifuged	again	 for	 5	minutes.	Supernatants	were	 collected	and	
digested	overnight	 in	 a	water-bath	with	 3	μg	Trypsin	Gold	 at	 37°C.	The	next	 day,	
peptides	 were	 desalted	 and	 cleaned	 using	 150	 μg-Empore	 C18-SD	 4	 mm/1	 ml	
Extraction	disc	 cartridges.	Washing	was	performed	with	1	ml	of	0.1	%	 formic	acid	
and	peptides	were	eluted	with	200	μl	60	%	acetonitrile/0.1	%	formic	acid	and	dried	
at	45°C	for	45	minutes	with	a	vacuum	concentrator	plus	 (Eppendorf).	The	cleaned	
peptides	were	resuspended	with	30	μl	0.1	%	formic	acid.		
	 Isolated	crude	heart	mitochondria	were	prepared	for	mass	spectrometry	by	
pelleting	 100	μg	of	mitochondria	 at	 10,000x	g	 for	 5	minutes	 at	 4°C	 and	 lysis	with	
MS-lysis	 buffer.	Next,	 50	μg	of	 lyzed	mitochondria	were	diluted	 1:10	with	 20	mM	
Tris	pH	8.3	and	digested	overnight	 in	a	water-bath	at	37°C	with	1	μg	Trypsin	Gold	
(Promega,	 V5280).	 The	 digest	 was	 stopped	 using	 formic	 acid	 to	 a	 final	
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concentration	 of	 1	 %.	 Peptides	 were	 cleaned	 using	 home-made	 45	 µg-StageTips	
(Empore	Octadecyl	C18,	 3M)	and	eluted	with	80	μl	60	%	acetonitrile/0.1	%	 formic	
acid	and	subsequently	dried	at	45°C	for	45	minutes	with	a	vacuum	concentrator	plus	
(Eppendorf).	Peptides	were	resuspended	in	10	μl	of	0,1	%	formic	acid.		
	 A	high	pH	reversed	phase	separation	was	applied	to	SILAC-labeled	samples.	
SILAC-labeled	peptides	derived	from	each	biological	replicate	were	separated	on	a	
4.6	x	250	mm	ZORBAX	300	Extend-C18,	5	μm,	column	(Agilent	Technologies)	at	a	1	
ml	flow	rate	using	a	NGC	Quest	10	chromatography	system	(Bio-Rad).	Buffer	A	was	
5	 %	 acetonitrile	 0.01	 M	 ammonium	 bicarbonate,	 buffer	 B	 was	 80	 %	 acetonitrile	
0.01M	 ammonium	 bicarbonate.	 All	 buffers	 were	 prepared	 with	 liquid	
chromatography–mass	 spectrometry	 grade	 water.	 Peptide	 separation	 was	
performed	using	a	 segmented	gradient	 from	5	%	 to	27	%	buffer	B	 for	65	minutes	
and	from	27	%	to	45	%	buffer	B	for	30	minutes.	Eluting	peptides	were	collected	for	
72	minutes	using	a	BioFrac	 fraction	collector	 (Bio-Rad).	Fraction	collection	pattern	
was	set	to	row	and	fraction	collection	size	was	set	to	0.75	ml.	 In	total,	96	fractions	
were	collected	 in	a	1.2	ml	V-shaped	96	well	plate	(Biotix).	Upon	sample	collection,	
plates	were	dried	overnight	and	peptides	were	resuspended	 in	20	μL	0.1	%	formic	
acid.	All	96	fractions	were	concatenated	into	12	final	fractions	by	combining	every	
12th,	 following	 the	 row	 based	 collection.	 Each	 peptide	 pool	 was	 dried	 and	
resuspended	in	10	μL	0.1	%	formic	acid	from	which	5	μL	were	used	for	analysis	by	
liquid	chromatography	–	mass	spectrometry	(LC-MS/MS	analysis).	
	 LC-MS/MS	analysis	of	SILAC-labeled	peptides	were	separated	on	a	25	cm,	75	
μm	 internal	 diameter	 PicoFrit	 analytical	 column	 (New	Objective)	 packed	with	 1.9	
μm	 ReproSil-Pur	 media	 (Dr.	 Maisch)	 using	 an	 EASY-nLC	 1200	 (Thermo	 Fisher	
Scientific).	The	column	was	maintained	at	50°C.	Buffer	A	and	B	were	0.1	%	formic	
acid	 in	water	and	80	%	acetonitrile,	0.1	%	formic	acid,	 respectively.	Peptides	were	
separated	on	a	segmented	gradient	from	5	%	to	31	%	buffer	B	for	80	minutes,	and	
from	 31	%	 to	 44	%	 buffer	 B	 for	 10	minutes	 at	 200	 nl/min.	 Eluting	 peptides	 were	
analyzed	on	a	QExactive	HF	mass	spectrometer	(Thermo	Fisher	Scientific).	Peptide	
precursor	 mass	 to	 charge	 ratio	 (m/z)	 measurements	 (MS1)	 were	 carried	 out	 at	
120,000	 resolution	 in	 the	 350	 to	 1,500	 m/z	 range.	 The	 top	 ten	 most	 intense	
precursors,	 with	 charge	 state	 from	 2	 to	 6	 only,	 were	 selected	 for	 higher-energy	
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collisional	dissociation	(HCD)	fragmentation	using	27	%	normalized	collision	energy.	
The	m/z	of	the	peptide	fragments	(MS2)	were	measured	at	30,000	resolution	using	
an	 AGC	 target	 of	 2e5	 and	 80	 ms	 maximum	 injection	 time.	 Upon	 fragmentation	
precursors	were	put	on	an	exclusion	list	for	45	seconds.	
	 For	 shot-gun	 LC-MS/MS	 of	 non-labelled	 peptides,	 the	 same	 column	 and	
EASY-nLC	1200	were	used.	The	LC	runs	lasted	180	minutes	with	a	concentration	of	
6	%	solvent	B	 (0.1	%	 formic	acid	 in	80	%	acetonitrile)	 increasing	 to	31	%	over	155	
minutes	and	further	to	50	%	over	20	minutes.	The	column	was	subsequently	washed	
and	 re-equilibrated.	The	 flowing	 rate	was	200	nl/min.	Spectra	were	 acquired	on	 a	
QExactive	 HF	 mass	 spectrometer	 (Thermo	 Fisher	 Scientific).	 For	 MS1,	 the	 mass	
range	was	 set	 to	 300−1500	m/z	 and	 resolution	 to	 60K	 at	 200	m/z.	 The	 automatic	
gain	 control	 (AGC)	 target	of	MS	was	 set	 to	 3e6,	 and	 the	maximum	 injection	 time	
was	 80	ms.	 Peptides	were	 fragmented	with	 HCD	with	 collision	 energy	 of	 25.	 For	
MS2,	 the	 resolution	 was	 set	 to	 30K.	 The	 AGC	 target	 of	 MSMS	 was	 5e5	 and	 the	
maximum	injection	time	was	100	ms.	
	 Raw	 data	 were	 analyzed	 using	 MaxQuant	 version	 1.5.2.8.	 Peptide	
fragmentation	spectra	were	searched	against	the	canonical	and	isoform	sequences	
of	 the	mouse	 reference	proteome	 (proteome	 ID	UP000000589,	August	2015	 from	
UniProt).	 MaxQuant	 complemented	 the	 database	 with	 245	 sequences	 of	
contaminating	 proteins.	 For	 the	 analysis	 methionine	 oxidation	 and	 protein	 N-
terminal	 acetylation	were	 set	 as	 variable	modifications.	 The	digestion	parameters	
were	set	to	“specific”	and	“Trypsin/P,”	allowing	for	cleavage	after	lysine	and	arginine	
also	 when	 followed	 by	 proline.	 The	 minimum	 number	 of	 peptides	 and	 razor	
peptides	for	protein	 identification	was	1;	the	minimum	number	of	unique	peptides	
was	 0.	 Protein	 identification	 was	 performed	 at	 a	 peptide	 spectrum	matches	 and	
protein	false	discovery	rate	of	0.01.	The	“second	peptide”	option	was	on	to	identify	
co-fragmented	peptides.	For	SILAC	quantification,	multiplicity	was	set	 to	 two	and	
heavy	 labels	 were	 set	 to	 Arg10	 and	 Lys8.	 A	 minimum	 ratio	 count	 of	 one	 was	
required	for	protein	quantification.	For	label-free	quantification,	the	minimum	ratio	
count	 was	 set	 to	 two.	 Also,	 ‘’match	 between	 runs’’	 was	 selected	 for	 advanced	
identification.	Protein	quantification	was	based	on	razor	plus	unique	peptides.		
	 Analysis	of	the	quantitative	proteomic	of	SILAC	data	was	performed	using	R	
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(R	Development	Core	Team,	2010).	Proteins	assigned	as	“Reverse”,	“Only	identified	
by	 site”,	 and	 “Potential	 contaminant”	were	 removed.	Normalized	 ratio	H/L	 values	
were	 log2	 transformed	 and	 the	 ratio	 H/L	 values	 for	 selected	 experiments	 were	
reversed	in	order	to	contain	higher	ratio	H/L	values	for	proteins	with	higher	protein	
expression	 in	 the	dMfn	KO	compared	 to	 the	 control	MEFs.	Differential	 expression	
analysis	was	performed	using	limma.	Proteins	with	an	adjusted	p-value	(Benjamini-
Hochberg	correction)	of	less	than	0.05	were	designated	as	differentially	expressed.	
	 Protein	quantification	 significant	analysis	of	 label-free	data	was	performed	
with	 the	 Perseus	 statistical	 framework	 (http://www.perseus-framework.org/)	
version	 1.5.2.4.	 After	 removing	 the	 contaminants	 and	 reverse	 identifications,	 the	
intensities	were	transformed	to	 log2	and	followed	by	Z	Score	normalization.	Two-
sample	test	was	performed	to	 identify	the	significantly	different	proteins	between	
knockout	 and	 control	 groups.	 Proteins	 with	 an	 adjusted	 p-value	 (Benjamini-
Hochberg	correction)	of	less	than	0.05	were	designated	as	differentially	expressed.	
	 The	database	for	annotation,	visualization	and	integrated	discovery	(DAVID)	
bioinformatics	 resources	 6.8	was	 used	 to	 determine	 the	 enrichment	 of	 functional	
annotation	 terms	 (Huang	 et	 al.,	 2008).	 Protein	 IDs	 of	 down-regulated	 proteins	
based	on	the	LC-MS/MS	data	analysis	were	used	for	functional	annotation.	Protein	
IDs	were	converted	to	a	gene	list	using	DAVID	gene	accession	conversion	tool.	Mus	
musculus	was	selected	as	species	and	background.	Functional	annotation	clustering	
of	the	gene	list	was	performed	using	the	Kyoto	encyclopedia	of	genes	and	genomes	
pathway	(KEGG;	(Kanehisa	and	Goto,	2000)	and	gene	ontology	(GO;	(Ashburner	et	
al.,	 2000).	 	 The	 GO	 domain	 for	 functional	 annotation	 of	 biological	 process	
(GOTERM_BP_FAT)	was	used.	Categories	showing	a	Benjamini	adjusted	p-value	for	
enrichment	 of	 0.05	 or	 lower	 were	 considered	 significant.	 Benjamini	 adjusted	 p-
values	were	expressed	as	the	-log10.		
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5.9	MICROSCOPY		
	
5.9.1	Immunocytochemistry		
MEFs	 (approximately	 80,000	 cells	 per	 well)	 were	 plated	 into	 12-well	 plates	
containing	 15	 mm	 autoclaved	 glass	 coverslips	 and	 standard	 culture	 media.	 The	
following	 day,	 cells	 were	 washed	 with	 PBS,	 fixed	 with	 4%	 paraformaldehyde	
(Thermo	 Fisher	 Scientific,	 28908)	 for	 10	 minutes	 at	 room	 temperature,	 cells	
hydrated	with	two	washes	of	PBS,	and	stored	at	4°C	until	further	processing.		
	 Immunocytochemistry	 was	 performed	 as	 follows	 for	 fixed	 cells;	 cells	 were	
permeabilized	with	0.1	%	Triton	X-100	(Sigma-Aldrich,	X100)	in	PBS	for	5	minutes,	
coverslips	 transferred	 to	 a	 humid	 chamber,	 blocked	 in	 3	 %	 protease-free	 BSA	
(Sigma-Aldrich,	A3059)	in	PBS	for	30	minutes,	and	incubated	overnight	at	4°C	with	
primary	antibodies	prepared	in	3	%	BSA/PBS,	Table	11.	The	following	day,	coverslips	
were	washed	3x	with	3	%	BSA/PBS	for	10	minutes	and	secondary	antibodies	were	
applied	 for	 2	 hours	 at	 room	 temperature	 at	 dilution	 of	 1:500	 prepared	 in	 3	 %	
BSA/PBS.	Coverslips	were	extensively	washed	with	PBS,	nuclei	counterstained	with	
DAPI	 in	 PBS	 (1:1000,	 Invitrogen,	 62248)	 before	 mounting	 with	 Aqua/Poly-mount	
(Polyscience	Inc.,	18606-20).	
	 Freshly	 isolated	hearts	were	 fixed	by	 immersion	 in	4	%	paraformaldehyde,	
cryopreserved	in	30	%	sucrose	and	frozen	in	optimal	cutting	temperature	compound	
(Sakura,	 SA62550).	 10	 μm-thick	 cryosections	 were	 cut	 and	 air	 dried	 prior	 to	
fluorescent	immunohistochemistry.	Sections	were	permeabilized	in	0.5	%	Triton	X-
100	in	PBS	and	binding	of	antibodies	to	unspecific	sites	was	prevented	by	incubation	
in	3	%	BSA/PBS	 for	30	minutes.	Primary	antibody	 incubation	 in	3	%	BSA/PBS	was	
performed	 overnight	 at	 4°C,	 see	 Table	 11.	 The	 following	 day,	 coverslips	 were	
washed	3x	with	3	%	BSA/PBS	for	10	minutes	and	secondary	antibodies	were	applied	
for	 2	 hours	 at	 room	 temperature	 at	 dilution	 of	 1:500	 prepared	 in	 3	 %	 BSA/PBS.	
Coverslips	were	 extensively	washed	with	PBS,	 nuclei	 counterstained	with	DAPI	 in	
PBS	(1:1000)	before	mounting	a	coverslip	with	Aqua/Poly-mount.	
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Table	11:	Primary	and	secondary	antibodies	immunocytochemistry	
Target		 Host	 Source		 Catalogue	#	 Dilution	
Fixed-	MEFs	
Anti-DNA	 Mouse	IgM	 Progen	 61014	 1:250	
Anti-TOM20		 Rabbit	 Santa	Cruz	 sc-11415	 1:1000	
Anti-HSP60		 Goat	 Santa	Cruz	 sc-1052	 1:500	
Anti-LRPPRC		 Rabbit	 Santa	Cruz	 sc-66844	 1:500	
Anti-BrdU		 Rat	 Abcam	 ab6326	 1:250	
Anti-TFAM		 Rabbit	 Abcam	 ab131607	 1:1000	
Anti-TFAM		 Rabbit	 Agrisera	 custom-order	 1:3000	
Anti-SSBP1	 Rabbit	 Sigma	 HPA002866	 1:500	
Anti-GFP	(heart	sections)	 Chicken	 Aves	 GFP-1020	 1:500	
Anti-ATP5A		 Mouse	 Abcam	 ab14748	 1:1000	
Anti-mouse	IgM	Alexa	488	 Donkey	 Jackson	Immuno	 	 715-546-020	 1:500	
Anti-goat	Alexa	633	 Donkey	 Thermo	Fisher	Scientific	 A21082	 1:500	
Anti-rat	DyLight	488	 Donkey	 Thermo	Fisher	Scientific	 SA5-10026	 1:500	
Anti-rabbit	Cy3	 Donkey	 Jackson	Immuno	 	 711-165-152	 1:500	
	 	 	 	 	
Frozen	Heart	sections	
Anti-DNA		 Mouse	IgM	 Progen	 61014	 1:100	
Anti-chicken	Alexa	488		 Donkey	 Jackson	Immuno	 703-546-155	 1:500	
Anti-mouse	IgM	Alexa	594		 Goat	 Thermo	Fisher	Scientific	 A21044	 1:500	
	
5.9.2	Fluorescence	in	situ	Hybridization	(FISH)	
MEFs	 were	 prepared	 on	 coverslips	 and	 fixed	 with	 4	 %	 paraformaldehyde	 as	
described	in	the	Immunocytochemistry	section.	FISH	was	performed	first	to	visualize	
mRNA	 using	 the	 ViewRNA	 ISH	 Cell	 Assay	 (Thermo	 Fisher	 Scientific,	 QVC0001),	
following	the	manufacturer’s	instructions.	This	assay	entailed	hybridizing	cells	for	3	
hours	at	40°C	with	Cox1mRNA	probe	at	 a	dilution	of	 1:500	 in	hybridization	buffer	
provided	 in	 the	 kit	 (Thermo	 Fisher	 Scientific,	 VB4-3116013-VC).	 Probe	 specificity	
towards	 RNA	was	 confirmed	with	 RNAse	 T1	 (New	 England	 Biolabs,	 EN0542)	 and	
DNAse1	 (New	 England	 Biolabs,	 M03035)	 treatments	 (both	 at	 250U/mL,	 37°C,	 40	
minutes.	After	FISH,	samples	were	processed	for	standard	immunocytochemistry.		
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5.9.3	Bromouridine	Labeling	
MEFs	 were	 prepared	 on	 coverslips	 and	 fixed	 with	 4	 %	 paraformaldehyde	 as	
described	in	the	Immunocytochemistry	section.	Expect	for	this	experiment	cells	were	
cultured	on	coverslips	with	DMEM	medium,	containing	no	uridine	supplementation	
for	24	hours.	BrU	(Sigma-Aldrich,	850187)	was	prepared	fresh	for	each	experiment.	
Newly	synthesized	RNA	was	labeled	with	5	mM	BrU	for	1	hour	at	37°C.	A	short	chase	
to	 remove	background	was	performed	using	DMEM	medium	containing	 50	μg/ml	
uridine,	 followed	by	a	PBS	wash	prior	 to	 fixation.	Standard	 immunocytochemistry	
procedures	 were	 carried	 out	 to	 visualize	 the	mitochondrial	 network,	mtDNA,	 the	
mt-RNA	binding	protein	LRPPRC,	and	nascent	BrU-labeled	RNA.		
	
5.9.4	Confocal	Microscopy	
Fluorescence	images	were	acquired	using	a	laser-scanning	Leica	TCS	SP8-X	inverted	
confocal	microscope,	equipped	with	a	white	light	laser,	a	405-diode	UV	laser,	Leica	
HyD	photodetectors,	 and	a	 100x	oil	 immersion	objective	 (HCX	PL	APO	100x,	 1.46	
N.A).	Stack	images	were	acquired	in	sequential	mode	using	a	scanning	speed	of	400	
Hz,	an	image	size	of	1,024	x	1,024	pixels,	and	z-step	of	0.2-0.3	μm	or	0.15	μm	when	
300x	zoom	was	applied.			
	
5.9.5	Confocal	Microscopy	Image	Analysis	
The	amount	mtDNA	foci	per	cell	was	determined	using	stacked	images	acquired	by	
confocal	microscopy	and	analyzed	with	ImageJ.	Prior	to	analysis,	the	DAPI	channel	
was	used	to	manually	trace	nuclear	DNA	with	the	polygon	section	tool,	a	region	of	
interest	 (ROI)	 selected,	and	this	 same	area	omitted	 from	the	anti-DNA	channel	 to	
quantify	 only	mtDNA	 foci	 for	 each	 cell.	 The	 find	maxima	 tool	 was	 used	 to	 count	
mtDNA	 foci	 with	 noise	 tolerance	 manually	 determined	 between	 50-60.	 To	
determine	the	levels	of	mtDNA	relative	to	TOM20	surface	area,	binary	images	were	
generated	from	stacked	images.	An	ROI	encompassing	the	mitochondrial	network,	
as	 visualized	 by	 immunostaining	 for	 TOM20,	 was	 selected	 for	 each	 cell	 and	 the	
analyze	particles	tool	was	used	to	determine	the	total	surface	area.	The	same	ROI	
was	 then	 applied	 to	 the	 anti-DNA	 image	 with	 an	 omitted	 nuclear	 DNA	 area	 to	
determine	the	total	number	of	mtDNA	particles.	
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	 Analysis	 of	 Cox1	mRNA	 and	 BrU-labeled	 RNA	 in	 MEFs	 was	 performed	 in	
ImageJ.	For	quantification	of	Cox1	mRNA	and	BrU-labeled	RNA	amount	per	cell,	a	
ROI	 corresponding	 to	 the	 cell	 boundaries	 was	 drawn,	 and	 the	 DAPI	 channel	 was	
used	to	exclude	the	nuclear	region	prior	to	analysis.	Integrated	density	of	the	signal	
coming	 from	 the	 COX1	mRNA	 channel	 or	 the	 BrU	 channel	 was	 then	 quantified	
based	 on	 surface	 area	 per	 cell.	 For	 quantification	 of	 nucleoids	 positive	 for	 Cox1	
mRNA	 or	 BrU-labeled	 RNA,	 dual	 color	 pictures	 of	 DNA,	 Cox1	 mRNA,	 and	 BrU	
channels	 were	 generated	 in	 ImageJ.	 Nucleoids	 were	 then	 classified	 based	 on	 the	
presence	or	absence	of	Cox1	mRNA	foci	or	BrU	foci	in	their	proximity	and	quantified	
using	the	Cell	Counter	plug-in	from	ImageJ.		
	
5.9.6	Cytochemistry	for	STED	Microscopy		
Cells	 were	 grown	 on	 coverslips	 overnight,	 fixed	 with	 methanol	 at	 -20°C	 for	 5	
minutes,	 blocked	 with	 5	 %	 BSA	 in	 PBS	 for	 5	 minutes,	 incubated	 with	 20	 μg/ml	
RNAse	A	(Sigma	Aldrich,	R6513)	in	0.5	%	Tween	20	(Sigma	Aldrich,	P1379)	in	PBS	for	
2	 hours	 at	 37°C.	 Cells	 were	 incubated	 with	 Quant-iT	 PicoGreen	 dsDNA	 Reagent	
(Thermo	 Fisher	 Scientific,	 P11496)	 in	 PBS	 for	 30	minutes	 or	 incubated	 for	 1	 hour	
with	 anti-dsDNA	 antibodies	 (Abcam,	 ab27156).	 After	 several	 washing	 steps,	 the	
samples	were	mounted	 in	Mowiol.	Samples	were	 imaged	within	 three	hours	after	
the	sample	preparation.	
	
5.9.7	STED	Microscopy		
STED	 images	were	 acquired	with	 a	 two-color	Abberior	 STED	 775	QUAD	 scanning	
nanoscope	(Abberior	Instruments,	Goettingen	Germany)	using	a	485	nm	excitation	
laser	and	a	pulsed	595	nm	STED	 laser	 (PicoGreen	 labeling)	or	a	640	nm	excitation	
laser	 together	 with	 a	 775	 nm	 STED	 laser	 (Antibody	 labeling)	 and	 a	 100x	 oil	
immersion	objective	lens	and	N.A	of	1.4.		
	
5.9.8	STED	Microscopy	Image	Analysis	
Image	 analysis	was	 performed	manually	 using	 Imspector	 Software,	 by	measuring	
the	 diameter	 of	 nucleoids	 at	 full	 width	 at	 half	 maximum	 (Abberior	 Instruments,	
Goettingen	Germany).		
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5.9.9	Transmission	Electron	Microscopy		
Electron	micrographs	of	heart	mitochondria	were	obtained	from	small	pieces	of	the	
left	 myocardium.	 Tissues	 were	 fixed	 in	 a	 mix	 of	 2	 %	 glutaraldehyde	 and	 1	 %	
paraformaldehyde	 in	 0.1	M	 phosphate	 buffer	 pH	 7.4,	 at	 room	 temperature	 for	 30	
minutes,	 followed	by	24	hours	at	4°C.	Specimens	were	 rinsed	 in	0.1	M	phosphate	
buffer	 and	 post-fixed	 in	 2	 %	 osmium	 tetroxide	 for	 2	 hours,	 dehydrated	 and	
embedded	 in	 LX-112	 resin.	 Ultra-thin	 sections	 (approximately	 50–60	 nm)	 from	
longitudinal	parts	were	cut	and	sections	were	examined	 in	a	transmission	electron	
microscope	 (Tecnai	 12,	 FEI	 Company,	 Netherlands)	 at	 80	 kV.	 Digital	 images	 at	 a	
final	magnification	 of	 8,200x	were	 randomly	 taken	on	myofibrils	 from	 sections	 of	
the	 myocardium.	 The	 volume	 density	 of	 mitochondria	 was	 calculated	 on	 printed	
digital	 images	 by	 point	 counting	 using	 a	 2	 cm	 square	 lattice	 (Weibel,	 1979).	 To	
determine	the	number	of	images	needed	for	an	appropriate	sampling,	a	cumulative	
mean	plot	was	used	(Weibel,	1979).	15	randomly	taken	images	were	used	from	each	
animal.	
	
5.9.10	Image	Processing	
Image	panels	were	assembled	with	Photoshop	(Adobe);	no	digital	manipulation	was	
applied	except	for	adjustment	of	brightness	and	contrast.		
	
5.10	QUANTIFICATION	AND	STATISTICAL	ANALYSIS		
Data	 are	 presented	 as	mean	 ±	 SEM	 unless	 otherwise	 indicated	 in	 figure	 legends.	
Sample	 number	 (n)	 indicates	 the	 number	 of	 independent	 biological	 samples	
(individual	 mice,	 number	 of	 cells,	 or	 wells	 of	 cells)	 in	 each	 experiment.	 Sample	
numbers	and	experimental	repeats	are	indicated	in	the	figures.	Data	were	analyzed	
using	 the	 unpaired	 Student’s	 t-test,	 one-way	 ANOVA	 using	 Turkey’s	 multiple	
comparison	 test,	 two-way	 ANOVA	 using	 Bonferroni	 multiple	 comparison	 test	
between	 group	 comparison,	 as	 indicated	 in	 figure	 legends.	 A	 p-value	 ≤	 0.05	 was	
considered	statistically	significant.	
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6.0	ABBREVIATIONS		
Abbreviation	 Full	name	
13C6	 Carbon-13	
15N4	 Nitrogen-15	
ADP	 Adenosine	diphosphate	
AfP	 Affinity	purified		
AGC	 Automatic	gain	control		
ANOVA	 Analysis	of	variance		
Arg10	 13C6,	15N4-labeled	arginine	
ATAD3A	 ATPase	family	AAA	domain	containing	3A	protein	
ATP	 Adenosine	triphosphate	
ATP5A	 ATP	synthase	F1	subunit	alpha	
ATP6	 Mitochondrially	Encoded	ATP	Synthase	Membrane	Subunit	6	
ATP8	 Mitochondrially	Encoded	ATP	Synthase	Membrane	Subunit	8	
BN-PAGE	 Blue	native	polyacrylamide	gel	electrophoresis	
BrU	 Bromouridine	
BSA	 Bovine	serum	albumin	
Ckmm	 Muscle	creatinine	kinase	
CO	 Complex	
CO2	 Carbon	dioxide	
CoQ	 Coenzyme	Q	
Cox1	 Cytochrome	C	oxidase	I	
Cre	 Cre-recombinase	protein	
CTRL	 Control	
Cyt.c	 Cytochrome	c		
D-loop	 Displacement	loop	
DC	 Detergent	compatible	
DCPIP	 dichlorophenolindophenol	
DDM	 n-Dodecyl	β-D-maltoside		
Dguok	 deoxyguanosine	kinase	
DMEM	 Dulbecco's	modified	eagle	medium	
dMfn	 Double	mitofusin1-2	
DNA	 Deoxyribonucleic	acid	
DNM2	 Dynamin	2	
dNTP	 Deoxynucleotide	
DRP1	 Dynamin-related	protein	1	
DTNB	 5,5’-dithiobis-2-nitrobenzoic	acid	
DTT	 Dithiothreitol	
EDTA	 Ethylenediaminetetraacetic	acid	
EGTA	 Ethylene	glycol-bis(β-aminoethyl	ether)-N,N,N',N'-tetraacetic	acid	
ER	 Endoplasmic	reticulum		
et	al	 Latin	phrase	meaning	‘and	others’		
EtBr	 Ethidium	bromide	
ETC	 Electron	transport	chain		
FAD2H	 Flavin	adenine	dinucleotide	
FELASA	 Federation	of	European	Laboratory	Animal	Science	Associations	
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FISH	 Fluorescence	in	situ	hybridization	
Flp	 Flippase	
For	 Forward	
Frt	 Flippase	recognition	target	
Fzo1p	 FuZzy	Onions		1	protein	
GFP	 Green	fluorescence	protein	
GSH	 Oxidized	glutathione		
GSH/GSSH	 Glutathione	
GSSH	 Reduced	glutathione	
GTPase	 Guanosine	triphosphate	hydrolase	
H-strand	 Heavy-strand	
H2O2	 Hydrogen	peroxide	
HCD	 Higher-energy	collisional	dissociation		
HCl	 Hydrochloric	acid	
HClO4	 Perchloric	acid	
HEPES	 4-(2-hydroxyethyl)-1-piperazineethanesulfonic	acid	
HR2	 Heptad	repeat	2	
HSP	 H-strand	promoter	
HSP60	 Heat	shock	protein	60	
IMM	 Inner	mitochondrial	membrane	
IMS	 Intermembrane	space		
IMS	 Intermembrane	space	
KCl	 Potassium	chloride	
KCN	 Potassium	cyanide	
KH2PO4	 Monopotassium	phosphate	
KO	 Knockout	
KOH	 Potassium	hydroxide	
L-isoform	 Large	isoform	
L-strand	 Light-strand	
LC-MS/MS	 Liquid	chromatography-tandem	mass	spectrometry	
LETM1	 Leucine	zipper	and	EF-hand	containing	transmembrane	protein	1	
loxP	 Locus	of	crossover	x	in	P1	
LRPPRC	 Leucine	rich	pentatricopeptide	repeat	containing	protein	
LSP	 L-strand	promoter	
Lys8	 13C6,	15N2-labeled	lysine	
MEF	 Mouse	embryonic	fibroblast	
MFF	 Mitochondrial	fission	factor	
MFN	 Mitofusin	
MgCl2	 Magnesium	chloride	
MGME1	 Mitochondrial	genome	maintenance	exonuclease	1	
MIB	 Mitochondria	isolation	buffer	
MIC60	 MICOS	complex	subunit	60	
MiD49	 Mitochondrial	dynamics	proteins	49	
MiD51	 Mitochondrial	dynamics	proteins	51	
MLB	 Mitochondrial	lysis	buffer	
MOPS	 3-(N-morpholino)propanesulfonic	acid	
mRNA	 Messenger	ribonucleic	acid	
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mRNA		 Messenger	RNA	
MS	 Mass	spectrometry	
MSH	 Mannitol,	sucrose,	HEPES	
mt-	 Mitochondrial	
Mt-transcription	 Mitochondrial	transcription	
mtDNA	 Mitochondrial	DNA	
MTERF1	 Mitochondrial	transcription	termination	factor	1	
MTERF3	 Mitochondrial	transcription	termination	factor	3	
mtSSB		 Mitochondrial	single-stranded	DNA	binding	protein	
NADH	 Nicotinamide	adenine	dinucleotide	
NaOH	 Sodium	hydroxide	
NCR	 Non-coding	region	
ND4L	 NADH:Ubiquinone	Oxidoreductase	Core	Subunit	4L	
NP-40	 Nonyl	phenoxypolyethoxylethanol	-40	
OH	 H-strand	
OL	 L-strand	
OMM	 Outer	mitochondrial	membrane	
OPA1	 Optic	atrophy	protein	1	
OXPHOS		 Oxidative	phosphorylation	system	
pAMI	 Vector	containing	the	entire	mouse	mtDNA	genome	cloned	
PBS	 Phosphate	buffered	saline	
PCR	 Polymerase	chain	reaction	
PEO	 Progressive	external	opthalmoplegia	
pH	 Potential	hydrogen	
POLRMT	 RNA	polymerase	mitochondrial	
Polβ	 DNA	Polymerase	Beta	
Polγ	 Mitochondrial	DNA	polymerase	γ	
PolγA	 Mitochondrial	DNA	polymerase	γ	subunit	A	
PolγB	 Mitochondrial	DNA	polymerase	γ	subunit	B	
Polζ	 DNA	Polymerase	Zeta	
Polθ	 DNA	Polymerase	Theta	
PrimPol	 Primase	And	DNA	Directed	Polymerase	
PVDF	 polyvinylidene	difluoride		
qPCR	 Quantitative	polymerase	chain	reaction	
R-loops	 RNA:DNA	hybrids	
Rev	 Reverse	
RNA	 Ribonucleic	acid	
RNASEH1	 Ribonuclease	H1	
ROI	 Region	of	interest		
ROS	 Reactive	oxygen	species		
RPKM	 Reads	per	kilobase	of	transcript,	per	million	mapped	reads	
rRNA	 Ribosomal	ribonucleic	acid	
S-isoform	 Small	isoform	
SDS	 Sodium	dodecyl	sulfate	
SDS-PAGE	 Sodium	dodecyl	sulfate	polyacrylamide	gel	electrophoresis	
SILAC	 Stable	isotope	labeling	by	amino	acids		
SLIRP	 SRA	Stem-Loop	Interacting	RNA	Binding	Protein	
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SSBP1	 The	single-stranded	DNA	binding	protein	1	
SSC	 Saline-sodium	citrate	
STED	 Stimulated	emission	depletion	
TBS	 Tris	Buffered	Saline	
TCA	 Tricarboxylic	acid	
TE	 Tris,	EDTA	
TEFM	 Transcription	elongation	factor	
TFAM	 Mitochondrial	transcription	factor	activator	A	
TFB2M	 Mitochondrial	transcription	factor	B2	
Tg	 Transgenic	
Tk2	 Thymidine	kinase	
TMPD	 Tetramethylphenylendiamin	
TNES	 Tris,	NaCl,	EDTA,	SDS	
TOM20	 Translocase	of	outer	mitochondrial	membrane	20	
TOP3α	 Mitochondrial	topoisomerase3α	
Topo	 Topoisomerase	
tRNA	 Transfer	ribonucleic	acid	
TWNK	 Twinkle	
UPLC-MS/MS	 Ultra-performance	liquid	chromatography-tandem	mass	
spectrometry	
UV	 Ultraviolet		
VDAC	 Voltage-dependent	anion	channel	
WBSCR16	 Williams-Beuren	syndrome	critical	region	16	protein		
YFP	 Yellow	fluorescent	protein		
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Units	
%	 Percentage	
°C	 Degree	Celsius	
bp	 Base	pair	
cm	 Centimeter	
g	 Gram	
xg	 Normal	gravity	acceleration	(9,81	m	x	s-1)	
Hz	 Hertz	
J	 Joule	
m/z	 Mass	to	charge	ratio	
mg	 Micrometer	
ml	 Millimeter	
mM	 Millimolar	
N.A	 Numerical	aperture	
nM	 Nanomolar	
nm	 Nanometer	
pmol	 Picomolar	
rpm	 Revolution	per	minute		
U	 Unit	
μg	 Microgram	
μl	 Microliter	
μm	 Micromolar	
V	 Volt	
W	 Watt	
ε	 Extinction	coefficient	
	
Amino	acid	letter	codes	
1-letter		 Amino	Acid	 3-letter		
	
1-letter		 Amino	Acid	 3-letter		
A	 Alanine	 Ala	 	 M	 Methionine	 Met	
C	 Cysteine	 Cys	 	 N	 Asparagine	 Asn	
D	 Aspartic	Acid	 Asp	 	 P	 Proline	 Pro	
E	 Glutamic	Acid	 Glu	 	 Q	 Glutamine	 Gln	
F	 Phenylalanine	 Phe	 	 R	 Arginine	 Arg	
G	 Glycine	 Gly	 	 S	 Serine	 Ser	
H	 Histidine	 His	 	 T	 Threonine	 Thr	
I	 Isoleucine	 Ile	 	 V	 Valine	 Val	
K	 Lysine	 Lys	 	 W	 Tryptophan	 Trp	
L	 Leucine	 Leu	 	 Y	 Tyrosine	 Tyr	
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